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Introduction: Bullous lesions are common skin lesions particularly 
in childhood. Drug reactions, burns, insect bites, mosquito bites, skin 
diseases, autoimmune bullous dermatoses and bacterial infections are 
the most common etiologies. Herein, we report two children who have 
solitary mastocytoma presented with variable bullous lesions.
Case 1: A 3-year old boy admitted to our outpatient department suf-
fering from red, periodically vesicular and bullous lesions on his back 
of neck since birth. His medical history revealed that he had four 
attacks characterized by flushing, perioral paleness, and hypotension. 
The lesion became swollen and itchy when it was rubbed vigorously 
(positive Darier’s sign). Physical examination revealed a bullous lesion 
(2 × 3 cm) in his dorsal neck region. Laboratory investigations includ-
ing CBC, liver and kidney function tests and serum electrolytes were 
within normal limits. Histopathologic examination of a punch biopsy 
specimen revealed solitary mastocytoma and the patient is under reg-
ular antihistamine treatment.
Case 2: A 3-month old boy admitted with complaints of oval, erythe-
matous and periodically changing bullous lesions in his proximal of 
right ankle since birth. His medical history revealed that the lesion 
became bullous and itchy when his mother rubbed it vigorously. Phys-
ical examination revealed a bullous lesion (1 × 1 cm) in his left foot. 
Laboratory investigations for possible etiologic factors were within 
normal limits. Histopathologic examination of a punch biopsy speci-
men revealed solitary mastocytoma. The patient is uneventfully under 
regular follow up.
Conclusion: Solitary mastocytomas should be considered in the dif-
ferential diagnosis of periodically varying bullous reactions in children.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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The published version of this abstract can be found at [1].
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Background: Cold urticaria (CU) is a subtype of inducible urti-
caria, which can be responsible for severe reactions namely dur-
ing aquatic activities and winter season. The prevalence and 
clinical course in pediatric age is barely known. The authors 
describe the clinical features and the evolution of CU in pediatric 
patients.
Methods: Retrospective characterization of 15 pediatric patients with 
CU followed at our Immunoallergy Department, including clinical 
presentation, ice cube challenge test (ICCT) result, laboratory testing, 
allergen sensitization and outcome.
Results: The mean age of onset was 8.9 ± 4.2 years old, 73 % were 
female. Most patients had other allergic diseases (87 %), 40 % were 
atopic, two had also cholinergic urticaria and one case had fam-
ily history of CU. Five patients (33  %) had systemic reactions with 
hemodynamic collapse after cold exposure. Symptoms occurred 
few minutes after skin exposure to cold (median of 7  min; rang-
ing from immediate reactions to 20  min later); 73  % had several 
episodes (>5). Found one case secondary to cryoglobulinemia and 
the remaining cases were considered idiopathic. Aquatic activi-
ties (swimming, sea bathing) and cold air exposure were the main 
triggers. Some children developed reactions when touching cold 
objects (3), with cold beverages (1) and intraoperative (1). Positive 
ICCT with ≤3 min of stimulation in 5 patients (3 of 5 who had type III 
reactions), 5 min in 1, 10 min in 5 and 20 min in 3 of them. Patients 
were successfully controlled with prophylactic antihistamines and 
avoidance measures; adrenaline was prescribed when indicated. 
Five patients (33  %) overcame the symptoms in less than 5  years 
(mean: 3.6  years). Those who remain susceptible have so far a fol-
low-up period of 1–13 years.
Conclusions: In pediatric age, CU seems to be a persistent disor-
der. ICCT is a convenient tool to confirm the diagnosis, to assess 
the risk for severe reactions and follow-up. Severe reactions can 
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Angioedema with C1 inhibitor deficiency in a girl: a challenge 
diagnosis
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Introduction: Angioedema is defined as localised and self-limiting 
nonpitting recurrent edema of the skin and mucous membranes 
caused by the release of several vasoactive mediators.
Seven forms of angioedema were identified based on specific charac-
teristics and are classified as non-hereditary and hereditary forms.
Only Hereditary Angioedema with C1 inhibitor (C1-INH) deficiency 
had approved treatment.
The authors present a case of angioedema with C1 deficiency without 
family history of angioedema.
Clinical case: Five years old girl attended in emergency unit with 
angioedema of the face (Fig. 1) after left periorbital trauma. There was 
improvement of the clinical picture after administration of epineph-
rine, corticosteroids and antihistamine. She had a history of two pre-
vious similar episodes both triggered by trauma. Edema disappears 
completely after 5 days. Family history of angioedema is unknown.
The study carried out in outpatient pediatric allergy revealed: C4 very 
low (<5 mg/dl) and low esterase C1-INH (30 mg/L) with decreased func-
tion (10 %). She waits for genetic study of C1-INH gene (SERPING1).
Currently the child is medicated with an antihistamine without new 
episodes of angioedema.
Conclusion: Angioedema without urticaria in children is an infrequent 
condition and requires an exhaustive diagnostic investigation. Dosing 
C4 and C1-INH esterase becomes fundamental when no etiologic fac-
tor is identified. Deficit of C1-INH esterase with a decrease in C4 points 
to an acquired or a hereditary form of angioedema. Hereditary angi-
oedema with C1-INH deficiency is a rare disease with an estimated 
prevalence of 1/10,000–1/100,000 inhabitants and is due to a muta-
tion in one of the two alleles of the C1-INH gene (SERPING1). In the 
absence of family history, the genetic study becomes important to 
define possible prophylaxis.
Consent to publish
Written informed consent for publication of this clinical details and/
or clinical images was obtained from the patient/parent/guardian/
relative of the patient. A copy of the consent form is available for 
review by the Editor of this journal.
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Introduction: An immediate contact urticaria to food rich in palm 
date oil was developed by Julia at 2 years old. At 6 years old, she devel-
oped rhinoconjunctivitis and a severe onset of asthma on the 15th 
April 2014.
Method and results: SPT for panallergens profilin and polcalcin were 
positive which led to conduct to multiple false positive result for usual 
pollens’ SPT extracts [1].
Pollen calendar issued from the Swiss centre for meteorology gave this 
year for betulaceae like birch, a highest pollen count of 798 grains/m3 
on the 2.04.2014. No pollen count was really pertinent on the 15 April 
2014, date of the asthma crisis. Three days before, the highest pol-
len count of plane tree (400 grains/m3) and oak (360 grains/m3) were 
recorded. The ash highest pollen count was 62 grains/m3 on the 1st of 
April; the cupressaceae highest pollen count was 182 grains/m3 on the 
17th of March.
Conclusion: According to SPT and biology, profilin is probably the 
primer to explain contact food urticaria to palm oil pastries, Phod2 [2] 
being the major allergen contained in palm oil in accordance to SPT 
profilin.
According to molecular biology [1,3], the pathogenesis of accumu-
lated panallergens [4] due to multiple pollen expositions before the 
15th April might explain the severe pollinosis [5].
To my knowledge, this is the first case report of profilin contact derma-
titis in childhood. Recently, panallergens have been related to severe 
clinical pollinosis [6] and the role of enzyme activity of particular aller-
genic pollens has been described [7,8]. These mechanisms are prob-
ably involved predominantly in the delayed phase reaction of allergic 
asthma [9,10].
This observation should lead clinicians to improve their diagnosis 
and understanding of different panallergen and/or enzyme activ-
ity implications in allergy disease’ clinical onset and severity [11], 
particularly in multiple pollens exposed area and multi-ethnic areas 
[11,12].
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Introduction: Poorly controlled asthma involves higher costs related 
to emergency department visits, hospitalizations and scholar absen-
teeism. A survey of pediatric patients visiting their primary care pro-
viders revealed a 46  % prevalence of uncontrolled asthma (Liu AH 
et al. 2010).
Case report: We report a case of a 6-year-old male patient with 
uncontrolled asthma, receiving treatment with fluticasone and 
montelukast, who referred to our hospital for chronic cough and 
repeated asthma exacerbations. The patient was diagnosed with 
asthma at 4  years and with gastro-esophageal reflux at 5  years. 
He was also diagnosed with hypogammaglobulinemia and immu-
noglobulin A deficiency. The child’s mother is smoker. The parents 
were advised about the therapy and the measures they should 
take in order to improve their child’s outcome. Giving the repeated 
asthma exacerbations despite the indication of correct treatment, 
differential diagnosis and comorbidities were taken into account. 
The spirometry revealed obstructive syndrome reversible after 
200 μg salbutamol administration. Thoracic CT scan showed bron-
chiectasis located in the middle lobe and lingula. Bronchoscopy 
revealed severe inflammation of traheobronhic mucosa and bron-
chial dyskinesia. FENO was 1  ppb and the sweat test was normal. 
Chest X-ray revealed increased interstitial markings and the X-ray 
for the sinuses was normal. Allergy testing and diamine oxidase 
activity were normal. All the tests revealed lack of control both for 
the asthma and for the gastro-esophageal reflux, despite the treat-
ment, leading to important complications such as bronchiectasis. 
Repeated history revealed that the child did not receive the treat-
ment correctly, daily, ant the mother continued to smoke close to 
the child.
Acknowledgements: This paper was co-financed from the European 
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Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Aim: To report clinical features, food allergens, reaction threshold 
doses and age of tolerance within a pediatric population with food 
protein-induced enterocolitis syndrome (FPIES).
Methods: Retrospective study of children with suspected FPIES who 
have undergone an oral food challenge (OFC) for tolerance evaluation 
from June 2008 to December 2013. Variables registered: age at OFC, 
gender, family and personal atopic history, symptoms, food involved, 
skin prick test (SPT), total and specific IgE and OFC outcomes.
Results: 82 patients with FPIES were included, 52.4  % boys, 42.7  % 
with atopic family history and 18.3  % had atopic dermatitis. Vomit-
ing, lethargy, pallor and diarrhea were reported in 95.1, 67.1, 48.8 
and 41.5  %, respectively, with an average time of reaction of 2  h 
post-ingestion (1.5–6). Food allergens implicated: fish (53.7  %), cow’s 
milk (25.6  %), egg (11  %), rice and corn (9.8  %). Mean age at OFC: 
38.7 months (6–106 months) and 58.5 % (n 48) resulted tolerant.
The mean age at which tolerance was achieved differed according 
to the trigger food with statistical significance: 51.2  months for fish, 
29.9 months for cow’s milk, 45.1 months for egg and 33.4 months for 
cereals. Of the 20 children (n 44) who tolerated one fish at OFC, 16 also 
tested negative with other fish families.
The reaction threshold doses were: 1.6  g for cow’s milk, about 2  g for 
egg and 0.5 g of protein for rice. Regarding fish, the reaction threshold 
dose was different depending on the fish family involved: half of the 
positive OFC had tested hake (n 13) and 69 % (n 9) reacted with 3.6 g 
of protein.
Conclusion: This study shows high prevalence of FPIES for fish in our 
environment. Fish tolerance resolves later than other foods and the 
outcome can usually be applied to other fish families. We detect low 
reaction threshold doses especially for cereals and fish.
OP02 
Characteristics of infants with food protein‑induced enterocolitis 
syndrome and allergic proctocolitis
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Sackesen
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Background: Food protein-induced enterocolitis syndrome (FPIES) 
and allergic proctocolitis (AP) are rare non-IgE-mediated food allergies 
in early childhood. We aimed to determine the clinical and laboratory 
features of FPIES and AP in infants.
Page 4 of 60Clin Transl Allergy 2016, 6(Suppl 1):42
Method: FPIES was diagnosed in the presence of gastrointestinal 
symptoms within 24 h after the ingestion of incriminated foods, with-
out any other cause for the symptoms; or a positive open food chal-
lenge result with causative food or removal of causative food from the 
diet resulting in the resolution of symptoms in infants. AP was diag-
nosed in the presence of bloody stool after ingesting incriminated 
food and disappearance of blood with elimination of incriminated 
food or with positive challenge test.
Results: We analyzed 52 patients (23 FPIES and 29 AP) between 2010 
and 2014. The age at admission was significantly lower in patients with 
AP than FPIES [4.2 (3.1–7.2) vs. 8.9 (4.4–12.7) month, p =  0.008] and 
age of initial symptoms was slightly lower in AP than FPIES [2 (1–3 vs. 
4.5 (1–6) month, p > 0.05]. Cow’s milk was determined as the most fre-
quent trigger with 90.4 %. The other incriminated foods are hen’s egg 
(n = 7), rice (n = 2), fish (n = 2), potato (n = 1), lentil (n = 1), wheat 
(n =  1), soy (n =  1) and banana (n =  1). Three patients had positive 
skin prick test with the suspected food, 7 (13.5  %) had concomitant 
IgE-mediated food allergy (egg, milk walnut), and 15 (28.8  %) had 
atopic dermatitis. Oral food challenge test was performed in 40 
patients and 13 of those (32.5 %) resulted positive. The age of recovery 
of diseases was similar in FPIES and AP [12 (10.5–15.3) and 13 (12–20.3) 
months, respectively].
Conclusion: Our results denoted that cow’s milk is the most common 
trigger of FPIES and AP. Although the age of onset for initial symptoms 
seems to be earlier in AP compared with FPIES, resolution age was 
similar.
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Background: This RCT aimed to compare clinical and immunological 
outcomes after 6 months consumption of baked egg (BE) with an egg 
free diet in 1–5 year old BE tolerant, but raw egg allergic children.
Methods: Children were recruited at the Women’s and Children’s 
Hospital, Adelaide, Australia Allergy Clinic and randomised into two 
groups according to a protocol approved by the Institutional Human 
Research Ethics Committee, (REC2400/9/14; ACTRN 12612000173897). 
The intervention group consumed 10 g BE per serve of the provided 
muffins, biscuits or cake, two to three times per week for 6  months. 
The control group consumed identical egg free products. Both groups 
maintained egg free diets during the trial. The final assessment was a 
medically supervised raw egg oral food challenge (OFC) at 7 months. 
Immune markers, including skin prick testing (SPT), egg specific IgE 
and IgG4, Th1/Th2 cytokines and T cell phenotype were assessed at 
baseline and 7 months.
Results: 43 children were randomised into the study (intervention 
group n =  21; control group n =  22). The final analysis included 35 
children (intervention group n = 17; control group n = 18) who had 
raw egg OFCs. Ten children (4/17 intervention group and 6/18 con-
trol group) tolerated raw egg at the end of the intervention. Toler-
ance was independent of age and amount of BE consumed. Both 
groups demonstrated decreased SPT weal sizes and whole egg, egg 
white, ovalbumin specific serum IgE titre and increased whole egg 
IgG4. No difference between the groups was observed in the percent-
age of naive (CD4+ CD45RA+), central (CCR7−CD45RA−) or effector 
(CCR7+CD45RA−) memory T-cells or cytokine excretion after culture of 
cells with egg allergens.
Conclusion: The results suggest that BE tolerant 1–5 year old egg aller-
gic children are evolving tolerance to raw egg which is not hastened 
by short term, regular inclusion of BE. Further trials of larger sample 
size, including children of different age groups are required.
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Background: There is considerable interest in oral immunotherapy 
(OIT) to treat food allergy. Because the major drawback of OIT is severe 
side effects, we designed a low allergenic hydrolysed egg (HE) product 
and tested its efficacy for desensitisation.
Method: In a double-blind placebo control multicentre pilot study 
(Athens, Davos, Padua), 29 patients (aged 1–5.5 years), diagnosed with 
IgE-mediated egg allergy were included. A tolerance assessment was 
performed at day 1 and afterwards 9 ±  1  g HE (n =  15) or placebo 
(n =  14) was administered daily for 6  months. Primary outcome was 
the result for OFC to boiled egg performed at the end of the study. 
Basophil activation and specific IgE and IgG4 were assessed at the 
start and end of the study.
Results: All egg allergic patients randomized to HE (n = 15) tolerated 
the full dose at day 1. No significant difference was observed on the 
primary outcome (36 % and 21 % had a negative OFC in the treatment 
and placebo group, respectively). While no significant difference was 
observed regarding egg specific IgE levels, IgG4 to egg white, egg yolk 
and ovalbumin increased significantly more over time in the treatment 
than in the placebo group (p = 0.07, p = 0.01 and p = 0.04, respec-
tively). A higher increase over time in the treatment group compared 
to the placebo group was also observed for specific IgG4/specific IgE. 
In the basophil activation test, a significant decrease in both CD203c+ 
(p = 0.04) and CD63+ (p = 0.07) was observed after stimulation with 
0.01  µg/ml ovalbumin in the treatment group, as compared to an 
increase over time in the placebo group.
Conclusion: HE given for 6  months did not change significantly 
the proportion of patients becoming tolerant to egg. However, HE 
induced a modulation of the immune response towards better toler-
ance. A larger study considering a longer treatment period and/or a 
higher dose could improve the clinical outcome.
Conflicts of interest AM, SN, TB and YMV are employees of Nestec Ltd. 
The study was sponsored by Nestec Ltd.
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Background: Peanuts are responsible for the induction of the majority 
of food related anaphylactic reactions. A curative treatment is not yet 
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available for peanut-allergic patients. A chemically modified peanut 
extract is being investigated for its potential use in immunotherapy.
Methods: Peanut extract (PE) was reduced and subsequent alkylated 
resulting in modified PE (MPE) followed by adsorption to aluminium 
hydroxide (AlOH3). IgE-binding assays using a set of sera from peanut-
allergic patients and mediator release assays (MRA) using human 
basophils were performed. The immunogenicity of PE and MPE was 
evaluated by the induction of PE-specific IgG after i.p. injections of PE 
and MPE in mice. In addition, mice were sensitized intra-gastrically 
for PE and either (1) s.c. challenged with (M) PE ±  Al(OH)3 to assess 
safety, or (2) de-sensitized by s.c. injections of PE or MPE ±  Al(OH)3 
for 3–6 weeks, followed by oral and i.p. challenges to assess efficacy. 
Body temperature was measured after challenge as an objective 
parameter for an anaphylactic shock response. During the course of 
immunotherapy, blood samples were taken for analysis of antibody 
responses.
Results: The IgE-binding of MPE was decreased (mean remaining 
potency: 7.2 ±  5  %) when tested in all patient sera. The potency 
of MPE in MRA was also reduced for all patients (mean reduction: 
10- to 100-fold, range 3- to >10,000-fold). PE and MPE were equally 
potent in inducing PE-specific IgG antibodies in mice. Mice sensi-
tized for PE experienced severe anaphylactic symptoms upon s.c. 
challenge with PE. These effects were aborted after modification of 
PE or after complete binding of PE to Al(OH)3. Immunotherapy with 
both PE and MPE (±alum) resulted in a dose-dependent reduction 
of the anaphylactic response upon systemic challenge. In addition, 
both PE and MPE (±alum) were able to induce strong increases in 
the levels of PE-specific IgG1 and IgG2a compared to non-desensi-
tized mice.
Conclusions: Various in vitro and in vivo model systems have shown 
that MPE adsorbed to Al(OH)3 has a significantly improved safety pro-
file compared to PE while retaining its efficacy profile.
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Administration of the yellow fever vaccine in egg allergic children
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Objectives: Yellow Fever Vaccine (YFV) was developed in the 1930s 
for the prevention of YF. In the UK it is administered to those trav-
elling to countries where there is a risk of contracting the disease. 
Adverse reactions are possible following administration of YFV: 
mild localised erythema, malaise or more severe, but rare, neuro-
tropic or viscerotropic disease. YFV is propagated on hen’s egg and 
as such poses a risk of allergic reaction to those children with an 
egg allergy.
Children in the UK with an egg allergy were unable to receive the YFV 
until GSTT Children’s Allergy Service was awarded a licence to be an 
YFV centre in 2013. There are few studies looking at the administration 
of YFV in patients with an egg allergy, suggesting this can be admin-
istered in divided doses and protective immunity achieved following 
intradermal administration 1/5 of the dose.
Methods: A prospective evaluation of patients receiving the YFV 
between 2013 and 2015 was performed. The administration protocol 
includes: counselling regarding geographical area to which travel is 
planned, risks and benefits of receiving the YFV, SPT, and YFV admin-
istered as a subcutaneous injection in divided doses—1/10 dose and 
30  min later 9/10 dose. The patient is observed for one hour post 
administration.
Results: Fifteen patients attended the service for administration of 
the YFV with an age range of 10 months–20 years. Two (13 %) children 
had positive SPT and did not receive the vaccine. Two (13 %) children 
had previously had anaphylaxis to egg, both tolerated the YFV. Three 
(20  %) children tolerated baked egg in their diet—they all tolerated 
administration of the vaccine, which was administered in divided 
doses.
Conclusions: YFV can be safely administered to children who are 
allergic to egg. We should explore the possibility of administering 
1/5 of the dose intradermally to those children who are positive on 
SPT.
ORAL ABSTRACT SESSION 2: Asthma (OP07–OP12)
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Previous exacerbation is the most important risk factor for future 
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Background: Acute asthma exacerbation is one of the most frequent 
emergencies in childhood. We aimed to investigate the risk factors 
associated with exacerbations in school-age children with asthma.
Method: Children who attended to a tertiary outpatient pediatric 
allergy and asthma department and diagnosed with asthma were 
enrolled in the study. A questionnaire including demographic fea-
tures and parameters to determine socioeconomic status along with 
previous disease history were applied in the admission visit. Recent 
GINA guidelines were used to determine the asthma control status 
of patients and for the diagnosis of asthma exacerbation. Labora-
tory investigations including complete blood counts with differential, 
total IgE levels, skin prick tests and pulmonary function tests were also 
performed.
Results: A total of 431 children (288 male (66.8 %); with a median age 
[interquartile range] of 8.1 [6.3–11.2] years were included. Asthma was 
controlled in 154 children (35.7  %), whereas partially controlled and 
uncontrolled in 53 (12.3 %) and 143 (33.2 %) patients, respectively. 81 
patients (18.8 %) presented with an asthma exacerbation. Multivariate 
logistic regression analysis revealed that history of asthma exacerba-
tion in the last year (Odds Ratio [Confidence Interval]) (16.51 [6.97–
39.11]; p < 0.001), lack of previous asthma diagnosis (3.02 [1.53–5.96]; 
p =  0.001), history of ER admission in the last year (2.34 [1.18–4.66]; 
p  =  0.015) and lack of regular controller therapy (2.80 [1.03–7.61]; 
p = 0.044) were related with asthma exacerbation whereas presence 
of rhinitis emerged as a “protective” factor (0.43 [0.24–0.79]; p = 0.006) 
in school-age children with asthma.
Conclusion: Awareness of risk factors related with asthma exacerba-
tion may alert physicians who deal with school-age children with 
asthma and may help prompt and rational interventions in order to 
prevent asthma exacerbations.
OP08 
Comparative study of degree of severity and laboratory changes 
between asthmatic children using different acupuncture 
modalities
Nagwa Hassan1, Hala Shaaban2, Hazem El‑Hariri1,  
Ahmed Kamel Inas E. Mahfouz1
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University, Cairo, Egypt  
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Background: Asthma is a chronic airway inflammation characterized 
by being a heterogenous disease. Acupuncture is one of traditional 
Chinese medicine (TCM) modalities and it is considered the back-
bone of complementary and alternative medicine Laser acupuncture 
specially low-level laser therapy (LLLT) is a noninvasive form of photo-
therapy which being acceptable for treating children instead of needle 
acupuncture.
Methodology: Our study formed on sixty asthmatic children under 
ordinary medical treatment for bronchial asthma and they were 
divided randomly into 3 groups. Group A: Twenty children were given 
laser Acupuncture session three times per week for 1 month group B: 
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twenty patients given needle acupuncture sessions by a rate same as 
laser group and group C (control group) under their asthmatic medica-
tions only. Assessing of the clinical condition of the patient (frequency 
of attack and severity of asthma) and laboratory (IgE level and Eosino-
phil count) before and after the study.
Results: Frequency of asthmatic attack diminished in group A 
(p  <  0.001) more than in group B (p =  0.002) and least in group C 
(p =  0.147) at the end of the study, Clinical severity of group A sig-
nificantly improved (p  <  0.001) than group B and C, IgE level were 
significantly improved in both groups A and B (p < 0.001) better than 
changes occurred in group C (p = 0.057). Eosinophilic count showed 
more significantly improvement in group A (p < 0.001) than group B 
(p = 0.206) and group C (p = 0.784).
Conclusions: Application of laser acupuncture sessions beside medi-
cal treatment results in more significantly improvement of the asthma 
frequency of attack, the degree of asthma severity, IgE level and eosin-
ophilic count in asthmatic children than the use of needle acupunc-
ture or medications used only.
OP09 
The concentration of exhaled carbon monoxide in asthmatic 
children with different controlled stadium
Papp Gabor, Biro Gabor, Kovacs Csaba
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Introduction: The exhaled carbon monoxide is an important bio-
marker of the oxidative stress and the airways inflammation. Most 
scientific publications account of increase values in asthma. How-
ever our known literature does not have data on the relationship 
between different stadiums of asthma control and the exhaled 
carbon monoxide values. The aim of this study was to access this 
correlation.
Method: Our patients are well controlled, partly and uncontrolled 
asthma bronchial children, who are treated in outpatient clinic. Each 
of them has treatment according to GINA protocol. Before spirometry, 
patients were made deep inhalation, then they were made slow exha-
lation to the carbon monoxide measure equipment. (PiCO + Smoker-
lyzer) The exhaled carbon monoxide values were only known by the 
assistant, so that these values wouldn’t influence when putting in a cat-
egory. We made the statistic by InStat softver. We used non-parametric 
procedures.
Results: We found significant differences between the groups of well 
controlled and group of partly or uncontrolled in concentration of 
exhaled carbon monoxide, but significant difference was not demon-
strable between the group of partly controlled and group of uncon-
trolled (Table 1).
Conclusion: According to our investigation/examinations the 
exhaled carbon monoxide is significantly higher in partly or uncon-
trolled stadium of asthma bronchial than in well controlled stadium 
of asthma. This higher amount of exhaled carbon monoxide values 
show the raising of airways inflammation and the finish of well con-
trolled stadium. The exhaled carbon monoxide suggests the inflam-
mation aspect of asthma bronchial. Detailed analysis of our results 
shows that the eCO can be used to estimate the compliance of 
patients (Table 2).
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Effect of vitamin D3 supplementation during pregnancy on risk 
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Importance: Observational studies have suggested that increased 
dietary Vitamin D intake during pregnancy may protect the offspring 
against preschool wheezing, which is the most common disorder in 
young children.
Objective: To determine whether supplementation of Vitamin D3 dur-
ing third trimester of pregnancy reduces the risk of persistent wheeze 
in the offspring.
Design, setting and participants: The study was a double-blinded, 
single-center, randomized controlled trial conducted within the 
Copenhagen Prospective Study on Asthma in Childhood (COPSAC2010) 
unselected mother–child cohort. A total of 627 women were recruited 
for the Vitamin D trial at 24 weeks of pregnancy, between March 4th 
2009 and November 17th 2010. Clinical follow-up of the children 
(n = 581) was completed when the youngest child turned 3 years and 
unblinded on March 28th 2014.
Intervention: Vitamin D3 (2400 IU/day) supplementation or matching 
placebo tablets from pregnancy week 24 to 1 week postpartum.
Main outcome measure: Persistent wheeze at age 0–5  years diag-
nosed solely by the intervention-blinded study pediatricians strictly 
adherent to a predefined algorithm based on 11 scheduled and addi-
tional acute clinic visits and a day-to-day symptom diary filled by the 
parents from birth. Secondary outcomes were number of wheezy epi-
sodes, asthma, neonatal airway immunology, respiratory infections, 
allergic sensitization and eczema.
Results: Occurrence of persistent wheeze did not differ between the 
Vitamin D3 supplement and control group (incidence, 18 % vs. 21 %; 
hazard ratio, 0.79; 95 % CI, 0.54–1.14, P = 0.21). The number of wheezy 
episodes was reduced by the Vitamin D3 intervention (mean 5.9 vs. 7.2 
episodes; incidence risk ratio, 0.83; 95  % CI, 0.71–0.97, P =  0.02) and 
the airway immune profile at age one month was up-regulated (prin-
ciple component analysis, P = 0.04). There was no effect on additional 
end-points.
Conclusion: The use of Vitamin D3 supplementation during pregnancy 
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Age 11.13 11.23 10.97 p > 0.05
FVC% 94.53 94.06 94.74 p > 0.05
FEV1% 95.29 92.24 91.57 p > 0.05
FEV1/FVC 88.24 85.68 85.41 P < 0.05 
(p = 0.0186)
FEF25–75 % 94.82 85.95 86.65 P < 0.05 
(p = 0.0163)
eCO/ppm/ 3.21 4.88 5.55 P < 0.05 
(p < 0.0001)
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Lung function development in childhood
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Background: We have previously shown that children who develop 
asthma in childhood have reduced lung function already at birth. The 
objective of this study was to examine if the inborn lung function defi-
cit in asthmatic children is sustained until adolescence, even if symp-
toms cease.
Methods: This study included 366 children of the Copenhagen Pro-
spective Studies on Asthma in Childhood (COPSAC2000) high-risk birth 
cohort. Lung function was measured repetitively from 0 to 13  years 
by spirometry (FEVx) and plethysmography (sRaw). Asthma was diag-
nosed solely by the COPSAC pediatricians according to a strict prede-
fined algorithm based on symptom load and response to treatment. 
Age at onset and remission was monitored by daily diary cards.
Association analysis was performed using generalized estimating 
equation models.
Results: Children developing asthma during childhood compared to 
children never experiencing asthma symptoms had reduced forced 
expiratory flow: FEVx (z-score): −0.31 [−0.47; −0.16], p < 0.0001, and 
increased airway resistance: sRaw (z-score): 0.41 [0.24;0.59], p < 0.0001. 
The lung function was reduced in the asthmatics already before onset 
of symptoms (FEVx (z-score): −0.32 [−0.49; −0.14], p =  0.0004 and 
sRaw (z-score): 0.47 [0.21;0.72], p =  0.0003) and not improving after 
remission of symptoms (FEVx (z-score): 0.03 [−0.03;0.07], p = 0.31 and 
sRaw (z-score): 0.02 [−0.03;0.07], p = 0.39).
The level of lung function was not correlated with the duration of 
symptoms (FEVx (z-score): −0.03 [−0.10;0.04], p  =  0.44 and sRaw 
(z-score): 0.01 [−0.05;0.07], p = 0.68).
Conclusion: The reduced lung function characterizing newborn 
children developing asthma later in childhood is sustained till ado-
lescence independent of remission of symptoms and not further 
deteriorated by increased disease duration. This suggests that the 
lung function deficit accompanying asthma propensity is primarily an 
inherited trait.
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Is the effect of maternal and paternal asthma different in female 
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Background: Parental allergy is one of the strongest risk factors for 
asthma during childhood, but data on sex/gender-specific effects by 
maternal and paternal asthma separately are lacking. Our aim was 
to evaluate the prevalence of asthma in males and females before 
puberty by maternal and paternal asthma separately.
Methods: We analysed the prospective follow-up data from two dec-
ades of the urban multicenter birth cohort study MAS which recruited 
1314 children in 5 German cities in 1990. Definition of current asthma 
was based on the presence of at least 2 of the following criteria: (i) 
wheeze in the last 12 months; (ii) asthma medication last 12 months; 
(iii) parent-/self-reported doctor diagnoses asthma ever.
Results: Among girls at age 9, 22 % (n = 11, 95 % CI 11–35 %) with an 
asthmatic mother had asthma themselves compared to 18 % (n = 6, 
95  % CI 7–35  %) with an asthmatic father and 67  % (n =  4, 95  % CI 
22–96 %) where both parents had asthma. The corresponding results 
in boys aged 9 were 17 % (n = 6, 95 % CI 7–33 %), 22 % (n = 8, 95 % 
CI 10–38  %) and none. In children without an asthmatic parent 4  % 
(n = 12, 95 % CI 2–6 %) of girls and 8 % (n = 30, 95 % CI 6–11 %) of 
boys had asthma at 9 years of age. Analyses of assessments in puberty 
and adolescence are currently ongoing.
Conclusion: The tendency of different sex-specific paternal and mater-
nal effects on asthma at age 9 needs to be interpreted with caution 
(wide confidence intervals). More information will be gained by consid-
ering the MAS data from puberty and during adolescence up to age 20.
ORAL ABSTRACT SESSION 3: Epidemiology—genetics (OP13–OP18)
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Lifestyle is associated with incidence and category of allergen 
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Background: Environmental and lifestyle factors are considered to 
contribute to the global increase in allergen sensitization. Pre- and 
post-natal periods are important time windows for immune system 
development. Lifestyle is associated with lower prevalence of allergic 
sensitization. We aimed to determine if the age at onset, and category 
of allergic sensitization, is associated with lifestyle.
Methods: Children (n  =  474) from the prospective cohort study 
ALADDIN were followed from birth to 5  years. Families were divided 
into 3 lifestyle groups: anthroposophic (n  =  100), partly anthropo-
sophic (n = 209) and non-anthroposophic (n = 165). IgE-sensitization 
to food- (hen’s egg, cow’s milk and peanut), animal- (cat and dog) and 
pollen allergen (birch and timothy) was analyzed in blood samples 
from the children at 6, 12, 24 and 60 months of age.
Results: 118 developed an allergen sensitization up to 5 years of age. 
Out of these, 18 were from the anthroposophic-, 44 from the partly- 
and 56 from the non-anthroposophic group. The incidence rate in the 
children from families with an anthroposophic and partly anthropo-
sophic lifestyle was significantly lower compared to the non-anthrop-
osophic group up to 6  months. Up to 12  months, the incidence rate 
remained significantly lower in the anthroposophic group compared 
to the non-anthroposophic group. The differences were explained by 
the sensitization to food allergens in early infancy.
Conclusions: Anthroposophic lifestyle is associated with reduced 
risk of allergic sensitization in early childhood. This seems largely 
explained by the absence of food sensitization before one year of age. 
We propose that this lifestyle affects the pattern of the allergic march.
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Maternal filaggrin mutations increase the risk of atopic dermatitis 
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Epidemiological studies have shown that maternal allergy is a stronger 
risk factor for the offspring than paternal allergy, suggesting a 
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preferential maternal transmission of disease risk. However, the molec-
ular mechanism underlying this observation is currently unknown. 
Loss-of-function mutations in the filaggrin gene (FLG) cause skin bar-
rier deficiency and strongly predispose to atopic dermatitis (AD). We 
analyzed the 4 most prevalent European FLG mutations (c.2282del4, 
p.R501X, p.R2447X, and p.S3247X) in two family-based samples (759 
and 450 AD families) and applied the PREMIM/EMIM tool to test for 
parent-of-origin effects. As expected from the known role of these 
mutations on AD, children carrying a FLG mutation had a 2.4 fold 
increased disease risk (R1meta-analysis = 2.4, P = 1.0 × 10−36). Strik-
ingly, we also observed a strong maternal FLG genotype effect indicat-
ing that children of FLG-carrier mothers had a 1.5-fold increased AD 
risk (S1 = 1.50, Pmeta-analysis = 8.4 × 10−8). This maternal effect that 
was consistent in both sets of families and for all 4 mutations analyzed. 
Our results point to two independent scenarios where FLG mutations 
increase AD risk: (i) carrying a mutation and (ii) having a mutation car-
rier mother. This maternal effect was independent of mutation inherit-
ance and can be seen as a non-genetic transmission of a genetic effect. 
Interestingly, the FLG maternal effect was observed only when moth-
ers had allergic sensitization, suggesting that FLG-induced changes 
in the maternal immune response shape the child’s immune system 
through feto-maternal cross-talk and increase the child’s risk for AD. 
Overall, our study indicates that maternal FLG mutations act as strong 
environmental risk factors for the child and highlights the potential of 
family-based studies in uncovering novel disease mechanisms in the 
field of allergy susceptibility.
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The published version of this abstract can be found at [1].
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Background: Anaphylaxis is a severe life-threatening condition, fre-
quently underdiagnosed and undertreated. The incidence of anaphy-
laxis is increasing, especially among children. We aimed to examine 
the changes in anaphylaxis frequency and characteristics over a 5 year 
period.
Methods: Comparative analysis report on data from two cross-
sectional independent samples of children with anaphylaxis, col-
lected 5 years apart in 2006 (sample A) and 2011 (sample B). In both 
samples, we included patients <18  years with history of anaphylaxis, 
observed in an Immunoallergy Department in Lisbon, Portugal, during 
12 months.
Results: The frequency of anaphylaxis was 0.98  % (A, n =  56/5734) 
and 1.76  % (B, n  =  64/3646), respectively (p  =  0.001). Median age 
was 7 years (A, 1–17 years; B, 18 days–17 years); 71 % (A) and 61 % (B) 
male. Median age of first anaphylactic episode was 2 years (A, 29 days–
16 years) and 3 years (B, 4 days–17 years); 57 % (A) and 44 % (B) had 
history of asthma. Food-induced anaphylaxis occurred in 70 % (A) and 
84 % (B) of children and drug-induced anaphylaxis was reported in 9 % 
(A) and 8 % (B). Less common triggers were cold exposure, latex and 
insect sting. Most children had no previous etiologic diagnosis [70 % 
(A); 73 % (B)]; anaphylaxis triggers were identified in all patients after 
proper clinical investigation. Clinical manifestations of anaphylaxis 
were similar in both samples: mucocutaneous [100 % (A); 94 % (B)] and 
respiratory [75  % (A); 84  % (B)] symptoms were more common than 
gastrointestinal [39 % (A); 42 % (B)] and cardiovascular [21 % (A); 25 % 
(B)] manifestations. In 89 % (A) and 88 % (B), the anaphylactic reaction 
occurred in the first 30  min after trigger exposure. Only about one-
third of children with anaphylaxis had been treated with adrenaline 
[32 % (A); 33 % (B)].
Conclusions: The frequency of anaphylaxis was significantly higher 
in 2011; food allergy was the leading cause. The percentages of chil-
dren with anaphylaxis with previous unknown etiologic diagnosis 
and treated with adrenaline were fairly similar in both time points. 
This data suggests the need for improved awareness and educa-
tional programs for the recognition and management of children with 
anaphylaxis.
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The presence of molds as a source of perennial allergens and multiple 
bacteria has been related to the appearance of respiratory symptoms 
in several studies. Yet, its role in eczema has not been elucidated.
Aim: The aim of this study was to investigate the association between 
exposure to indoor visible molds/dampness and the manifestation of 
eczema in children.
Materials and methods: The study is part of the Greek contribution 
to ISAAC IΙ that includes 2023 students of randomly selected pub-
lic primary schools in Athens and Thessaloniki, aged 9–10  years. The 
children represented a general population sample and were evalu-
ated according to ISAAC II questionnaire, validated for Greek language. 
Additionally, skin prick tests (SPT), to aero-allergens were performed 
and children were examined for active lesions.
Results: 13 % had suffered from eczema in the past, 9 % had current 
and 2 % atopic eczema (positive SPT). Out of the children examined, 
half reported that eczema first appeared after the age of 5  years 
whereas 68  % mentioned persistence of eczema since infancy. 10.8 
and 6.4 % of children were currently exposed to indoor dampness and 
visible mold respectively, while 77, 5  % of them confirmed exposure 
since birth. 10 % of the sensitized children were positive to house dust 
mites and Alternaria. In logistic regression analysis evaluating 20 envi-
ronmental risk factors, a significant association was noted between 
the presence of indoor visible mold and dampness in infancy, and the 
presence of current eczema OR 1, 89 (95 % CI 1.25–2.85). This associa-
tion remained significant irrespective of the family history of atopy.
Conclusions: Frequently eczema first appears at early school age. 
The presence of visible mold and dampness at home during infancy 
appears to be an initial enhancing risk factor for the development but 
also for the persistence of the disease throughout school age.
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ORAL ABSTRACT SESSION 4: Pediatric rhinitis—immunotherapy 
(OP19–OP24)
OP19 
Associations between residential greenness and childhood 
allergic rhinitis and aeroallergen sensitisation in seven birth 
cohorts
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Introduction: Inconsistent associations have been reported between 
the green environment and childhood asthma and allergic health out-
comes. We conducted a meta-analysis on residential greenness and 
allergic rhinitis and aeroallergen sensitization based on data from Swed-
ish (BAMSE), Australian (MACS), Dutch (PIAMA), Canadian (CAPPS and 
SAGE) and German (GINIplus and LISAplus) birth cohorts (N = 13,016).
Methods: Allergic rhinitis (doctor diagnosis or symptoms) and aeroal-
lergen sensitization were assessed in children aged 6–8  years in six 
cohorts and 10–12  years in five cohorts. Residential greenness was 
defined as the mean Normalized Difference Vegetation Index (NDVI) 
in 500 m and 1000 m buffers around the home address at the time of 
health assessment. Cohort-specific associations between NDVI (per 0.2 
unit increase) and allergic rhinitis and aeroallergen sensitization were 
assessed using logistic regression models adjusted for host and envi-
ronmental confounders. The findings were combined in a random-
effects meta-analysis.
Results: Heterogeneous associations for a range of outcomes 
were observed across cohorts. Greenness in a 500 buffer was posi-
tively associated with allergic rhinitis at 6–8  years in BAMSE (odds 
ratio  =  1.42, 95  % confidence interval [1.13, 1.79]) and GINI/LISA 
South (1.69, [1.19, 2.41]) but negatively associated in GINI/LISA North 
(0.61 [0.36, 1.01]) and PIAMA (0.67 [0.47, 0.95]). The direction of the 
effect estimates in the Canadian cohorts were also conflicting but 
not significant (0.63 [0.32, 1.23] and 1.22 [0.76, 1.95] for CAPPS and 
SAGE, respectively). All meta-analytic estimates were null. Results 
were similar for aeroallergen sensitization at 6–8 years and both out-
comes at 10–12 years, and were independent of buffer size. Stratifi-
cation by four urbanization markers (particulate matter smaller than 
2.5 µm concentrations, nitrogen dioxide concentrations, population 
density and urban versus rural surroundings) did not reveal consist-
ent trends within subgroups.
Conclusions: Although residential greenness appears to be associ-
ated with childhood allergic rhinitis and aeroallergen sensitization, the 
direction of the effect varies by location.
OP20 
Full symptom control in pediatric patients with allergic 
rhinitis and asthma: results of a 2‑year sublingual allergen 
immunotherapy study
Zorica Zivkovic, Ivana Djuric‑Filipovic, Jasmina Jocić‑Stevanovic, Snežana 
Zivanovic
Children Hospital for Pulmonary Diseases and Tuberculosis, Belgrade, 
Serbia  
Correspondence: Ivana Djuric‑Filipovic
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Introduction: Our study was designed to assess the efficacy of SLIT 
in allergic rhinitis and asthma in pediatric population. Here we report 
interim analysis done after 2 years. The aim of this study was to docu-
ment the clinical implication of allergen specific drops on symptom 
severity and medication in children with allergic rhinitis and asthma.
Methods: In this observational case control study we have col-
lected information from 59 children with AR or/and asthma. 34 chil-
dren received SLIT drops plus symptomatic treatment whereas 25 
of patients received only symptomatic therapy. During the follow 
up period the patients rate their symptoms (rhinitis, conjunctivitis, 
asthma and atopic dermatitis) as combined score of severity—tradi-
tional symptom score assessment (graded from 0 to 3) plus recording 
of doses of symptomatic medications. The beneficial effects of SLIT on 
asthma and rhinitis scores and medication use have been observed for 
two consecutive years of treatment.
Results: Both asthma and rhinitis scores were decreased during the 
first year of treatment, with the tendency of further decrease in the sec-
ond year of follow up period. The most important effects of SLIT were 
observed for the symptom of wheezing and night cough (Χ2 = 56,790; 
p < 0.001, Χ2 = 56,142; p < 0.001) only in the experimental group. On 
the other side the biggest success of SLIT for rhinitis symptoms were 
detected for nasal congestion and rhinorrhea (Χ2 = 43,607; p < 0.001, 
Χ2 = 41,809; p < 0.001), without any significant changes in the control 
group. No differences have been detected for ocular and symptoms 
of atopic dermatitis. Additional significant improvements were also 
observed for symptomatic medication: antihistaminic: Χ2  =  32,774; 
p < 0.001, inhalation corticosteroids: Χ2 = 30,022; p < 0.001, intrana-
sal corticosteroids: Χ2 = 30,785; p < 0.001, beta2agonist Q = 28,783; 
p < 0.001, LTRA: Q = 12,000; p = 0.002, but only in the experimental 
group.
Conclusion: The results of this study indicate favorable clinical effi-
cacy of SLIT drops in children with asthma and allergic rhinitis. These 
findings also suggest that SLIT drops may have potential to alter 
the natural history of atopic disease with the convenience of home 
administration and the benefit of oral rather than subcutaneous 
administration.
OP21 
Nasal epithelium of different ages of atopic subjects present 
increased levels of oxidative stress and increased cell cytotoxicity 
upon rhinovirus infection
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Background: The respiratory epithelium is critical both for the clear-
ance of infections and the development of adaptive responses. There 
is still a significant gap of knowledge on the interplay between matu-
ration of innate immunity, exposure and vulnerability to infections in 
the development of allergic responses. The aim of the present study 
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was to determine the role of viral infections in the maturation of the 
immune response in relation to age.
Method: Primary nasal epithelial cells (PNECs) were derived from 
non atopic (n = 17) and atopic (n = 13) individuals (1–48 years). The 
existence of atopy was assessed by skin prick testing to common 
aeroallergens or/and egg white. PNECs were cultured and infected 
with Human Rhinovirus A1B (HRVA1B). Doubling time of PNECs was 
assessed using Least Squares Fitting. Reactive oxygen species (ROS) 
were measured at 1 h, 3 h, 24 h post infection with flow cytometry. 
Virus replication evaluated using titration method at 8 h, 24 h, 48 h 
and 72 h. CCL5 release was examined at 48 h using ELISA. Cytotoxic-
ity levels were evaluated at 24  h, 48  h and 72  h with crystal violet 
staining. Statistic analysis was performed using Linear regression 
analysis and oneway ANOVA.
Results: Epithelial cell growth rate was affected by age and specifi-
cally atopic children have higher doubling time than atopic adults. 
Also atopic individuals seem to have increased production of ROS at 
baseline and CCL5 production. PNECs from atopic individuals have 
increased induction of ROS at 3  h and 24  h (p  <  0.05) post infection 
and higher virus replication at 72 h (p < 0.1). Age is a factor that influ-
ence ROS production, CCL5 release and cytotoxicity after HRA1VB 
infection (p  <  0.05). Males produce higher levels of ROS in combina-
tion with increased cytotoxicity (p < 0.05).
Conclusion: This is the first study investigating the development of 
cell growth and ROS generation comparing atopic and non-atopic 
individuals. Age, atopy and gender are important factors to rhinovirus 
infection in PNECs.
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Cluster subcutaneous immunotherapy schedule: tolerability 
profile in children
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Background: Subcutaneous immunotherapy (SCIT) treatment begins 
with an allergen dose increase phase over a period of several weeks, 
followed by a maintenance phase. The aim of our study was to test the 
tolerance of a cluster schedule.
Methods: We recruited pediatric patients diagnosed with asthma 
and/or rhinoconjunctivitis due to mites or alternaria in which immu-
notherapy was indicated. A SCIT with non-modified allergens with 
aluminium hydroxide as adjuvant was chosen. On the 1st day patients 
received two injections (6000 and 9000SQ+) within 30  min. Spirom-
etry was performed baseline and 30 min after the second dose or/and 
at any time if respiratory symptoms appeared. A maintenance dose of 
15000SQ+ was administered after 28 days, spirometry was performed 
baseline and if respiratory symptoms appeared. Adverse events were 
recorded. Demographic data were collected.
Results: Ninety-five children (31 females) between age 5 and 18 years 
were evaluated. History of allergic disease: drug allergy 1  %, food 
allergy 7  %, atopic dermatitis 27  %, and no other allergic diseases 
65 %. 49/95 were monosensitised. 69 patients had asthma, 59 of them 
also rhinoconjunctivitis, and 26 only rhinoconjunctivitis. Patients were 
treated with a SCIT formulation with alternaria in 12, D. pteronyssi-
nus in 18, and a mix of mites in 65. Local and systemic reactions were 
reported by 2.1  % (2/95) of the patients. Both local reactions were 
delayed reactions (injection site swelling and erythema). Systemic 
reactions occurred within 30  min after the second dose on the first 
day. One patient had a mild asthma reaction, resolved with inhaled 
salbutamol, and tolerated subsequent doses. The second patient had a 
moderated asthma reaction, treated with inhaled salbutamol and oral 
corticosteroids, SCIT was withdrawn as any dose above 6000SQ+ pro-
duced asthma.
Conclusions: This cluster schedule has a good safety profile in chil-
dren. SCIT fast protocols improve compliance by reducing injections, 
appointments, and school/work absences.
OP23 
Rhinitis as a risk factor for asthma severity in 11‑year old children: 
population‑based cohort study
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Methods: A retrospective analysis of the children (6–18  years-old) 
with a medical diagnosis of asthma that performed spirometry during 
2014 in our lung function laboratory was made. GLI and Zapletal equa-
tions agreement was compared in three different obstruction criteria: 
FEV1 < 80 % predicted, FEV1 < LLN (lower limit of normal) and FEV1/
FVC < LLN. All the agreement analyses were performed using Cohen’s 
kappa test.
Results: 391 children were evaluated (61 % boys) with a mean age of 
12.4 years (standard-deviation ±3.1 years). Considering Zapletal equa-
tions the percentages of children classified as obstructed according 
to the different analyzed parameters were: 7.7 % for FEV1 < 80 % pre-
dicted, 8.7 % for FEV1 < LLN and 26.3 % for FEV1/FVC < LLN. Assum-
ing GLI 2012 equations the correspondent percentages were 12.0  % 
for FEV1 < 80 % predicted, 11.8 % for FEV1 < LLN and 29.2 % for FEV1/
FVC  <  LLN. Using the FEV1/FVC  <  0.70 ratio criteria 10.2  % of the 
patients were classified as obstructed. Cohen’s kappa coefficients for 
agreement between Zapletal and GLI 2012 equations to the analyzed 
parameters were: 0.67 for FEV1 < 80 % predicted, 0.64 for FEV1 < LLN 
and 0.85 for FEV1/FVC < LLN.
Conclusions: In our study there was a good agreement between the 
commonly used prediction equations (Zapletal equations) and GLI 
2012 equations. GLI 2012 equations adoption is a reasonable option 
in asthmatic children lung function evaluation, although maybe the 
changes in nowadays clinical practice will not be considerable.
POSTER DISCUSSION SESSION 1: Food allergy (PD01–PD05)
PD01 
Allergen‑specific humoral and cellular responses in children who 
fail egg oral immunotherapy due to allergic reactions
Marta Vazquez‑Ortiz1, Mariona Pascal2, Ana Maria Plaza1, Manel Juan2
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Introduction: Oral immunotherapy (OIT) may trigger significant 
allergic reactions. Our ability to identify children who are unable to 
undergo OIT safely is limited.
Aim: To characterize allergen-specific humoral and cellular responses 
in children who required “Early Discontinuation” (named “ED group”) 
due to allergic reactions, versus those who successfully completed 
egg-OIT (“non ED group”).
Methods: Children aged 5–16  years with DBPCFC-confirmed IgE-
mediated egg allergy were recruited for egg-OIT. Ovalbumin (OVA) and 
ovomucoid (OVM)- specific serum IgE, IgG4 and IgA were determined 
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by ImmunoCAP (Thermofisher Scientific, Sweden) at baseline. In a 
subset of patients, PBMCs (2  ×  105) were isolated and cultured (in 
duplicate) for 7 days at 37 °C in 5 % CO2 with OVA and OVM (both at 
100 ug/ml, Sigma Aldrich, Germany) with phytohaemaglutinin and 
medium alone as positive and negative controls respectively. After cen-
trifugation, supernatants were collected and analyzed for presence of 
IL-2, IL-4, IL-5, IL-13, IFNg, IL-10, IL-9, IL-17, IL-6 and TNFa by multiplex 
magnetic bead assay (Luminex, Invitrogen, Life technologies, USA). 
Comparative analysis between ED and non ED groups was performed 
using U-Mann-Withney test. A two-tailed p value <0.05 was considered 
significant.
Results: 50 children underwent egg-OIT, 9 of whom required “Early 
Discontinuation” (ED group). Specific IgE, IgG4 and IgA to OVA and 
OVM were higher in ED vs. non ED group (p < 0.005). IL-9 production 
by PBMC following OVM stimulation was higher in ED (n = 6) vs. non 
ED group (n =  10, p  <  0.006) and a similar trend was detected after 
OVA. IL-5 and IL-13 responses to OVM also tended to be higher in ED 
vs. non ED children. No differences were observed in other cytokines.
Conclusion: An IL-9 predominant cellular response as well as a strong 
allergen-specific poly-isotypic antibody response characterizes egg-
allergic children who fail OIT at early stages due to significant allergic 
reactions.
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FoxP3 epigenetic features in children with cow milk allergy
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Background and aim: Epigenetic changes in DNA methylation have 
been recently demonstrated during cow milk allergy (CMA) disease 
course (Berni Canani R et al. Clin Epigenet, 2015). The suppressive phe-
notype of regulatory T (Treg) cells, characterized by stable expression 
of transcription factor Forkhead box Protein 3 (FoxP3), is involved in oral 
tolerance acquisition. We aimed to assess whether tolerance acquisi-
tion in children with IgE-mediated CMA involves a different DNA meth-
ylation profile of FoxP3.
Methods: DNA methylation of CpGs in the promoter regions and 
respective mRNA levels of FoxP3 from peripheral blood mononuclear 
cells (PBMCs), were assessed in children with active IgE-mediated CMA 
(Group 1), CMA subjects with recent evidence of oral tolerance acquisi-
tion (Group 2) and in healthy controls (Group 3).
Results: 37 children (18 male, aged 3–18  months) were enrolled: 16 
in Group 1, 10 in Group 2 and 11 Group 3. DNA methylation profiles 
of FoxP3 clearly separated active CMA patients from healthy controls. 
Active IgE-mediated CMA patients showed significantly higher rate 
of DNA methylation in FoxP3 promoter region compared to healthy 
controls (52 vs. 80  %; p  <  0.0001). DNA methylation analysis of this 
transcription factor clearly separated CMA patients by disease-state: 
tolerant subjects presented a significant different DNA methylation 
profile compared with active CMA patients (42 vs. 80 %, p < 0.0001). 
This profile was similar but not identical to that observed in healthy 
controls. A strong correlation between gene promoter DNA meth-
ylation rates and respective mRNA levels was also demonstrated 
(R2 = 0.946; p < 0.0001).
Conclusion: Tolerance acquisition in children with IgE-mediated CMA 
involves demethylation of promoter region of Foxp3 gene leading to 
an increased expression in Tregs. This feature could be a new epige-
netic biomarker to follow the CMA disease course.
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Combined milk and egg allergy in early childhood: let them eat 
cake?
Santanu Maity, Giuseppina Rotiroti, Minal Gandhi
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Background: Milk and egg allergies are the commonest food allergies 
in early childhood. Over 75 % may tolerate baked products avoiding 
unnecessary dietary restrictions and accelerating tolerance.
Objective: To audit our use of casein and ovomucoid recombinants in 
patients with combined milk and egg allergy to aid early dietary intro-
duction of baked products.
Method: Caesin and ovomucoid recombinant testing on combined 
milk and egg allergic children, not previously exposed to baked prod-
ucts. Challenge selections included consideration of current published 
predictive data for SPT and recombinant tests.
Results: 67 children, aged 5–74 months (median 9.5) were tested.
Milk allergy: 18/19 (94.7 %) children passed the baked milk challenge. The 
SPT milk solution was 0–10 mm (median 3.0 mm), SPT raw milk 0–23 mm 
(median 10 mm), casein 0–14.2 KU/l (median 0.59 KU/l, mean 2.54 KU/l). 
2/18 children who passed had a milk solution SPT of 6 mm or above but 
with a casein of 1.46 and 2.13. GG allergy: 18/21 (85.7 %) children passed 
the baked egg challenge. The SPT egg solution was 2–18 mm (median 
8.0  mm), SPT raw egg 7–22  mm (median 10  mm), ovomucoid 0–4.56 
KU/l (median 0.24, mean 0.59). 14/18 children had an egg solution SPT 
of 5 mm or above. These children’s’ ovomucoid was 0–4.56 KU/l (median 
0.36, mean 0.65). 3 children failed their baked egg challenge (SPT egg 
solution 11 mm, 6 mm & 4 mm, ovomucoid 28.8 KU/l, 0.0 KU/l, 0.79 KU/l). 
Two of these children are now tolerating baked egg. 33 children were not 
challenged. Their median SPT to milk solution was higher (median 6.0) as 
was the caesin (median 16.6). The egg solution SPT was similar (median 
10) with higher ovomucoid levels (median 12).
Conclusion: Caesin and Ovomucoid recombinants are useful addi-
tional predictive tools to aid patient selection for early introduction of 
dietary baked milk and egg.
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Introduction of complementary foods in relation to allergy 
and gut microbiota in farm and non‑farm children
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Background and aim: Evidence is emerging that postponed introduc-
tion of complementary foods might increase the risk of allergy. Like-
wise, low “food diversity” in early age has been associated with allergy 
development. Interestingly, also low diversity of the early gut microbi-
ota has been linked to increased allergy risk. The incidence of allergy is 
markedly low in farm children; our aims are to investigate introduction 
practices in relation to: (1) farm environment, (2) allergy development, 
and (3) gut microbiota.
Methods: Subjects from the FARMFLORA birth-cohort, including 28 
farm and 37 non-farm parent-children pairs, were investigated. Practices 
of breastfeeding, formula and complementary feeding were recorded; 
month of introduction was registered for potatoes, vegetables, fruits, 
berries, nuts, peanuts, legumes, eggs, fish, meat, milk and flour. Allergies 
were diagnosed by doctors. Timing of introduction of complementary 
foods was analyzed in farm and non-farm infants and related to allergy 
development. Additionally, prevalence of microbes commonly found in 
the infant gut microbiota was analyzed on a genus level up to 18 months 
of age and will be related to formula and food introduction practices.
Preliminary results: Nuts were introduced earlier to farm children 
than non-farm children and flour was more frequent introduced to 
farm children at 7  months. In contrast, peanuts were less frequent 
introduced to farm children at 17  months. When allergic (1 farmer, 
10 non-farmers) and healthy children were compared, fish was more 
frequent introduced to healthy infants at 10  months; the association 
was strengthened in children of non-allergic mothers but weakened 
when the analysis was confined to non-farm children. Legumes were 
more frequent introduced to healthy infants at 8  months, although 
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non-significantly when maternal heredity was considered. Eggs were 
less frequent introduced to healthy infants at 11  months; the signifi-
cance disappeared when considering maternal heredity. No differ-
ences in food diversity were observed at 6  months, or in total up to 
18 months, between farm and non-farm children or between healthy 
and allergic children. Microbial analyses are ongoing.
POSTER DISCUSSION SESSION 2: Asthma and wheeze (PD06–PD16)
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The association between asthma and exhaled nitric oxide is 
influenced by genetics and sensitisation
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Background: Rationale was to enhance knowledge about fraction of 
exhaled nitric oxide (FeNO) as a biomarker. The aim was to analyze the 
association between asthma and FeNO, and to take genetics, inhaled 
corticosteroids (ICS), and sensitization into account.
Methods: The population based STOPPA study of 681 twins (53  % 
monozygotic (MZ) and 47  % dizygotic (DZ), average age 12.6; SD 
1.5) was used. Measurements were FeNO (parts per billion), parental 
report of current asthma with and without ICS and airborne sensitiza-
tion (allergen-specific immunoglobulin E ≥ 0.35 kUA/l). The association 
between FeNO and asthma was analyzed between and within twin 
pairs (DZ and MZ) in regression models, the latter giving adjustment 
for shared environmental and genetic factors. Regression coefficients 
(β) and 95  % confidence interval (CI) per unit increase of log-trans-
formed FeNO were presented.
Results demonstrated an association between current asthma and FeNO 
in between pairs analysis; β 0.31 (0.13–0.50), which was significantly 
stronger within DZ; β 0.41 (0.17–0.64), compared to MZ; β 0.07 (−0.18–
0.31), and DZ vs. MZ, (p = 0.049). This indication of genetic confounding 
remained in twins without regular treatment with ICS (p =  0.022), but 
not in those with regular ICS. There was no increase in FeNO in children 
with asthma but without sensitization in between pairs analysis; β −0.01 
(−0.27–0.24), compared to children with neither asthma nor sensitiza-
tion. However, sensitization only, β 0.33 (0.14–0.53), and together with 
asthma, β 0.62 (0.32–0.92) were associated with increased FeNO.
Conclusions: This study shows that genetics and sensitization are 
strong influences for the association between asthma and FeNO.
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Aim: Pre-school wheeze is a significant health problem worldwide. 
This analysis aimed to assess prevalence patterns of wheeze in the first 
2 years of life and identify how risk factors for this vary across Europe 
focusing on food allergy, breastfeeding and smoke exposure.
Methods: Children from nine European countries were recruited 
into the EuroPrevall birth cohort between 2005 and 2010. At 
recruitment, data were collected on birth details, familial allergies, 
socio-demographic status and environmental exposures, including 
cigarette smoke. At 12 and 24 months, data on feeding, symptoms and 
signs of allergic disease, wheeze, cigarette smoke exposure, infections 
and day care attendance were collected. The primary outcome for this 
study was wheeze in the second year of life using Poisson regression 
to identify risk factors (STATA SE 13).
Results: The EuroPrevall birth cohort included 12049 infants. Data 
on wheeze in the second year of life was available in 8775 (72.8  %). 
Prevalence rates varied across Europe with a broadly north-western to 
south-eastern gradient (Table 3). In multivariate analysis of the whole 
cohort, male gender, maternal asthma, maternal smoking, day care 
attendance and frequent respiratory tract infections were identified as 
risk factors for wheeze in the second year of life. Analysis of individual 
country data revealed different risk factor patterns. Food allergy was 
only associated with wheeze in univariate analysis. Breastfeeding did 
not appear to protect against wheeze.
Conclusions: In this study, the prevalence of wheeze in the second 
year of life varied considerably across Europe. A priori risk factors for 
preschool wheeze did not explain this variation. Other factors may be 
operating within countries.
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Table 3 Prevalence of  wheeze in  the second year of  life 
by country








17.2 % 13.1 % 10.8 % 11.8 % 1.7 % 1.9 % 3.0 % 9.5 % 2.8 % 7.8 %
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Background: Plant pollen are known to be strong airborne elicitors of 
asthma in humans, and the role of allergenic proteins in the allergic 
response is well established. To better understand the exacerbation 
episodes of asthma in patients, other pathophysiologic mechanisms 
based on airways mechanics need to be considered. Both mecha-
nisms regulated by cation channels such as TRPA1 and by the lipid 
kinase PIP5Kγ, regulate the intracellular Ca2+ concentration, having 
as an effect the smooth muscle contractionand consequent airways 
constriction. To explore a possible contribution of non-allergenic small 
molecules in pollen to the clinical outcome of asthma, we analyzed 
and compared the phytochemical profiles of pollen originating from 
Ambrosia artemisiifolia and other 29 plant species causing pollen aller-
genicity of varying severity.
Methods: Profiling was performed with high performance liquid 
chromatography (HPLC) coupled with electrospray ionization mass 
spectrometry (ESIMS), photodiode array (PDA) and evaporative light 
scattering (ELSD) detectors, and supported by microprobe nuclear 
magnetic resonance (NMR) spectroscopy and spectrophotometric 
analysis.
Results: The presence of conjugated polyamineswas a characteristic 
feature of pollen from the family of Asteraceae (Ambrosia and Artemi-
sia ssp.). Compounds with Michael acceptor properties, such as ses-
quiterpene lactones (STLs) were present in pollen of different families.
Conclusion: Polyamines, such as spermine and spermidine, activate 
the lipid kinase PIP5Kγ. Sesquiterpene lactones activate cation chan-
nel TRPA1. Thus, the possible contribution of these small molecules in 
the exacerbation of airway constriction after exposure to plant aeroal-
lergenes should be explored in more detail. The immunologic modu-
lation through allergens might not be the only responsible for the 
asthma exacerbation episodes.
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Background: Teenagers with asthma often find it difficult to manage 
their asthma and there is little robust evidence on how health care 
professionals can facilitate teenagers’ efforts.
Aim: To understand the facilitators and barriers to asthma self-man-
agement in teenagers.
Methods: We recruited teenagers aged 12–18  years with asthma 
to take part in either a focus group or one-to-one interview as pre-
ferred by the participants. Separate focus groups and interviews 
were also conducted with their parents and healthcare professionals 
(HCP-pediatrician, nurse, family doctor). A thematic data analysis was 
undertaken.
Findings: 28 teenagers (1 focus group; 22 1:1 interviews), 12 parents (2 
focus groups; 4 interviews) and 13 health professionals (2 focus groups, 
3 interviews) were recruited. Themes included: 1) medication: forgetting, 
being prepared, need for routines or reminders, device issues, insuf-
ficient time; 2) symptom management: breathing techniques, keeping 
calm, recognising symptoms; 3) trigger avoidance: avoiding triggers, 
preparing for unavoidable triggers; 4) beliefs about medication and 
asthma: effectiveness of medication, need for medication, lack of con-
trol, outgrowing asthma; 5) attitudes to asthma: motivation, acceptance, 
seriousness, embarrassment, confidence, taking responsibility; 6) knowl-
edge: consequences of not taking medication, understanding of condi-
tion and understanding of treatment, others not understanding asthma; 
7) parents: reminders, education and information, monitoring, commu-
nication with HCP, providing support, help with treatments; 8) HCP: pro-
viding treatment, education and information, support, communication, 
conflicting and inaccurate information, honesty, lack of action, clinic 
setup; 9) others: friends, schools/teachers. In general, similar issues were 
voiced by the adolescents, parents and HCP.
Discussion: The potential facilitators and barriers to asthma self-
management were similar to themes that were identified in our recent 
narrative systematic review of the literature (Holley et al., submitted). 
These could be targeted to support teenagers to become empow-
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Introduction: Bronchial asthma is a pulmonary disease characterized 
by chronic inflammation of the airways and bronchial hyperrespon-
siveness. Asthma is a multifactorial disease influenced by genetic and 
environmental factors. Nitric oxide (NO) has recently attracted atten-
tion in the pathophysiology of bronchial asthma. NO has protective 
effects on airways such as muscle relaxation & attenuation of airway 
hyper-responsiveness to bronchoconstrictor stimuli. In contrast, 
adverse effects of NO include vasodilation of the bronchial circulation 
& increased airway secretions. NO is synthesized by the enzyme NO 
synthase (NOS), which exists in three distinct isoforms: neural (nNOS), 
inducible (iNOS) and endothelial (eNOS).
Purpose: To investigate the association between Glu298Asp poly-
morphism of eNOS gene (rs1799983) and development of bronchial 
asthma in children from Egypt.
Methods: 93 asthmatic children who were able to perform pulmo-
nary function tests efficiently & had a history of mild persistent asthma 
were included in this study. In addition, ninety healthy age matched 
subjects who had neither clinical evidence nor personal or familial 
history of asthma, served as control group. All participants were sub-
jected to thorough medical history taking, clinical examination, pul-
monary function testing, and estimation of eNOS (Glu298Asp) gene 
polymorphism using conventional PCR.
Results: A statistically significant difference was observed as regards 
genotype distribution of the Glu298Asp polymorphism between children 
with and without bronchial asthma. The prevalence of the T allele was sig-
nificantly higher in asthmatic groups in comparison to control group.
Conclusion: This study showed the presence of a strong association 
between Glu298Asp polymorphism of the eNOS gene and the risk of 
development of bronchial asthma among Egyptian children. Genetic 
associations are often inconsistent across ethnic barriers. The results of this 
study provide the rationale for further studies with larger sample sizes.
POSTER DISCUSSION SESSION 3: Mechanisms—Epidemiology 
(PD17–PD21)
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Background: It is suggested that the infantile period is crucial for 
immune modulation. Pregnancy outcomes, such as gestational age 
and birth weight, have been associated with risk for developing aller-
gic disease later in life.
Aim: To analyze the influence of gestational age, birth weight, birth 
length and head circumference at birth on later allergy development 
in children born at term in a Swedish birth-cohort (BAS).
Method: All 1231 children born during a 1-year period from February 
1996 to January 1997 at the Östersund Hospital in Jämtland, Sweden, 
were included in the BAS cohort and were followed from pregnancy 
until 13  years of age, with regular assessments of allergic sensitisa-
tion by skin prick tests and allergic symptoms by questionnaires. Data 
regarding gestational age, birth weight, birth length, and head circum-
ference at birth, were derived from the Swedish Medical Birth Register, 
and related to atopic eczema and respiratory allergy at 13 years of age 
in children born at term (gestational week 37–42, n = 1052).
Results: Higher gestational age was a risk factor for developing res-
piratory allergy at 13 years of age (OR = 1.20, P = 0.041). No associa-
tion was found for gestational age and prevalence of atopic eczema 
at 13  years of age. No association was found for birth weight, birth 
length or head circumference at birth and risk of developing respira-
tory allergy or atopic eczema at 13 years of age.
Conclusion: Higher gestational age was a risk factor for respiratory 
allergy at 13 years of age for children born at term.
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Background: The allergic IgE response to grass pollen starts as a weak 
monosensitisation or oligosensitisation phenomenon and increase 
through a “molecular spreading” process. We aimed this study to inves-
tigate the development of the IgE response to house dust mite.
Materials and methods: The Multicenter Allergy Study (MAS), a birth 
cohort study, started in 1990 and recruiting 1314 infants in 5 Ger-
man cities. Blood samples were collected at 1, 2, 3, 5, 6, 7, 10, 13 and 
20 years of age. Sera with IgE antibodies to an extract of Dermatopha-
goides pteronyssinus (D.pt) (ImmunoCAP, TFS) were further tested for 
the presence of IgE to Der p1, Der p2, Der p4, Der p5, Der p7, Der p11, 
Der p14, Der p15, Der p18, Der p21, Der p23, Clone 16 (in the con-
text of a MeDALL chip). The concentration of Der p1 was measured in 
house dust samples collected at 6–18 months of age.
Results: Overall, 168 subjects produced serum-IgE to D.pt. and its 
molecules. Der p2, Der p1 and Der p23 were the molecules most fre-
quently recognized by IgE, working as “initiators molecules” in 98 % of 
the children. IgE to Der p4, 5, 7, 11, and 21 were frequently observed 
(20–37 %) while those to Der p 14, 15, 18 and to clone 16 were less fre-
quent (11–18 %). This ranking of prevalence was stable during the first 
two decades of life. The IgE sensitization profiles to the 12 molecules 
were extremely heterogeneous in the population at all ages. Twenty-
one subjects remained prospectively sensitized to only one molecule 
(stable”monomolecular” sensitization). The remaining 147 subjects 
developed a molecularly complex sensitization. The complexity of 
the IgE response to D.pt molecules was higher in the children most 
exposed to Der p1 at 6–18  months of age than in the least exposed 
ones (highest vs. lowest exposure quartile).
Conclusions: In the MAS birth cohort, Der p1, Der p2 and Der p23 are 
the “initiators” of the IgE response to D. pt. High exposure to Der p1 in 
early childhood is associated with a stronger “molecular spreading” of 
the IgE response to D.pt.
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Background: IgE sensitization to non-specific lipid transfer proteins 
(nsLTP) molecules is very frequent in Southern Europe, but not in 
Northern and Central Europe. Information on the geographical distri-
bution of IgG responses to nsLTP in Europe is limited.
Aim: To evaluate the longitudinal development of IgE and IgG 
responses to nsLTP molecules in a population of German children.
Methods: Children of the German Multicenter Allergy Study (MAS) 
were included in the present analysis if they had provided: (1) ≥1 
serum sample at age 1–3 years, (2) ≥2 serum samples at ages 5–7 years, 
(3) a serum sample at age 10 years. IgG (cut-off ≥0.1 ISU/L) and IgE (cut-
off ≥0.3 ISU/L) to four nsLTP molecules (rPar j2, nArt v3, nPru p3, rCor 
a8) were tested by microarray (ISAC, TFS). Sera with undetectable IgE 
(<0.35 kU/l) against a panel of nine common foodborne and airborne 
allergenic extracts (ImmunoCAP, TFS) were considered negative for IgE 
against the four nsLTPs and were tested only for IgG.
Results: Overall, 586 sera from 104 children were examined. Of these, 
389 (66 %) were negative for IgE to extracts and not tested for IgE to 
nsLTP. Only 1/104 (1 %) child had IgE to a nsLTP (only once, to nArt v3). 
By contrast, all 104 children but one (99 %) developed IgG to at least 
one of the examined nsLTPs. IgG responses to all the nsLTPs were fre-
quent: nPru p3 = 72 % (419/586 sera), rCor a8 = 67 %, nPar j2 = 63 %, 
rArt v3 = 16 %. IgG to rCor a8 showed the highest concentration [geo-
metric mean value: 1.62 (ISU/L)], followed by nPru p3 [1.40 (ISU/L)], 
nArt v3 [0.92 (ISU/L)], and rPar j2 [0.87 (ISU/L)]. The prevalence of IgG 
responses to rPar j2, nPru p3, and rCor a8 rapidly increased until age 5 
and plateaued thereafter. The average concentration of IgG antibodies 
against all four nsLTP molecules remained quite stable at population 
level until age 10 years.
Conclusions: Our results confirm that IgE responses to nsLTPs are rare 
among children living in Central-Northern Europe. On the contrary, 
IgG responses to nsLTPs are very frequent in our German-MAS birth 
cohort. The biological and clinical implications of our observations 
require further investigation.
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Introduction: The human gut microbiota influences immune maturation 
during early life and associates with the development of immune medi-
ated diseases. Several studies support the idea that the gut microbiota 
influences the FOXP3+ T-regulatory cells, which are important for immune 
homeostasis and tolerance. Lactobacilli are present in the early infant gut 
and correlated with a lower risk of allergy later in life. In addition, lacto-
bacilli dampen in vitro immune activation induced by Staphylococcus (S.) 
aureus, a gut bacteria associated with an increased risk for allergy.
Aims: Here we investigated if early life colonization with lactobacilli 
and S. aureus influences the maturation and functional responses of 
FOXP3+ T-cells later in life. Further, we studied how soluble products 
from these bacteria affect FOXP3+ T-cells in vitro.
Materials and methods: RT PCR was used to detect and quantify bacte-
rial DNA in faeces from infants and associated with immune data at age 
two. Peripheral blood mononuclear cells from children at age two and 
adults were analysed basally or after stimulation with cell free superna-
tants (CFS) from Lactobacillus (L.) reuteri DSM 17938 or/and S. aureus 161:2. 
The cells were stained with antibodies and analysed by flow cytometry.
Results: Children colonized with S. aureus had a higher percentage 
of FOXP3+ cells that produced IL-10 and expressed CD161, a T-cell 
marker connected to high cytokine-producing capacity. Further, 
in vitro stimulation with S. aureus-CFS induced CD161-expression and 
production of IL-10 and IFN-γ in FOXP3+ cells. In opposite, lactobacilli-
colonization associated with a lower percentage of IL-10-producing 
FOXP3+ cells after stimulation. L. reuteri-CFS also dampened S. aureus-
induced activation of FOXP3+ cells in vitro.
Conclusions: We conclude that species in the early gut microbiota are dif-
ferentially linked to the development and function of FOXP3+ cells later in 
life, perhaps by modulation of CD161-expression and cytokine responses.
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Introduction: The atopic march refers to the sequential development 
of allergic conditions in childhood and is associated with severe and 
persistent disease manifestations. Up to 30 % of infants with eczema 
develop asthma in childhood which is the most common pattern of 
the atopic march.
Aim of the study: We conducted a multi-stage genome-wide associa-
tion study (GWAS) for infantile eczema followed by childhood asthma to 
unravel the genes underlying this characteristic pattern of allergic disease.
Methods: GWASs were performed in 6 study populations (discovery 
phase). Selected SNPs were replicated in another 6 study populations 
(replication phase). Our study included 2428 cases and 17,034 controls 
of European descent. Association was calculated by logistic regression 
using an additive allele-dosage model. Meta-analyses were carried out 
with METAL using the inverse variance fixed effects model.
Results: We identified 7 loci associated with the atopic march at 
genome-wide significance. Two chromosomal loci at 6p12.3 and 
12q21.3 were specific for the combined eczema plus asthma phenotype 
and associated with allergic disease for the first time. Four additional loci 
at 1q21.3, 5q31.1, 11q13.1, and 11q13.5 were previously identified in 
GWASs on eczema while, at 17q21, a single asthma-specific locus was 
detected. By inspecting all known GWAS loci for eczema or asthma in 
the discovery set, we found that eczema loci were significantly more 
likely to be associated with the atopic march than asthma loci.
Conclusion: The two novel loci provide genetic support for a specific 
atopic march phenotype. In addition, we demonstrate that eczema loci 
were the main genetic determinants of the atopic march which may 
point to the development of eczema as a key event initiating this unfa-
vorable disease course. We suggest that the prevention or early treat-
ment of infantile eczema could be a promising approach in order to 
reduce the burden of allergic diseases associated with the atopic march.
POSTER DISCUSSION SESSION 4: Food allergy—Anaphylaxis (PD22–
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Background: Atopy patch test (APT) has been proposed as a valuable 
tool in children with non-IgE mediated cow’s milk allergy, although 
studies are small and limited. We aimed to investigate the value of APT 
in solid food protein induced enterocolitis (FPIES).
Methods: We studied 22 children diagnosed as having FPIES caused 
by solid foods. Oral food challenge was performed to confirm the 
diagnosis, except in severe recent reactions. All children had negative 
skin prick test (SPT) to the offending food.
Patch tests were performed to a battery of foods implicated with the 
same extracts used for SPT (ALK, Abello, Denmark). They were applied 
into Finn chambers, placed on the back and removed after 48 h. Reac-
tions were scored at 72 h. Positive reactions included erythema with 
infiltration (+), with few papules (++) several papules (+++) and ves-
icles (++++) following the EAACI GA2LEN position paper.
APT were carried out in the first and in follow up visits.
A control group of 10 non atopic children with good tolerance to 
foods were also tested.
Results: 22 patients with FPIES to solid foods were studied. Mean age 
at diagnosis was 19 months (range 12–28 months). Eighteen patients 
were diagnosed by OFC, 4 with clinical history and OFC was not per-
formed because of a recent severe reaction.
Skin prick tests were negative in all.
At the first visit, 8 children showed positivity APT to the offending 
food, 14 were negative (sensitivity: 0.36, 36 %, specificity: 100 %). Chil-
dren in control group showed negative APT.
In the series of positive APT children, only 4 showed persistence of 
positivity when they were tested 24  months later. Patients in whom 
APT became negative (4), underwent OFC that confirmed persistence 
of symptoms.
Conclusions: APT in FPIES induced by solid foods has some diagnostic 
value, but OFC remains as the gold standard.
Although in some patients APT become negative, clinical symptoms 
persisted, so the age of diagnosis may be important, with loss of sensi-
tivity in older children.
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Background: Recently, there has been an increased recognition of 
patients who are allergic to the seeds but not the pulp of citrus fruit. 
A study of 100 patients with nut allergy demonstrated high rates of 
co-sensitisation between cashew and orange seed but the clinical rel-
evance of this state was not investigated by challenge. Watermelon 
(Citrullus lanatus), of the Cucurbitaceae family, has a high protein con-
tent in the seeds. Watermelon allergy predominantly presents as oral 
allergy syndrome but we describe a different manifestation.
Case history: 2 patients have presented to our pediatric allergy ser-
vice, both with a history of uneventfully enjoying consumption of 
watermelon on multiple occasions. A 6 years old boy, on one occasion 
of eating watermelon had swelling of his lips and widespread urticaria 
which resolved with anti-histamine and another young man of 7 years 
had anaphylaxis requiring an adrenaline autoinjector when he ate 
watermelon.
Investigations: Both tested negative to the watermelon pulp (0 mm) 
but had positive skin prick test to the seeds (4 mm and 25 mm). Inter-
estingly, both were also sensitised to cashew nut (3 mm and 6 mm). 
Neither has ever eaten cashew nut.
Discussion: Watermelon seeds are often swallowed whole or removed 
before eating, hence patients may appear to tolerate watermelon. 
When the seed contents are consumed the reaction occurs. Water-
melon seeds contain high levels of vicilin-like glycoprotein (seed stor-
age protein). In cashew nuts Ana o 1, a vicilin-like protein, is a major 
food allergen hence the possibility of cross-reactivity. Other vicilin-like 
proteins such as peanut (Ara h1), soya (gly m5) and sesame (Ses i3) 
may also need consideration.
Conclusions: Allergy to fruit seeds may be common and under-
recognised. One should consider seed allergy despite previous or 
ongoing apparent tolerance to the fruit pulp. Clinical significance of 
the co-sensitisation to the cashew nut is uncertain and needs further 
investigation.
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Background: With the increasing prevalence of allergic disease, 
the number of children presenting with cow’s milk protein allergy 
(CMPA) to primary care has also increased. They have little resource 
or access to allergy testing and may be unfamiliar with the inter-
pretation of results. Many guidelines have surfaced in the past few 
years but it is felt that the knowledge, uptake and application of 
these guidelines have been suboptimal. This project attempted to 
assess if an electronic version of a modified CMPA guideline can 
increase the confidence of primary care clinicians in the manage-
ment of children with possible CMPA. This was done by developing 
a template which was adapted and modified from a national guide-
line and was introduced into individual primary care computer 
systems.
Aim: To evaluate the usefulness of a guideline template for “managing 
cow’s milk allergy in primary care” based on confidence scoring from 
primary care clinicians.
Methodology: An electronic guideline template for managing CMPA 
was introduced for a period of two months in primary care electronic 
record keeping computer system. Confidence scoring was compared 
in GPs before and after this period to see whether use of the template 
resulted in changes in confidence scores.
Results: Nine clinicians participated in this study from five surgeries 
across North of England. Awareness of national guidelines was very 
low in this group (11 %) before the template was introduced. Follow-
ing the introduction of an electronic template to manage CMAP, a sig-
nificant increase in confidence scores was noted from all participants 
GPs (p  =  0.038). When asked if the template improved their confi-
dence levels, a significant number of respondents answered in the 
affirmative (p = 0.020). A significant number of respondents felt that 
using the templates helped them consider the diagnosis if CMPA in 
cases where such a diagnosis would not have been considered previ-
ously (p = 0.003). An additional finding was noted in this survey that 
the GPs did not refer the patients to dieticians (p = 0.007), which is a 
MAP guideline recommendation.
Conclusion: Our study, like many previous studies, has demonstrated 
that the uptake and use of national guidelines remains poor. Our study 
demonstrates that confidence levels in managing CMPA improved 
significantly by following an electronic template. We recommend that 
national and international bodies take note of the significance of these 
findings as these may guide future CMPA and other guideline imple-
mentation in primary care.
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Background: Cow’s milk (CM) is one of the major causes of food 
allergy in childhood. Oral immunotherapy (OIT), a novel strategy, has 
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been recognized as promising treatment for severe and long-lasting 
CM allergy. The authors describe the efficacy and safety of the CM-OIT 
protocol used in our Immunoallergy Department.
Methods: Systematic review of all children and adolescents, who 
underwent CM-OIT until March 2015. The protocol involves the intro-
duction of increasing amounts of non-diluted CM, beginning with 
sublingual drops and gradual increases of the threshold dose at pre-
determined intervals. The doses increments and establishment of the 
dose for daily ingestion at home were always performed in hospital 
sessions.
Results: A consecutive sample of 49 children and adolescents was 
included: mean age at initiation of the protocol was 7  years-old, 
59 % male and 96 % IgE-mediated reactions (20 % anaphylaxis). Most 
patients had other allergic diseases (69 % allergic rhinitis, 51 % asthma, 
33 % atopic dermatitis) and 24 % multiple food allergy. The target dose 
(200 mL/day) was reached in 92 % of children, after a mean period of 
time of 5.2 months (ranging from 1.5 to 15 months). There were 4 fail-
ures: 2 due to gastrointestinal symptoms and 2 by poor adherence. 
During the protocol occurred mild to moderate reactions in 86 % and 
severe in 3 cases: milk-dependent exercise-induced anaphylaxis, acci-
dental exposure and due to poor adherence to the recommended pro-
tocol. All reactions were controlled with rescue treatment.
Conclusions: CM-OIT is a safe and effective treatment for severe and 
long-lasting CM allergy. The protocol used allowed to achieve toler-
ance within a short period of time. Maintenance of 200 mL daily inges-
tion enables a diet without restrictions, with a clear positive impact on 
quality of life.
POSTER DISCUSSION SESSION 5: Prevention and treatment—
Allergy (PD27–PD36)
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Introduction: Numerous epidemiological studies provide strong evi-
dence that frequent contact to a traditional farm environment in early 
life protects children from the development of allergic airway diseases 
like hay fever and asthma. We have previously demonstrated that 
intranasal application of the cowshed-derived lactic acid bacterium 
Lactococcus lactis G121 (LL) resulted in protection from allergic disease 
in different murine asthma models. However, details of the underly-
ing mode-of-action of this protective immune response are largely 
unknown.
Materials and methods: Cellular mechanisms involved in cytokine 
induction upon LL exposure were analysed in human monocyte 
derived dendritic cells (moDCs) and murine bone marrow-derived 
dendritic cells (BMDCs) by use of specific inhibitors for uptake and 
endosomal acidification. Functional relevance was assessed in vivo in 
a murine model of allergic airway inflammation with sensitisation via 
intranasal transfer of ovalbumin (OVA)-pulsed BMDCs to naïve mice.
Results: LL exposure of moDCs and BMDCs led to release of sev-
eral cytokines including IL-12p70 and IL-10. Preincubation with the 
inhibitors Cytochalasin D or Bafilomycin A1 (Baf ) strongly decreased 
the cytokine production indicating the importance of both uptake 
of the bacteria and endosomal acidification. In vivo, sensitisation of 
mice could be achieved by intranasal administration of OVA-pulsed 
BMDC. Administration of BMDC which were exposed to LL prior to 
pulsing with allergen (G121/OVA group) protected mice from the 
development of allergic airway inflammation upon allergen chal-
lenge. However, treatment of BMDC with Baf prior to LL exposure sig-
nificantly reduced the protective effect resulting in a restored allergic 
phenotype.
Conclusion: We revealed uptake of LL in dendritic cells and subse-
quent endosomal acidification as key elements of the mode-of-action 
of allergy protection mediated by the cowshed-derived bacterium. 
These findings will greatly support the further development of a Lac-
tococcus-based primary prophylaxis against hay fever and asthma for 
protection of children early in life.
Funding: KS and HH were supported by DFG, SFB/TR22, project A2.
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Introduction: Hospitalisation with bronchiolitis in infancy is associ-
ated with increased asthma risk and reduced quality of life (QoL). 
Stress may negatively impact morning cortisol and possibly asthma 
development. We aimed to investigate the association between corti-
sol and QoL in young children and the potential modifying effect of 
having been hospitalised for bronchiolitis.
Method: In children recruited during hospitalisation in their first year 
of life for moderate to severe bronchiolitis (n  =  207), and controls 
(n = 152), with mean ages at follow-up 23.5 and 24.0 months, morn-
ing salivary cortisol and parentally completed QoL questionnaires, 
ITQOL™, were collected. 10.5 % of controls and 32.4 % of bronchiolitis 
children had asthma diagnosis or inhaled steroids daily. Cortisol was 
analysed at Karolinska Institutet by RIA. By robust regression, cortisol 
results were analysed as dependent of QoL quartiles, adjusting for 
age and gender, and subsequently also for asthma severity, graded 
depending of follow-up plans or daily steroid inhalations.
Results: Cortisol did not differ significantly between the groups, but 
was lower the more severe the asthma. Mean QoL scores were higher 
in the control group for Overall health and General Health, but higher in 
the bronchiolitis group for Change in health (compared to 1 year ago). 
Increasing QoL for 11 of 13 domains was associated with increasing 
morning cortisol in the bronchiolitis group but not in controls except for 
two domains. Controls had results for one domain pointing the opposite 
way. After adjustment for asthma severity, the associations remained 
significant for 9 of 13 domains in the bronchiolitis group. We found 
interaction between hospitalisation for bronchiolitis and QoL quartiles.
Conclusion: Increasing QoL at 2  years of age was associated with 
increasing morning cortisol only in the bronchiolitis group. The group 
differences are possibly due to different asthma frequencies and sever-
ities, but not explainable only by our measured asthma severity.
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Background: MP29-02* (a novel intranasal formulation of azelastine 
hydrochloride (AZE) and fluticasone propionate (FP)) is approved for 
use in patients aged 12  years or older with moderate/severe allergic 
rhinitis (AR). Superior efficacy of MP29-02* over FP has already been 
established in seasonal AR patients (aged ≥12 years) [1,2] and in per-
ennial AR patients (aged 12–80 years) [3]. The objective of this analysis 
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was to evaluate the efficacy of MP29-02* compared to FP, adminis-
tered as 1 spray per nostril twice daily, in pediatric AR subjects aged 
≥6 to <12 years.
Methods: This was a randomized, open-label, 3-month safety study 
in patients (≥4 to 12 years). Qualified subjects had a history of AR, 
were in good health, and had no evidence of nasal mucosal ero-
sion, nasal ulceration, nasal septum perforation, or any significant 
nasal disease. Subjects were randomized in a 3:1 ratio to MP29-02* 
(n =  304) or FP (n =  101). Efficacy was also assessed by subject-
reported assessment of overall allergy symptom severity, in a sub-
set of patients (aged 6–12  years; MP29-02*: n =  264; FP: n =  89). 
Symptom severity was rated daily on a 4 point scale from 0 to 3 
(0 = no symptoms; 1 = mild symptoms; 2 = moderate symptoms; 
3 = severe symptoms).
Results: The total symptom score at baseline was 1.73 for patients in 
the MP29-02* group and 1.80 for patients in the FP group (max score: 
3). Over the entire study period patients treated with MP29-02* expe-
rienced a −0.68 pt reduction in overall symptom score (correspond-
ing to a −5.44 change from baseline in AM + PM reflective total nasal 
symptom score (rTNSS; max = 24), significantly greater relief than that 
afforded by FP (−0.54 pt reduction; Diff: −0.14; 95 % CI: −0.28, −0.01; 
p = 0.04).
Conclusion: MP29-02* provides significantly greater AR symptom 
relief than FP in a pediatric population (aged ≥6–12  years) and has 
been granted approval for use in this age group by the FDA.
*Dymista
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Background: The H1 antihistamine Bilastine is approved in adults 
for seasonal and perennial allergic rhinoconjunctivitis (SAR/PAR) 
and urticaria. A model based drug development strategy, supported 
by a set of prior data from adults (N = 310) receiving bilastine, per-
mitted extrapolation of the PK to children, selection of the appro-
priate dose for the pediatric subset, and then design of an adaptive 
limited sampling trial to confirm the adequacy of the proposed 
regimen.
Objective: A clinical trial was performed in children (2–11 years) with 
SAR/PAR or urticaria to ascertain whether the proposed dose (10 mg/
day) matched the systemic exposure in adults (20 mg/day), via phar-
macokinetic (PK) assessment.
Methods: Blood samples were drawn from each child after multi-
ple administrations of 10  mg of bilastine as oral dispersible tablet. 
The PK schedule was optimally designed to minimize the number 
of samples and the total volume per child. Dataset (N = 31) analysis 
was with NONMEM® VI. Final model establishment and validation 
was done using standard statistical and diagnostic criteria for para-
metric non-linear mixed effects models. Individual PK parameters 
were used to calculate the exposure (AUC0→∞), which was then 
applied in the statistical assessment of the suitability of the pro-
posed dose.
Results: The population parameters in children, expressed as mean 
(SEE%) were the following: Ka 1.29 (22.2) h
−1, CL/F 12.5 (5.90) L/h, Vc/F 
19.7 (12.8) L, Q/F 2.01 (34.0) L/h, Vp/F 17.4 (14.8) L. Interindividual var-
iability was estimated for CL and Ka15 % and 67 %, respectively and 
also a proportional error variance (35 (22)  %). The model served to 
characterize the PK in children and to confirm the universal validity of 
the proposed 10 mg dose for the whole pediatric range.
Conclusion: A daily dose of 10  mg bilastine in children adequately 
produces similar exposure (1265 ng h/mL) to that observed in adults 
(1105 ng h/mL) after the therapeutic dose of 20 mg.
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Introduction: Asthma is a major cause of chronic morbidity and mor-
tality throughout the world in terms of access to emergency services, 
number of hospitalization days, school absence.
IOEASMA program used an integrative care model, implemented 
international asthma guidelines, to address pediatric asthma with a 
multidisciplinary approach.
Methods: Since 2007 the center “Io e l’Asma” implemented the pro-
gramme as follows:
  • 2007–2009, Path Diagnostic Therapeutic (PDT): 3 visits every 
4/6 weeks, with follow-up after 6 months. During the protocol, 
skin prick tests and spirometry were administered.
  • The family physician and/or the patient’s parents communicated 
to specialists any symptoms and treatments used.
  • 2010–2011: Path Diagnostic Therapeutic Educational (PDTE): 
3 visits every 8  weeks, followed by semiannual or annual visit. 
After the first visit, children and parents undertook an individual 
therapeutic education course, conducted by the health person-
nel, about: environmental prevention, asthma attacks manage-
ment, daily therapy use, proper use of devices, self-management 
disease control.
 •  2012–2013, Path Diagnostic Therapeutic Educational (PDTE) reis-
sued as ECCM, extended to lifestyles above 6 years of age. The 
ECCM, after the first visit, addressed the following health adver-
sity: social interaction, diet, physical activity, smoking.
Results: A percentage decrease (Δ%), in “activity limitations”: −37.5 % 
(PDT); −39.4  % (PDTE); −40.4  % (PTDE  +  ECCM). “Nocturnal symp-
toms”: −32.1 % (PDT); −33.8 % (PDTE); −34.3 % (PTDE + ECCM); reach-
ing the highest value in the (PDTE + ECCM). A significant percentage 
decrease of “daily symptoms” in each group (Δ −37.5 %); −31.7 (PDTE); 
−23.7  % (PTDE +  ECCM). The “relievers therapies” decreased in each 
group with a more significant percentage change in the first period (Δ 
−17.3 %) compared to PDTE (Δ −9 %) and to PDTE + ECCM (Δ −14 %); 
initial number of patients were really different in the three groups at 
the beginning, so the gap is explained.
Conclusions: An integrated and structured diagnostic and thera-
peutic pathway can significantly reduce the impact of asthma and its 
comorbidities and improve children’s quality of life.
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Background: The difficulty to sensitize most strains of laboratory 
rodents to ovalbumin (OVA) -and especially through the airways-, 
without the addition of adjuvant is well-known. It is also well-known 
that even if sensitization does occur, it is difficult to model longstand-
ing disease, as the rodents gradually develop tolerance to OVA and 
usually only one or two exposures are carried out before sacrifice.
Aim: We opted to design a rodent model of allergic rhinitis/asthma in 
which we could both sensitize the rodents to the innocuous aeroaller-
gen OVA through the airways, but also manage to sustain longstand-
ing disease even after several exposures.
Methods: Three week-old ether-anesthetized male Wistar rats (n = 20) 
were given ovalbumin (OVA) in saline vehicle, intranasally (i.n). Fifteen 
days later, awake rats were re-challenged i.n with OVA (n = 10-active 
group) or saline (n = 10-control group) and subsequent sneezes were 
counted. The rodents were re-exposed every third day for a total of 13 
exposures. They were sacrificed 54  days from the start of the experi-
ment. Inflammation of the nasal mucosa was semi-quantitatively 
assessed with Haematoxylin & Eosin stain.
Results: OVA-challenged rats demonstrated signs of allergic rhini-
tis as evidenced by a statistically significant increase in the number 
of sneezes and presence of marked nasal mucosal inflammation, as 
opposed to the control group.
Conclusions: We present an experimental model whereby we managed 
to sensitize to OVA, rats of a sensitization-tolerant strain. These rats were 
of weaning age upon first exposure and sensitization. Furthermore, 
these weaning rats were sensitized via the airways without the addition 
of adjuvant, and multiple exposures to OVA failed to tolerise them to 
this innocuous aeroallergen. It is likely that exposure to inert aeroaller-
gens at a very early age and in the context of in irritant (ether), rendered 
these rats susceptible to sensitization and longstanding disease.
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Background: Development of allergic sensitization may be regulated 
by microbial exposure. Children spend a lot of their time in school, 
under an extensive diversity of biological aerosols, such as bacteria 
and fungi. We aimed characterize indoor air microbiological exposure 
as a predictor of allergic sensitization.
Methods: A total of 858 children, aged 8–10  years, attending 71 
classrooms in 20 primary schools were submitted to skin-prick tests 
(SPT) to house-dust mites, mixed weed, mixed grasses, cat, dog and 
Alternaria alternata. Atopy was defined by a positive SPT to at least 
one of the allergens. Air samples were collected in all the participat-
ing classrooms and respective outdoor locations using a single-stage 
microbiological air impactor through TSA and MEA plates at a 100 L/
min rate. Quantification was performed by naked eye count. Endo-
toxins were collected using a 2 L/min flow control pump for 4 h and 
analysed by limulus amebocyte lysate assay. Mann–Whitney tests and 
logistic regression models were used to statistically analyse the data.
Results: Prevalence of atopy was 34.1  %. The risk of sensitization to 
inhalant allergens increased with increasing endotoxin exposure in 
classrooms (p = 0.015). Similarly, higher concentrations of Penicillium 
spp. showed higher risk of having a positive SPT (1.682 [95 % CI 1.180–
2.398]) while children in classrooms with higher concentrations of 
Aspergilus fumigatus, Aspergilus niger and Chaetomium spp. had lower 
risk of sensitization (0.64 [95 % CI: 0.47–0.87], 0.62 [95 % CI: 0.45–0.87] 
and 0.61 [95 % CI: 0.39–0.96], respectively).
Conclusion: Although the cross sectional nature of our study does 
not allow to establish causal relationships, our results further sug-
gest that current exposure to higher levels of endotoxin is associated 
with increasing odds of allergic sensitization in children. However, 
some fungi species, such as Aspergilus fumigatus, Aspergilus niger and 
Chaetomium spp., but not Penicillium spp., may also have effect in pro-
tecting from allergic sensitization.
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Introduction: Allergic rhinitis (AR) is a highly prevalent disease among 
the worldwide population, with significant impact on quality of life 
and healthcare costs that affects both pediatric and adults. Numer-
ous studies describe the characteristics of AR in adult and pediat-
ric patients, but do not compare the characteristics between both 
populations.
Objectives: The aim was to compare the characteristic of AR between 
child and adults.
Methods: Two observational, cross-sectional, multicenter studies were 
performed with data collection consecutively in two phases, the study 
in children and study in adults. The AR was classified according to the 
criteria original Allergic Rhinitis and Its Impact on Asthma (o-ARIA) and 
a modification of this classification (m-ARIA), and comorbidities were 
also assessed. We compared both databases, and we was performed a 
database in common, for analysis by SPSS 15.0
Results: 5405 patients (children: 1275; adults: 4130) were included, 
mean age 37.5 (±13.4) years in adults and 9.05 (±1.93) years children. 
Distribution by gender was 41 % girls and 52 % female. According to 
their duration, was intermittent in 59.5 % children and 51.5 % adults 
(p  <  0.001). According o-ARIA classification adults was 26  % mild, 
74 % moderate and severe. Children was 10.3 % mild, 90 % moderate-
severe (p < 0.001). Depending on m-ARIA classification, AR adults was 
moderate 56.7 and 14.5 % severe. In children was moderate 68.3 and 
18.2 % severe (p < 0.0001). Adults T4SS (6.50 ± 2.8) were higher than 
children (6.25 ±  2.8; p  <  0.01). Moreover, adults VAS (39.78 ±  23.60) 
were higher than children (36.99 ± 25.47; p < 0.0001). According clas-
sification allergen implicated adults was perennial 35 % of them and, 
children 39  % (p  <  0.001). Regarding comorbidities, 49.5  % children 
had asthma and 20  % adults; 54  % children had conjunctivitis and 
28 % adults (p < 0.0001).
Conclusion: We found significant differences between the character-
istics of AR between children and adults. Rhinitis is more intermittent 
and severe in children, being also more prevalent comorbidities.
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Background: Asthma and rhinitis are the commonest chronic diseases 
in pregnancy, with possible outgrowth in progeny.
Objective: This study aimed to characterize the immune profile of 
atopic asthmatic women in late pregnancy, and to further evaluate 
its relation with the development of atopic signs and symptoms in 
newborns.
Methods: Third trimester asthmatic pregnant women (n =  15) were 
recruited between the 31st and 36th weeks of gestation. At this time 
point, peripheral blood samples from each woman were collected 
and analyzed by Flow Cytometry, in order to characterize T and B cell 
subsets. Six months after birth, the babies were clinically assessed and 
atopic manifestations were investigated (atopic dermatitis, recurrent 
wheeze). Statistical analysis was done using GraphPadPrism6 (statisti-
cal significance: p-value <0.05).
Results achieved: After separating the mothers in two groups (BW-
babies with complications, n  =  6, and BWO-babies without com-
plications, n  =  9), differences were observed, with BW mothers 
presenting increased circulating activated CD4+CD25+ T cells and 
decreased effector memory CD8+ T cells (p < 0.05) in late pregnancy. 
Within B cells, BW mothers had a significantly higher percentage of 
transitional CD38++IgM++ B cells (p < 0.001).
Conclusion: BW mothers do have distinguishing immune features in 
late pregnancy, with a more activated T cell compartment and loss of 
circulating effector memory CD8+ T cells. Interestingly, effector mem-
ory CD8+ T cells, highly activated, are the most important subset of T 
cells at the fetal–maternal interface.[1] We speculate that BW mothers 
have a higher migration of effector memory CD8+ T cells into the fetal-
maternal interface, and this activation status may alter the immune 
response of the child. Transitional B cells point towards a more effec-
tive B cell output in BW mothers. These are preliminary data that need 
further confirmation, but can be useful in the future development of 
atopy risk markers in children from atopic mothers.
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Background: It was suggested that bacterial infections in children at 
early ages can protect allergic reactions in future. Nevertheless, con-
tact to bacterial products such as endotoxins in early childhood may 
protect development of allergic diseases later in childhood is still a 
dilemma.
Aim: The aim of the study is to assess the impact of neonatal sepsis 
on development of asthma, allergic rhinitis and atopic dermatitis in 
children.
Methods: 126 children were divided into two groups. Group 1 was 
consists of 63 subjects (mean age 67.2  ±  8.4  months) who have 
been hospitalized or have had sepsis in neonatal period. Another 63 
children (mean age 91.4 ±  24.2  months) were in group 2 who were 
chosen among the siblings of group 1 to minimize genetical and envi-
ronmental factors which affect developing allergic diseases. The preva-
lence of asthma, atopic dermatitis and allergic rhinitis were compared 
between two groups. Comprehensive examination was performed for 
all subjects by the same pediatric allergist. The Turkish version of Inter-
national Study of Asthma and Allergies in Children (ISAAC) question-
naires were utilized for each subject. Face to face methodology was 
used to complete all ISAAC questionnaires. In addition, total blood 
count for eosinophilia, total IgE levels were measured and skin prick 
tests were performed for each subjects.
Results: Total IgE levels and sensitivity of dermatophagoides pteron-
yssinus, dermatophagoides farinea were significantly lower (p < 0.05) 
in group 1. In addition, prevalence of allergic symptoms and diag-
nosed asthma were also found significantly lower (p < 0.05) in group 
1. However, we found no significant difference between two groups in 
terms of prevalence of allergic rhinitis and atopic dermatitis.
Conclusion: Our study has highlighted that severe infections such as 
sepsis in neonatal period can protect from sensitization to environ-
mental allergens and developing asthma in later childhood.
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Selective IgE deficiency was recently associated with immune system 
dysregulation leading to lung diseases, autoimmunity and chronic 
urticaria in adults and children. Seventy-six children with selective 
IgE deficiency have been studied since 2005 (44.7 % boys, mean age 
55.7 ± 34, ranging from 11 to 120 months). Clinical history was taken, 
SPT, nasal as well as sputum cultures, lung function test and chest 
x-ray were performed.
Results: Recurrent upper and lower airway infections were reported 
in 54 % whereas 23 % were admitted to hospital due to serious infec-
tion or respiratory distress. Abnormal CXR was detected in 26.3 % of 
cases. Family atopic history was positive in 33 % whereas 58 % of cases 
were passive smokers. 15.7 % had active asthma and 14 % sensitiza-
tion to aeroallergens but no relation was detected between asthma 
symptoms and allergy sensitization or parental atopic history. Six cases 
(8  %) suffered from chronic rhinosinusitis and one child had chronic 
urticaria and Hashimoto disease. 17 % had reported atopic dermatitis.
Conclusions: Selective IgE deficiency seems to be related to increased 
prevalence of lung diseases and non atopic asthma. Low serum total 
IgE may be used as a marker of immune dysregulation.
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Non skeletal effects of vitamin D have been discussed in recent stud-
ies and many reports refer to its role in health and disease. There is 
also evidence that vitamin D deficiency can impair immune function, 
resulting in both, overactivity or suppression. However, there are no 
studies relating Vitamin D levels to total IgE, a basic marker of allergic 
diseases. The main aim of this study was to relate levels of 25(ΟΗ) Vita-
min D3 to total IgE in general population. Clinical and laboratory data 
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from 223 children and adolescence (54.3 % boys, mean age 10.8 years, 
4.5–18  years) who proceeded to the pediatric unit for vaccination, 
were analyzed. Serums were collected during winter 17.4  %, spring 
43 %, summer 19.7 % and autumn 19.7 %.
Results: Mean levels of 25(ΟΗ) Vitamin D3 was 25.66  ±  10.02  pg/
ml whereas deficiency (<20  pg/ml) was detected in 35  % of the 
cases. Mean level of IgE was 203 ± 70 KU/L whereas 30, 20.5 and 5 % 
reported active asthma, allergic rhinitis and eczema respectively. Lev-
els of 25(ΟΗ) Vitamin D3 showed a negative association with total IgE 
(p = 0.001). This association was constant when total IgE was >60 IU/
ml and independent of season, sex and age.
Conclusion: Total IgE was inversely related to 25 (ΟΗ) Vitamin D3 in 
serums. Allergic diseases might influence vitamin D synthesis or vice 
versa, low levels of vitamin D might increase allergic markers. More 




Clinical and Translational Allergy 2016, 6(Suppl 1):PP05
PP06
WITHDRAWN
Clinical and Translational Allergy 2016, 6(Suppl 1):PP06
PP07 
Asthma control questionnaire and specific IgE in children
 Snezhina Lazova, Guergana Petrova, Dimitrinka Miteva, Penka 
Perenovska
Pediatric Clinic, University Hospital “Alexandrovska”, Sofia, Bulgaria  
Correspondence: Snezhina Lazova
Clinical and Translational Allergy 2016, 6(Suppl 1):PP07
Background: Atopy and allergy have long been associated with 
asthma. Usually the presence of atopy or any allergic diseases could 
interfere and obstacle the control of asthma.
Method: For a period of 6 months we evaluated medical history data 
of 113 children with asthma aged 3–17 years. For all children we drew 
blood for IgE against inhalation and food allergies antibodies detec-
tion and asked them to fill ACQ. IgE were detected with the prede-
signed kit EurolinePediatric.
Results: We found that the children claiming to have more limited 
physical activities to have inadequate asthma control (ACQ ≥ 1.5) Ele-
vated titer against specific IgE (especially birch, D. pteronyssinus and D. 
farinae) are correlated with worse asthma control (p < 0.05).
Conclusion: Closer monitoring for patients sensitive to birch, D. pter-
onyssinus and D. farinae is needed in order to prevent bad asthma 
control.
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Objective: To study the clinical features of the current chronic urti-
caria (CU) of adolescents.
Materials and methods: The study involved 28 patients aged 
17–19  years. A comparison group was presented of 34 patients mid-
dle-aged (30–50  years) with CU. All patients had a comprehensive 
examination, including clinical history, physical examination, labora-
tory and instrumental examination, specific allergy tests.
Results: Among adolescents with CU dominated male (79 %), among 
the middle-aged patients were predominantly female (85 %). The most 
common form of CU of adolescents was inducible (63.8  %): dermo-
graphic (39 %), and the combination of cold contact and cholinergic 
forms (14.3 %). The inducible CU met among young men 2 times more 
often (72.1 %) than girls (32 %). Spontaneous CU prevailed among the 
middle-aged patients (75 %), this form met with the same frequency 
among men and women. It should be noted that spontaneous urti-
caria of adolescents was predominantly moderate. Middle-aged 
patients had not only moderate disease, but mild (19.6 %) and severe 
(9.8 %) CU also. Urticaria in half of boys and girls was observed more 
than a year. 70 % of men over 30 years had symptoms of CU less than 
6  months, while 55.2  % of women with CU had urticaria more than 
1 year. Most common comorbidities of adolescents were a disease of 
gastrointestinal system (57.1 %) and helminth infections and parasito-
sis (21.4 %). Patients of middle age had also pathology gastrointestinal 
system (48.4  %), parasitosis with helminths occurred in 2 times less, 
and 16 % of patients diagnosed with autoimmune thyroiditis.
Conclusions: CU of adolescents had certain features. Urticaria 
observed among young men mainly. The symptoms of urticaria 
induced mainly by physical factors. The most common forms of urti-
caria is inducible: dermographic and combination cold contact with 
cholinergic. Idiopathic CU usually has moderate forms. The most com-
mon comorbidities are diseases of the gastrointestinal system, hel-
minth infections and parasitosis.
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Objectives: To characterize the clinical features, response to therapy, 
evolution and prognosis of pediatric cutaneous mastocytosis in a chil-
dren hospital in Athens, Greece.
Methods: We conducted a file review of children diagnosed with cuta-
neous mastocytosis at Children’s Hospital in Athens, Greece, over the 
last year. We evaluated gender, age at onset, character and distribution 
of lesions, associated symptoms and course of the disease.
Results: In total 8 children were diagnosed with mastocytosis based 
on clinical presentation and on histological examination of the skin 
using special stains. There were 62.5 % cases of urticaria pigmentosa, 
12.5 % of cases of mastocytoma and 25 % of diffuse cutaneous mas-
tocytosis. In 100 % of cases disease onset was in the first year of life. 
There was a male predominance 2:1. There was a male predominance 
2:1. The majority of lesions were distributed over the trunk and limbs. 
Different kinds of associated symptoms were noticed. None of the 
cases was familial. Treatment did not modify the disease evolution.
Conclusion: Pediatric onset mastocytosis is an unusual disease with 
an often benign course. Most cases of pediatric mastocytosis appeared 
within the first year of life, especially on the trunk. The most common 
clinical form of mastocytosis was urticaria pigmentosa followed by dif-
fuse cutaneous mastocytosis and mastocytoma. The disease in child-
hood is less likely to have a systemic component. The prognosis of 
pediatric mastocytosis in general is good.
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Introduction: Egg allergy is one of the most common food allergies in 
children. Even if tolerance has developed in 70 % of the children by the 
age of 16, there is evidence that children outgrow their allergy at older 
age now compared to past decades. There is a variety of symptoms 
from eczema to anaphylaxis. Comorbidity with other allergic diseases 
is common. The aim of this study was to evaluate if specific symptoms, 
comorbidities or biochemical markers could be used as prognostic fac-
tors in the development of tolerance.
Methods: 52 children (28 boys and 24 girls) with a mean age of 7.8 
(±4.1) years underwent oral egg challenge in 2012–2013. Their his-
tories included comorbidities like atopic eczema (40  %) and peanut 
allergy (40  %). 17  % of the participants had no comorbidities. When 
exposed to egg 79 % of children had a history of skin symptoms, 46 % 
gastrointestinal tract symptoms, 11 % airway symptoms and 4 % ana-
phylaxis. Using logistic regression, we have searched for associations 
between age, gender as well as specific clinical characteristics and bio-
chemical markers (IgE to egg and ovomucoid) and the oral egg chal-
lenge result.
Results: 33 children had a positive egg challenge. Preliminary analy-
sis not including any covariates showed nominally significant associa-
tions between IgE to egg ≥0.35 kU/l and IgE to the egg component 
ovomucoid ≥0.35 kU/l and positive oral egg challenge result (p-values 
0.028 and 0.028 respectively). However, adjusting for age at provoca-
tion, only the association between IgE to egg and the oral challenge 
result remained nominally significant. There was no association 
between comorbidities or a specific symptom and the oral egg chal-
lenge result.
Conclusions: Positive IgE to egg was the only factor that could be 
used as a prognostic factor for the result of an oral egg challenge in 
children with a history of egg allergy.
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Background: Nearly 2.2–2.5  % of infants and children under 3  years 
of age are diagnosed with cow’s milk protein allergy (CMPA), resulting 
in atopic dermatitis, diarrhea, urticaria, vomiting, and gastroesopha-
geal reflux (GER) [1,2]. Current management for infants and children 
with CMPA includes complete avoidance of cow’s milk protein and 
initiation of extensively hydrolyzed protein (EHP) formula. However, 
in infants and children unable to tolerate EHP formulas, amino acid-
based formulas are often recommended.
Objective: To evaluate the efficacy of an amino acid-based formula in 
infants between the ages of 1–12 months with CMPA who had history 
of weight loss of >0.5 WHO Reference z-score while on an EHP formula.
Methods: This was an observational, prospective, multi-center study 
conducted in France. Infants were put on an amino acid-based formula 
for 12  weeks. The primary outcome for this study was infant z-score 
change over the 12 weeks of feeding. Formula efficacy was evaluated by 
body weight gain and evaluation of allergic manifestations (atopic der-
matitis (AD), bloody stools, GER score, chronic diarrhea, and urticaria).
Results: Thirty (30) of 32 infants completed the 12-week feeding 
period. Mean weight gain over the 12  week feeding period was 
+0.43 ± 0.28 (mean ± SD). Improvement was observed for all aller-
gic manifestations, both in terms of the number of infants present-
ing symptoms and the intensity of symptoms. For AD, 13 presented 
and 7 continued at end of study (SCORAD improvement p = 0.02). 
Over the 12  week feeding period, an improvement of the over-
all GER score was observed, −10.5 ±  1.8 (mean ±  standard error, 
p < 0.01).
Conclusions: The amino acid formula supported healthy weight gain 
and improvement in allergic manifestations in CMPA infants who had 
a history of intolerance to EHP formulas.
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Background: Anaphylactic shock is a life-threatening circumstance 
which requires urgent and proper medical management. The delay 
in making an accurate diagnosis, initiating appropriate treatment and 
inappropriate use of epinephrine can lead to death.
Objectives: This study is designed to evaluate and emphasize the par-
amount importance of the trainee knowledge about anaphylaxis, the 
treatment methods, life-saving medications, the route of administra-
tion and the dosage.
Method: This is a cross-sectional two phase questionnaire based sur-
vey at Hamad General Hospital’s Pediatrics department, in Doha-Qatar.
Results: In phase 1, the questionnaires were distributed to 96 train-
ees. The response was 98  % (94 responses). 84 trainees (89.3  %) 
reported knowing how to treat and a total of 44 (50  %) claimed not 
being trained at all. Epinephrine was selected as a life saving drug by 
89 (94 %). Correct Epinephrine concentration was known by 77 (83 %). 
For phase 2, questionnaires were distributed to 94 trainees who 
responded to the stage 1 and the response rate was 89 % (84). 84 % 
claimed they heard about Epinephrine Auto injector, 72  % claimed 
knowing when to use it .23 (27 %) did not know. Anaphylaxis was the 
case of using it in 71 %. Only 43 responders (51 %) know the right loca-
tion and the method of injection.
Conclusion: Although prompt treatment with epinephrine is 
deemed to be critically important for survival in anaphylaxis, we 
have huge gap between theoretical knowledge about epinephrine 
concentration and site of administration of epinephrine and funda-
mental practice among pediatrics trainees. Analysis of these data 
necessitates the urgent need of a concrete program for teaching the 
trainees, especially the pediatrics fellows to solidify their knowledge 
about anaphylaxis. More important practical guidelines about the 
site of administration, what concentration and how to act fast when 
faced with anaphylaxis is needed to be taught to current and future 
trainees.
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Hypothesis: Several studies suggest an increase in both the preva-
lence of food allergy and in the frequency of emergency department 
(ED) visits for food-related allergic reactions, including anaphylaxis.
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Aim: To describe the key features of anaphylactic reactions in chil-
dren and their management when presenting to the Emergency 
Department.
Study design and method: Patients aged 0–16 years who presented 
to a large academic ED, and met diagnostic criteria for anaphylaxis, 
were consecutively included from July 2013 to February 2015. We col-
lected data on patient characteristics, suspected triggers, signs and 
symptoms, ED management, and discharge recommendations.
Results: 48 cases presented to the ED with anaphylaxis, either 
directly (77  %) or referred by a General Practitioner (23  %). Anaphy-
laxis was the first allergic event in 81  % of the cases. Food caused 
73  % of events, with egg (25  %) and cashew nut (17  %) being the 
most common eliciting foods. Skin (92  %) and airway (89  %) symp-
toms predominated, with gastro-intestinal (48 %) and cardio-vascular 
symptoms (46 %) also frequent. Emergency medication was given by 
lay person before presenting to ED in 33 % of cases. Adrenaline i.m. 
was given in 50 % of the cases: in ED in 8/24 cases (33 %), self adminis-
tered in 5/24 cases (21 %), by GP prior to ED attendance in 9/24 cases 
(37 %), and in 2 cases by paramedics. 65 % were hospitalized. None 
of the 7 new patients (18 %) discharged directly from ED, were given 
adrenaline auto injectors prescription and training, but they were all 
referred to a specialist clinic.
Conclusions: Food allergens are the main triggers for anaphylaxis in 
Irish children. The rate of Adrenaline use in emergency setting clearly 
needs to improve in Ireland, and barriers to Adrenaline use must be 
addressed.
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Background: Allergic diseases can have detrimental effects on physi-
cal, emotional and social life especially in childhood and they can 
affect significantly children’s ability to flourish.
Aim: To develop an effective model of care for allergic children at 
school and ensure all staff are familiar with and able to implement it.
Methods: A self-completed postal questionnaire was sent to all 
Cumbrian schools (n =  312) to assess three primary areas of con-
cern: existing protocols for anaphylaxis management, training 
offered by and to schools and preventative measures. Subsequently, 
training on how to deal with anaphylaxis was offered to 10  % 
(n = 18) of all participating schools. A follow-up questionnaire was 
sent to measure the preparedness and confidence by staff following 
the training.
Results: Prior to training 47  % of all participating schools felt com-
pletely confident dealing with anaphylaxis while 55 % felt prepared for 
anaphylaxis in children without a prior history of allergies. 78 % of the 
schools felt that further training in anaphylaxis would be beneficial. 
82 % believed that a national school policy in managing anaphylaxis 
is needed and 96  % agreed with the genetic provision of adrenaline 
auto-injectors along with individual anaphylaxis plans to be kept at 
school.
45 % of the schools have a no-nut policy while 56 % have one on no 
food-sharing. However, only 38 % have a no eating-utensil sharing pol-
icy and 34 % one on no eating-on-transport to and from school.
The confidence level in dealing with anaphylaxis increased to 95  % 
post training while 100 % of them are updating their no-nut, no food 
and no eating-utensil sharing and no eating-on- transport to and from 
school policies.
Conclusions: Adopting a county-wide, age appropriate school proto-
col including training in anaphylaxis led by the school and supported 
by all the stake holders will ensure that all school staff can prevent, 
recognise and initiate safe treatment of anaphylaxis.
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Rationale: No tool currently exists to measure health related quality of 
life (HRQL) in Food Protein Enterocolitis Syndrome (FPIES). We investi-
gated the ability of the FPIES Quality of Life Questionnaire (FPIESQL), 
Parent and Child Short Form to accurately assess the impact of FPIES 
on the HRQL of children, aged 0+ years. FPIES are similar to severe 
forms of food allergy where there is the risk of death, but due to hypo-
volemic shock rather than anaphylaxis. FPIES are also different from 
classic IgE mediated food allergy, as the foods involved are often atypi-
cal foods and not validated tests exists.
Methods: Following initial validation with 148 Irish, UK, and US car-
egivers of children with FPIES of the protocol instrument, 68 Irish and 
UK parents completed the short online version of the questionnaire on 
the impact of FPIES on their child (10 items) and on the parent them-
selves (10 items). The measure underwent further psychometric analy-
sis including factor analysis and reliability analysis.
Results: Parents of children (58  % male) aged between 6  months 
and 8  years completed the questionnaires. Analyses demonstrated 
high reliability (α =  .92). Bartlett’s test of sphericity, Χ2(45) =  257.3, 
p ≤  .001, showed good correlation between items. Two components 
had eigenvalues over the KMO criterion of 1 and explained 70  % of 
the variance in the impact of FPIES on HRQL, demonstrating construct 
validity. There was a high positive correlation between independent 
clinical items and scores on the questionnaire.
Conclusions: The new questionnaire allows for a disease specific anal-
ysis of the impact of FPIES on HRQL in both parents and children. It will 
provide a powerful disease specific outcome and tracking measure in 
both research and clinical contexts.
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Rationale: There is limited research into coping and management 
strategies of teenagers and young adults living with food allergy, par-
ticularly with a strong developmental focus using either qualitative or 
quantitative methods.
Aim: The current study qualitatively investigates the experiences of 
teenagers and young adults in growing up and living with food allergy 
with emphasis on coping, management and risk, support, and social 
and self-identity.
Method: In-depth case study interviews were conducted with partici-
pants aged 18–24, and analysed following the method of Interpreta-
tive Phenomenological Analysis.
Results: The analysis yielded five super-ordinate themes: “change as 
a process”, “being consumed by panic”, “using mechanisms to cope 
with fear”, “creating internal and external stability”, and “compromis-
ing safety for normality”, with the overarching theme “gaining control”. 
Findings show that coping and management in food-allergic young 
adults is a journey. This journey is similar for all young adults in that 
they all are striving for control, though their experiences are unique. 
All are challenged by the developmental juncture with which they are 
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faced as young adults and are informed by previous developmental 
transition experience. While they move towards developing independ-
ence, young people rely on external support for their safety and to 
cope with the fear and anxiety around reactions.
Conclusions: The findings from this study add complexity to our 
existing knowledge of coping and management in food allergy from 
a developmental perspective, and can be used as a basis for interven-
tions or further qualitative and quantitative research in the field.
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Background: The epidemiology of cow’s milk protein allergy (CMPA) 
remains poorly defined in North Africa. The aim of this study is to 
report the epidemiological, clinical and evolutionary characteristics of 
CMPA in children living in Constantine.
Method: This is a retrospective study that included all children with 
CMPA seen in a pediatric allergy clinic from 1996 to 2013 and all avail-
able data were used.
Results: 62 cases were gathered (32 boys and 30 girls). The average 
age when the reaction to cow’s milk formula took place was 4 months 
(3  days–14  months) and 43  % received some cow’s milk supplement 
during the lactation period; a first degree family history of atopy was 
revealed in 54 % of cases. The clinical signs were in 54 % of cases cuta-
neous. Prick-tests were performed on 87 % of the children and CMP-
specific IgE in 45 % of them. 32 % had a Diagnostic elimination diet.
All patients adhered to strict avoidance of CMP and received an eHF 
with a good tolerance in 86 % of cases, goat’s milk used without medi-
cal advice induced urticaria or anaphylaxis and Camel’s milk was not 
tolerated. Reintroduction of CMP was conducted in hospital in 75  % 
of cases, the age of reintroduction varied from 12 months to 3 years. 
In 10 % of cases reintroduction was done at home by parents. CMPA 
remains persistent in 9  % of cases and 48  % of the patients in this 
study developed asthma and or allergic rhinitis.
Conclusion: CMPA is probably the most common food allergy in 
infants under 12 month in Algeria, CMPA testing should include other 
food allergens and aeroallergens. Home reintroduction of CMP and 
use of goat’s milk are not permitted. More studies on camel’s milk 
should be done. An early identification of, and intervention for, CMPA 
is essential to avoid vital complications.
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Aim: To report clinical features and outcomes of oral immunotherapy 
(OIT) in children with cow’s milk (CM) and egg allergy (EA).
Methods: Retrospective study of children with CM and EA who have 
undergone OIT with CM or raw egg from January 2011. Variables: age 
at oral food challenge (OFC), gender, atopic history, skin prick test 
(SPT), total and specific IgE (s-IgE) and OIT outcomes.
Results: 87 patients included, 39 with CMA and 48 with EA. 58.6  % 
boys, 67 % with atopic family history, 45 % had atopic dermatitis and 
55.2 % had one or more food allergies.
CM allergic children: 69.2  % (27) had anaphylaxis at OFC before OIT, 
needing epinephrine 30.8 % (12). Mean CM and casein SPT and s-IgE 
were: 10.11 mm (3.5–19), 8.9 mm (3.5–17.5), 80.5 KU/L (1.34–688), and 
80 KU/L (1–694), respectively. Mean time at build-up phase 8.7 months 
(2–33), with statistical significance for those with casein s-IgE >50 
KU/L. At the maintenance phase only 1 child withdrew due to adverse 
events. The achieved dose range was 75–200 ml.
EA children: 39.6  % (19) had anaphylaxis at OFC before OIT, needing 
epinephrine 47.3 % (9). Mean egg-white, ovoalbumin, ovomucoid SPT 
and s-IgE were: 8.3 mm (0–13.5), 8.3 mm (0–14.5), 7.4 mm (0–13.5), 17.6 
KU/L (0.35–101), 10.6 KU/L (0.35–101) and 12 KU/L (0.35–101), respec-
tively. Mean time at the build-up phase 7.2 months (2–25). 5 children 
withdrew due to adverse events, 3 at build-up and 2 at maintenance 
phase. The achieved dose range was 15–30 ml of raw egg-white.
Conclusion: Most of the children (93  %) completed our OIT proto-
col for CMA and EA. The time to complete the build-up period was 
longer for children with casein s-IgE >50 KU/L. In EA, drop-outs due to 
adverse events were more frequent.
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Background/Aims: In the UK it is estimated that 2–2.5  % of infants 
suffer from CMPA, but the diagnosis can be easily missed and it is 
important to recognise this condition promptly and treat effectively. 
Our aim was to investigate whether pediatric doctors, working in 
Betsi Cadwaladr University Health Board (BCUHB) comprising of North 
Wales Hospitals, were aware of the CMPA guidelines and if they imple-
mented these guidelines appropriately in clinical practice.
Methods: All pediatric doctors working in pediatric departments of 
BCUHB were asked to complete a specific questionnaire in order to 
determine their awareness on diagnosis and management of CMPA. Of 
the 50 distributed questionnaires, 40 were completed and returned to us.
Results: About 25 % of doctors were unaware of CMPA guidelines and 
30 % stated they were not confident in managing this condition. Nearly 
80 % of medical staff provided the right advice for CMPA in breast fed 
infants including duration of treatment and appropriately selected the 
hydrolysed formula for bottle fed infants. A good proportion of medical 
staff deviated from the guidelines regarding the management of CMPA 
in cases of anaphylaxis (52.5 %) and failure to thrive (FTT) (85 %).
Conclusions: Overall medical staff had a good understanding of 
CMPA guidelines. However nearly a quarter of staff was not aware of 
the existence of guidelines and another third stated they had not read 
them. In addition the majority deviated from guidelines in terms of 
FTT and anaphylaxis in CMPA. Therefore it is important to educate staff 
regarding the presence of guidelines and management of CMPA, as 
prompt and correct diagnosis of this condition will reduce the parental 
anxiety and will decrease the financial burden on the Health System.
PP21
WITHDRAWN
Clinical and Translational Allergy 2016, 6(Suppl 1):PP21
Page 25 of 60Clin Transl Allergy 2016, 6(Suppl 1):42
PP22 
Anaphylaxis: the great unknown for teachers. Presentation of a 
protocol for schools
 Mercedes Escarrer1, Agustín Madroñero1, Maria Teresa Guerra2, Juan 
Carlos Julia3, Juan Carlos Cerda3, Javier Contreras4, Eulalia Tauler5, Maria 
Jesus Vidorreta3, Ana Rojo6, Silvia Del Valle5
1Clínica Juaneda, Palma de Mallorca, Spain; 2Cadiz, Spain; 3Valencia, Spain; 
4Madrid, Spain; 5Barcelona, Spain; 6Granada, Spain  
Correspondence: Mercedes Escarrer
Clinical and Translational Allergy 2016, 6(Suppl 1):PP22
Background: The cases of food allergies have doubled in the last 
10 years and the number of hospitalisations caused by severe allergic 
reactions has increased seven fold in the same period.
Objective: To emphasise the importance of reaching an early diag-
nosis and appropriate treatment in order to prevent such serious inci-
dents and improve patients’ quality of life.
Methods: In 2014 we made a questionnaire on 2481 Spanish teach-
ers between November 2013 and January 2014, with the following 
questions:
(a) Do you know what anaphylaxis is?
(b) Are there any students in your class who have ever had an ana-
phylactic reaction?
(c) Would you know what to do if a student had an anaphylactic 
reaction in your school?
(d) Would you know how to administer the medication if a student 
had an anaphylactic reaction in your school?
Results: In the survey it became evident that knowledge about ana-
phylaxis was scarce, only 40.5 % reported knew what anaphylaxis was 
and only 11 % said they would know how to administer the auto-injec-
tor adrenaline (Fig. 2).
Conclusion: We present a protocol for teachers in case of anaphylaxis, 
where we explain simply the steps and how to use the auto-injector 
adrenaline with drawings.
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Background: Food allergy (FA) affects up to 4–7 % of primary school 
children in Europe. Despite the rise in diagnosis, many community 
members are unaware that a severe allergic reaction, such as anaphy-
laxis, could result in death. Food allergy can often be confused with 
food intolerances leading to misunderstandings regarding severe 
allergic reactions. It can also have a significant effect on the quality of 
life (QoL) of the FA child and their parents in social interactions.
Objective: The focus of this research is in the area of extra-curricular 
activities that FA children participate in. No previous FA studies have 
looked at this before. Such a study is of significance in order to under-
stand parental concerns and if necessary improve supports within the 
community.
Methods: A qualitative approach was used by conducting semi struc-
tured telephone interviews and analysed using thematic analysis.
Results: The interviews produced a number of key findings: food 
was regularly provided at one or more of the activities which the 
child engaged in, although primarily in team sports; parents tended 
to stay at the activity partly due to trust and also due to a sense of 
responsibility.
Conclusion: The main conclusion drawn from this study was that 
there is a lack of awareness and understanding of FA indicating that 
there is also no risk perceived by some coaches or instructors. Some 
sporting bodies were more proactive with regards training than oth-
ers, but central to the risk of food allergen exposure is the education 
of the coaches and instructors in all activities where there is a poten-
tial for food to be provided. This research proffers engagement with 
coaches and instructors at community level to recognise that this is 
a real concern for parents of FA children and also to get governing 
sports bodies involved in developing FA and anaphylaxis policies.
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Introduction: Parents often overestimate the likelihood of their child 
having a food allergy.[1] Food challenges allow the health care profes-
sional to determine if a true food allergy exists. Food challenge audits 
such as this will help tailor the decision whether or not a food chal-
lenge is required in this subpopulation.
Aims:
1) To review the activity of food allergen challenges.
2) To determine food challenge results verses international stand-
ards.
Methods: Data of food challenges that occurred from 2012–2014 were 
reviewed and placed into the following categories; suspect allergen, 
type of challenge performed, IgE sample obtained, skin prick testing 
(SPT) performed, passed challenge, failed challenge, type of reaction if 
failed, treatment given if failed and follow up at 24 h.
Exclusion Criteria: Drug allergy challenges and food challenges with 
incomplete information were excluded.
Results: A total of 164 challenges were performed over the time 
period. 161 of these were food related. The main food allergens chal-
lenged were milk (N = 54), peanut (N = 47) and egg (N = 40). There 
was one case of a food challenge (wheat) with exercise. A total of 45 
patients underwent SPT prior to the food challenge, 119 underwent 
IgE testing and 35 had both investigations. There were 119 (73  %) 
passed and 42 (27  %) failed food challenges. There was one case 
of anaphylaxis. The most common post challenge reaction noted 
was urticaria (N =  22). There were two incidents of respiratory reac-
tions requiring Beta-2 agonists. One case of eczema flare at 18 h was 
documented.
Conclusion: A significant number of food challenges occurred with-
out any prior investigation. There was a large discrepancy between 
Fig. 2 Protocol
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the number of those who passed verses failed the food challenges. In 
time, the international standard of a near 50  % pass verses 50  % fail 
rate should be reached with more stringent criteria.[2] Until then lim-
ited resources will lend to higher than averages pass rates.
References
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assessed food hypersensitivity amongst 6‑year old children: a population 
based study. Pediatr Allergy Immunol. 2006;17(5):356–63.
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Background: Anaphylaxis is a potentially life-threatening systemic 
hypersensitivity reaction and its first-choice treatment is Epinephrine 
given intramuscularly (IM). On discharge, all patients should be pre-
scribed epinephrine auto injectors, and referred to an allergist. But do 
we use the epinephrine appropriately in case of anaphylaxis or do we 
skip it?
Methods: We studied retrospectively 41 children who performed ana-
phylactic reaction and who were admitted to the emergency depart-
ment or were attended by emergency mobile units during a 9-years 
period (2006–2015) in a 700,000 population. We determined the prev-
alence of use of epinephrine as a first-choice treatment and the per-
centage of patients in whom epinephrine auto injector was prescribed 
when they were discharged.
Results: Only 22 % of the patients were treated with epinephrine IM 
when anaphylaxis was presented. Just 4.8 % of the patients received 
prescription of epinephrine auto injector when hospital/ED discharge. 
All patients were referred to an allergist.
Conclusions: The use of epinephrine as a first choice treatment is still 
not solid. The prescription of epinephrine auto injectors when patients 
are discharged from emergency departments is still an issue.
Keywords: anaphylaxis; emergency; infant; epinephrine.
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Background: It has been established that child allergies, such as 
asthma and rhinitis, have a direct impact on carers (usually the 
mother), increasing their likelihood of psychological disorders and 
social network deterioration. It is hypothesised a significant interac-
tion between mother’s psychological state and child’s food allergy 
(FA) symptoms; however, there is very little information on FA regard-
ing this topic. Therefore, this study compared the relative odds of the 
occurrence of gastric symptoms in the food allergic child given expo-
sure to maternal psychosocial factors.
Methods: Mother’s psychological state was evaluated and analysed 
against the occurrence of FA gastric symptoms in their children in a 
cross-sectional study involving 206 participants (mothers and chil-
dren). Logistic regressions were used to determine whether mother’s 
psychological state is a risk factor for child’s gastric symptoms and to 
compare the magnitude of different psychological variables as risk fac-
tors for a specific gastric symptom occurrence.
Results: High levels of anxiety were found in 44 % of the participants, 
depressive symptoms on the 21.4 and 68 % had moderate or high psy-
chosocial impact due to CFA. Low perceived social support was found 
in 21.4 % of the mothers. Higher CFA-Related Impact (CFA-RI) and CFA-
Related Social Impact (CFA-R SI) in the mother increase the possibility 
for abdominal pain (OR =  2.04; p  <  .001) and diarrhoea (OR =  1.32; 
p = .05) in the child. The possibility for abdominal bloating in the child 
increases when the mother suffer from higher anxiety (OR  =  4.45; 
p < .001), lower perceived social support (PSS) (OR = 3.17; p = .002) and 
CFA-RI (OR = 1.32; p < .05).
Conclusions: The psychological impact of caring a food allergic child 
and the perceived social support can predicts the occurrence of aller-
gic symptoms in children. CFA is propounded as a process where 
biological, psychological and social variables have a relationship of 
mutual influence. Therefore, a comprehensive care strategy that con-
siders the family perspective is proposed to achieve a more inclu-
sive and integrative care of CFA focused on “families living with food 
allergy”.
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Background: Tree nut allergy is a frequent medical problem. Some 
are allergic to tree nuts due to birch pollen cross reactivity whereas 
others have a primary tree nut allergy. There can be great regional 
variance in the serological profile and hence in clinical allergy. A pilot 
study suggested that hazelnuts, walnuts, pistachio nuts and cashew 
nuts were the most common nuts involved in allergic reactions in a 
Danish Pediatric population.
Aim: To investigate the correlation between sIgE towards four com-
mon tree nuts and the correlation between sIgE towards hazelnuts 
and birch pollen amongst patients in a Danish outpatient allergy clinic.
Method: Specific IgE in all patients born after January 1st 1991 with 
sensitization to tree nuts and birch pollen were sought in our sIgE 
(ImmunoCAP®) database.
GraphPad Prism 6 software was used for statistical analysis.
The interrelationship between sIgE was pictured in XY-plots and 
Spearman correlation was calculated for sIgE towards hazelnut and 
birch pollen and for sIgE towards hazelnut, walnut, pistachio and 
cashew measured in the same patients.
Results: The number of patients with sIgE >0.35 kU/l and median sIgE 
values:
  • Hazelnut: n = 560, median 10.75 kU/l
  • Cashew: n = 163, median 2.77 kU/l
  • Pistachio: n = 182, median 2.55 kU/l
  • Walnut: n = 164, median 3.85 kU/l
  • Spearman correlation coefficient between:
  • Hazelnut and birch: rs = 0.7947
  • Cashew and hazelnut: rs = 0.2172
  • Pistachio and hazelnut: rs = 0.2854
  • Walnut and hazelnut: rs = 0.3132
  • Walnut and cashew nut: rs = 0.4696
  • Pistachio nut and cashew nut: rs = 0.8313
 • Walnut and pistachio nut: rs = 0.4648
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Conclusions: Our findings show a strong relationship between sensi-
tization towards cashew nut and pistachio nut, and hazelnut and birch 
pollen and a moderate relationship towards walnut and cashew nut, 
and walnut and pistachio nut. Results from the same population are 
underway to determine the clinical association of these findings.
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Introduction: Worldwide, 8 % of the children are diagnosed with food 
allergy, which means 2 children in every classroom. In the last 10 years 
food allergies among children have increased by 50 % (CDC). In light 
of this concerning facts, more and more parents have to cope with 
an allergic child, being responsible for risk assessment and manage-
ment of their child’s condition. Nowadays, social media is a powerful 
tool that parents use to get informed. Despite this, little has been pub-
lished about social media role in health issues.
Objective: To evaluate the content of communication in parents dedi-
cated websites regarding topics on food allergy in children.
Design: We searched for non-medical online networking websites 
dedicated to parents, with topics and talks regarding food allergy in 
children and identified 19 online sites which we further evaluated in 
respect to content form (personal experience, information) and correc-
titude of information from a medical point of view.
Results: The number of answers to a topic was variable according to 
the popularity of the website, ranging from 8 to 215. However, the 
number of unique visualizations was exponentially higher, ranging 
from 3302 to 25.123.
Parents of children with food allergy either medically confirmed or sus-
pected use social media tools to ask for information and share personal 
experiences. The hierarchy of most common reasons to use the online 
media is the following: (1) to describe an acute reaction and ask for 
opinions on management and causes (2) to get informed about food 
diet and treatment and find out others experience with specific treat-
ment, including different brands, 3. Ask other parents to recommend 
a physician and/or a medical laboratory. Other important concerns 
raised by parents were the difficulties encountered regarding collec-
tivity attendance due to impossibility of providing food specific diet. 
There were some medically inaccurate recommendations such as use 
of homeopathic treatment or inadequate definition of medical terms.
Conclusions: Online social media provides a place to share personal 
experiences, receive emotional support and get information on medi-
cal management, suggesting that this tool should be better managed 
for greater efficiency.
Funding: This paper was co-financed from the European Social Fund, 
through the Sectorial Operational Programme Human Resources 
Development 2007–2013, contract POSDRU/187/1.5/S/155463 “Sup-
porting excellence in scientific interdisciplinary doctoral research in 
the economic, medical and social fields”, coordinator The Bucharest 
University of Economic Studies”.
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Introduction: Food allergy (FA) affects 8.5  % percent of children in 
Portugal. This study evaluates the impact of on quality of life (QoL).
Methods: We performed a study using the Food Allergy Quality of 
Life Questionnaire FAQLQ. The appropriate questionnaire will depend 
on the age of the patient. FAQLQ‑PF (0–12 years) as perceived by the 
parent. FAQLQ‑CF and FAQLQ‑TF are self-administered tools that 
measure the impact of FA on children (8–12  years) and teenagers 
(13–17 years). We applied the questionnaire to patients under 18 years 
diagnosed with FA in the last 2 months.
Information on food allergens and demographic data was collected 
for all children.
Results: The questionnaire FAQLP-PF was applied to 13 parents of chil-
dren under 12 years. The questionnaires FAQLP-CF and FAQLQ-TF were 
applied to 7 children and 9 teenagers, respectively.
The mean age of the food allergy population was 9  ±  5.2 
(1–17  years). 16 patients (55.2  %) were male; 34.5  % had rhinitis, 
27.6  % had atopic dermatitis and 13.8  % had asthma. 17 (58.6  %) 
were allergic to 1 or 2 foods; 12 (41.4 %) were allergic to 3 or more 
foods. The egg is the most common food allergen implicated in chil-
dren (37.9 %), followed by milk proteins (31.09 %), shrimp (31.09 %), 
and fresh fruits (27.6 %).
The median score of the questionnaires were: FAQLQ-PF = 5.2; FAQLQ-
CF = 4.9; FAQLQ-TF = 4.
The correlation between the severity of the reaction (Mueller classifi-
cation) and the FAQLQ is 0.3 (p = 0.05). The correlation between the 
number of food and impairment in the QoL was not found.
Conclusions: The parents were the group most affected about the 
impact on quality of life (FAQLQ-PF 5.2) as they indicated that FA sig-
nificantly impact meal preparation, impact on their level of stress, 
affected family social activities and affected their child’s school 
attendance. We found a positive but weak correlation between the 
severity of the reaction and the impairment in the quality of life 
(FAQLQ).
The results show that FA impairs the children’s quality of life in all age 
groups and also the quality of life of their families. We suggest the 
regular evaluation of the quality of life in the clinical management of 
children with FA.
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Background: Immediate reactions against contact to raw potato 
has been reported in adults with generally being in the form of an 
oral contact dermatitis or contact urticaria, but it may also manifest 
as rhinitis symptoms, wheezing or even anaphylaxis. Cooked or raw 
potato allergy has been rarely reported in children as some is being 
immediate and others being late reactions, and it usually results from 
ingestion.
Objective: We report two cases with a background of allergic diseases 
developed anaphylaxis one with cooked potato and the other one 
with raw potato.
Methods: We measured serum potato specific IgE and applied a skin 
prik test (SPT) with aeroallergens, food allergens and prick-to-prick 
test using raw and cooked potato.
Results: We found serum potato specific IgE 4.92 and 125 kU/L case 1 
and case 2 respectively. We also demonstrated SPT positivity aganist 
raw potato and cooked potato case 1 and case 2 respectively.
Conclusion: We aimed to emphasize potato allergy, a rare entity, and 
to remind potential disorders that could develop with or after potato 
allergy.
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Background: Food allergy results from an atypical response of the 
mucosal immune system to orally consumed allergens. Relationship 
between the offending food and natural course of the disease is a little 
known and controversial.
Aim: To determine the relationship between the causative food and 
the clinical presentation of food allergy and other associated allergic 
diseases.
Methods: This is a review of patients who underwent skin prick test-
ing, prick to prick testing, presence of food specific IgE and positive 
oral provocation test, in small number of patients.
Results: We were analysed 226 patients. There are ranged between 
4  months and 7  years. The implicated food were as follows: CMP 
(24.79  %), egg (17.70  %), peanut (12.83  %), wheat (11.50  %), soy 
(10.18  %), tree nuts (7.96  %), fish (7.96  %), kiwi fruit (7.08  %). The 
median age of the children was 28 months, 52 % were boys and 48 % 
were girls. The frequency of atopic dermatitis was higher in children 
with egg allergy (72 %), compared to those with milk (28 %), or wheat 
(24 %), or peanut (49 %), (p < 0.001). Asthma was more frequently in 
children with isolated peanut allergy (65  %) than children with milk 
(26.2  %) and egg allergy (24.4  %), (p  =  0.001). Allergic rhinitis was 
more frequent in children with isolated peanut allergy (41  %) com-
pared to children with milk (4.2 %) and egg allergy (3.8 %), (p < 0.001). 
The frequency of pollen sensitization was higher in children with pea-
nut allergy (64.4 %) compared to children with egg allergy (4.7 %), or 
milk allergy (4 %), (p < 0.001).
Conclusion: The type of culprit food may be important factor of clini-
cal presentation and prognosis of food allergy and may be reason for 
expression other allergic conditions.
Keywords: allergy; children; food.
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Introduction: Previous data from the University Children’s Hospital 
in Ljubljana, Slovenia, showed that adrenaline auto-injector was pre-
scribed to Slovenian children most frequently because of allergy to 
peanuts.
Methods: We prospectively collected data on interventions of imme-
diate reactions and allergic follow-up of children which had adrena-
line auto-injectors prescribed in year 2014 and were followed-up 
exclusively by regional paediatricians’ with special interest in paedi-
atric allergy.
Results: 76 children (52 boys, 24 girls) were followed-up exclusively by 
regional pediatricians with special interest in paediatric allergy. 10.5 % 
were babies, 27.6 % 1 to 5 years old, 55.3 % 6 to 14 years old and 6.5 % 
15 to 18 years old. Adrenaline auto-injector was prescribed in 63.1 % 
because of anaphylaxis and in 31.6 % because of urticaria and/or angi-
oedema. In 92.1 % of children adrenaline auto-injector was prescribed 
because of food allergy, most frequently because of allergy to pea-
nuts (44 children). 93.2 % of peanut allergic children had specific IgE 
antibodies to rArah h 2. Among food allergic children 7.2 % had mul-
tiple food allergies, 38.6 % asthma and 7.2 % suffered more than one 
immediate reaction. Other confirmed reasons for prescribing adrena-
line auto-injector were insect sting (4 children) and inhalant aller-
gens (1 child). In 5 % of children the cause of immediate reaction was 
unknown. 29.1 % of anaphylaxis was treated with adrenaline 43.7 % of 
children were admitted to hospital after anaphylaxis. For comparison, 
during 2014 adrenaline auto-injector was prescribed in 291 children 
during 2014 in Slovenia.
Conclusions: Demographic and clinical characteristics of children 
with prescribed adrenaline auto-injectors reported by regional pae-
diatricians with special interest in pediatric allergy were similar to our 
previous data though children had fewer different food allergies.
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Background: According to the French[1] and the EAACI[2] anaphylaxis 
guidelines, patients with a previous anaphylaxis (apart drug allergy) or 
at particular risk of anaphylaxis should require prescription of adrena-
line auto-injector (AAI). Our aim was to assess prescription practices 
of AAI by the French allergists from the Allergy Vigilance Network[3] 
(AVN) and to confront these to the European and French guidelines.
Methods: In January 2015, an electronic questionnaire was sent to the 
299 allergists of the AVN.
Results: 121 questionnaires (40  %) were analyzed. According to the 
European guidelines, 77 % of the allergists were used to prescribe AAI 
for at least 5 of the 6 absolute indications in children, 90 % of them in 
adults, and about 50 % of them in all absolute indications in children 
and adults. According to the French guidelines, 81 % of the allergists 
were used to prescribe AAI for at least 4 of the 5 absolute indications 
in children and 90 % in adults, but only 33 % validated all the absolute 
indications in children, 28 % in adults. History of isolated generalized 
hive was not considered as an indication by a third of the allergists. 
77 % of the allergists were used to prescribe AAI in children with co-
existing unstable or moderate-to-severe asthma, 66 % in adults, even 
if it was not initially considered as an absolute indication in the French 
guidelines. Food allergy due to traces was an indication for 78  % of 
the allergists, and adolescence for 16 % of them. In all, there was no 
significant difference between children and adults. A second AAI was 
systematically prescribed by the allergists in 34 % of the patients and 
half of them were used to prescribe a second adrenaline auto-injector 
for at least one of the 6 suggested indications of the European guide-
lines. The main criteria for choosing the AAI device were: availabil-
ity (56  %), ergonomics (38  %), availability of trainers (33  %), needle’s 
length (22 %).
Conclusions: Our findings may be useful to improve knowledge and 
adherence to the guidelines and to update French guidelines for pre-
scribing AAI.
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Introduction: According to our casuistry, nuts are the leading cause of 
anaphylaxis in children aged from 0 to 14 years.
Case report: A 7 year old boy diagnosed in 2011 of extrinsic bronchial 
asthma due to sensitisation to dog dander/epithelium. In May 2014, 
after 5–10  min of eating 3 cashews, he presented dyspnea, dyspha-
gia, sweating, and generalized urticaria. We performed him skin prick 
tests to panallergens (lipid transfer protein, polcalcina and profilin), to 
commercial extracts of nuts (peanut, hazelnut, almond, walnut, pista-
chio, pine nuts, sunflower seeds and chestnut) and natural extracts of 
fried and raw cashew and roasted and raw hazelnut, both degreased 
and without degreasing and prick by prick with cashew. Analytics 
with basal tryptase, total IgE and specific IgE by ImmunoCAP to pea-
nut, hazelnut, walnut, cashew and pistachio, and component resolved 
diagnostics (CRD) with recombinant allergens. Finally, an oral challenge 
with hazelnuts was performed with good tolerance and SDS-PAGE 
immunoblotting with cashew. The results of all tests were completely 
negative. Tryptase baseline: 4.03 mg/L. Total IgE: 339.5 U/l. Specific IgE: 
hazelnut, peanut, walnut, cashew and pistachio <0.10 kU/L. CRD: rJug 
r 3, rAra h 2, rAra h 9 and rAra h 8  <  0.10 kU/L. The patient tolerated 
20 g of hazelnuts and in the Immunoblotting SDS-PAGE one band cor-
responding to a protein of about 33 kDa was detected.
Conclusions: Basing on the results of the SDS-PAGE Immunoblotting, 
our patient was diagnosed of anaphylaxis by cashew nuts. The pro-
tein detected corresponds to an allergen described of cashew: Ana o 
2, which is an 11S globulin reservation. In our patient we have forbid-
den eating cashew and pistachio, being of the same family (Anacardi-
aceae) and they have cross-reactivity, but we have allowed the intake 
of other nuts.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Introduction: Honey is a mixture of flower nectar, pollens, and com-
ponents from bees. Honey allergy is a rare entity, however it may cause 
serious reactions in allergic individuals.
Case report: A 10-year-old boy admitted to our outpatient depart-
ment suffering from allergic reactions after consumption of honey. He 
was under regular follow-up due to asthma and pollen-induced aller-
gic rhinitis for 4 years. At different times, he presented with wheezing, 
swelling of the lips and eyelids within 5 min after ingestion of honey. 
His skin prick test with common aeroallergens revealed grass pollen 
and mold mix sensitivity and prick-to-prick tests with four different 
types of honey were found to be positive. Specific IgE to honey was 
also positive. Dietary elimination of honey was suggested and adrena-
line auto-injectors were provided.
Conclusion: Along with the leading causes of food allergy in childhood 
such as cow’s milk, egg and peanuts, rare foods such as honey may cause 
allergic reactions in children. Increase of the awareness by the physicians 
and the families may help better identification of rare food allergies.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Training children and teenagers to avoid, recognise and 
manage anaphylaxis is essential.
Methods: 95 food allergic children with prescribed adrenaline auto 
injectors were invited with their relatives and friends to attenuate 
courses on anaphylaxis management and families of 21 among them 
responded invitation. We have applied the questionnaire on avoiding, 
recognition and management of anaphylaxis to children before and 
after the 1.5 h long courses on anaphylaxis management.
Results: There were 26 participants (20 boys, 6 girls; age 10–18). 20 
children had prescribed adrenaline auto injectors because of food 
allergy, four children were relatives of food allergic child and two chil-
dren were colleagues of food allergic child. 96  % of children recog-
nised correctly signs of anaphylaxis before and 100 % after the course. 
Regarding preventive measures of anaphylaxis, the correct position 
during anaphylaxis and the correct order of management during the 
anaphylaxis all children answered correctly. 88  % of children would 
give adrenaline by auto injector during anaphylaxis before the course 
and all of them after the course.
Conclusions: The course enhanced theoretical ability and the willing-
ness of appropriate first-line management of anaphylaxis in children 
though children were already previously well prepared and motivated 
to act during anaphylaxis. Other modes of passing knowledge on ana-
phylaxis management beside courses during schooldays should be 
sought in order to educate more children.
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Introduction: It has been reported that many patients sensitized to 
inhaled dust mites are also sensitized to shellfish, due largely to the 
cross-reacting anti-tropomyosin (r Pen a1) IgE. That co-sensitization 
can also occur in the absence of cross-reactivity and clinical relevance 
may be different.
Purpose and methods: To characterize cases of allergy to shellfish 
and inhaled dust mites in children followed in outpatient Level II 
Hospital evaluating their sensitization profile and occurrence of any 
cross-reaction. Data were collected on shrimp, inhaled dust mites (der-
matophagoides pteronyssinus and dermatophagoides farinae) and tro-
pomyosin sensitization based on clinical history, skin prick tests (SPTs) 
(Leti®) or specific serum IgE (ImmunoCap®).
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Results: Three cases were selected, all male. There was a family history 
of allergy in 2 cases. In those the allergy to shrimp was the first mani-
festation of atopic disease. The age of diagnosis of shrimp allergy varied 
between 8 and 10  years, and clinical presentations were: anaphylaxis, 
urticaria, angioedema and pharyngeal itching. All cases had allergic 
rhinitis to inhaled dust mites. One case also had asthma and co-sensi-
tization to grass. All cases had co-sensitization with other food allergen 
(crustacean and mollusk). The specific serum IgE to shrimp and tropo-
myosin (r Pen a1) was positive in two cases (one case with a positive skin 
prick test to shrimp is waiting for the result). In 2 cases there was previ-
ous history of persistent rhinitis but the symptoms were not valued.
Conclusion: The authors present 3 cases of allergy to shrimp and 
inhaled dust mites with different clinical presentations. In all cases 
the rhinitis was the main atopic disease though often neglected. The 
presence of other food allergies to shellfish group is in favor of cross-
reactivity obtained by the panallergen tropomyosin.
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Background: London is home to 170 nationalities and 300 spoken 
languages. Many allergic families have experienced difficulty imple-
menting nut avoidance advice due to language barriers. This pilot 
investigates ability of allergic children, families and healthcare profes-
sionals to identify nuts to guide production of a targeted educational 
resource.
Method: 12 “nut playing cards” displaying large photos of common 
nuts were shown to families in a tertiary pediatric allergy clinic and to 
General Practitioners. Responses were recorded.
Results:
Children and parents:
  • 95 participants aged 6–62 (15 different languages spoken).
  • Only 1/5 participants correctly identified all nuts.
  • Average nut identification rate—67 % in English-speaking families 
Vs 44 % in non-English speaking families.
  • Only 30 % of subjects that were born outside the UK and did not 
speak English at home identified >6 nuts.
  • Only 50 % of families speaking languages other English identified 
>1/3 of nuts.
  • School-going age (5–18  years) identified fewest nuts correctly, 
averaging 5/12, compared to 9/12 in adults. Data is consistent 
with US findings summarised in 2006 and 2011 papers.
  • Poor scoring correlated with lower socioeconomic classes.
 • Only 30 % of subjects with a known nut allergy were able to cor-
rectly identify >6/12 nuts.
Healthcare Professionals:
  • GPs identified an average of 10/12 nuts.
  • 82 % of GPs felt that parents of children with nut allergies are most 
concerned about anaphylaxis and death.
 • GPs think effective management of nut allergy is limited by lan-
guage barriers, lack of education and misunderstanding of 
patients and health professionals, and time constraints (Fig. 3).
Conclusion:
  • Visual identification was particularly unreliable in younger indi-
viduals, individuals of low socioeconomic class, or those who do 
not speak English at home.
  • This pilot highlights an opportunity to develop multi-lingual 
educational resources such as online platforms and school pro-
grammes to support children and families from all backgrounds 
and ethnicities.
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Background: Occurrence of food allergy has significantly risen 
in recent years and its prevalence is 6–8  % in children and 3–4  % in 
adults. There are some differences in incidence of types of food allergy 
in different areas. Most commonly implicated foods in childhood are 
milk, egg, nuts, wheat, soy, fish and shellfish worldwide. There are 
some differences in incidence of types of food allergy in different 
areas. Only limited data are known about the most common causes of 
food allergy in Czech Republic.
Methods: DAFALL-Datase of Food Allergies is an electronic registry 
founded in 2014 aiming to gather epidemiological data describing 
food allergy in the Czech Republic. Most common triggers of food 
reactions, threshold doses, processing of food allergens, laboratory 
test results including component resolved diagnosis, skin prick tests 
and food challenges results and also allergology history of the patients 
were evaluated. Special attention was devoted to patients with food 
anaphylaxis.
Results: During the first 5 months until April 2015, 250 patients were 
enrolled from more than 20 collaborating allergology clinics, 58 % chil-
dren under age of 5  years, 24  % children aged 6–18  years and 18  % 
adults. In children under 1 year of age, cow’s milk is the most frequent 
food allergen 87  %). In 90  % of cases, first symptoms of milk allergy 
were recorded below age of 7 months and in 60 % of cases were noted 
in fully breast-fed infants. More than 50 % of milk reactions were non-
IgE mediated, with no prove of any positivity in skin prick tests and/or 
specific IgE against milk. Most common triggers of allergy in children 
under age of 5 years were milk, egg, tree nuts, fruits and peanuts. In 
patients offer 6 years were fruits, tree nuts, peanuts and vegetables the 
most common triggers. In patients older than 6 years, significant aller-
gens are also the seeds, mainly the sesame seed and poppy seed.
Conclusion: DAFALL is the first project in the Czech Republic describ-
ing relevant data on food allergy in the Czech population. Projected 
Fig. 3 The effect of language spoken at home on ability to correctly 
identify nuts
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period for data collection is 3 years and we expect to enroll 1500–2000 
patients from 30 collaborating centers.
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Background: Sensitization to wheat is common among patients 
with grass pollen allergy but is not always associated with symptoms 
to wheat. It is often unclear whether the reactivity reflects a wheat 
specific sensitization or cross-reactivity with pollen allergens. Two 
cross-reacting allergens are known, profilins and cross-reacting carbo-
hydrate determinants (CCDs).
Aim: To study the association between IgE sensitization to grass and 
wheat among wheat tolerant children with a diagnosis of grass pollen 
allergy.
Materials and methods: Seventy-two Swedish children (0–18  year) 
with a doctor’s diagnosis of grass pollen allergy, IgE antibody (IgE-ab) 
responses to grass and currently eating wheat were included. Serum 
analyses of IgE-ab to wheat, timothy and related components were 
performed. Inhibition with timothy and/or wheat extract was per-
formed on sera displaying IgE responses to both wheat and timothy.
Results: All children had IgE-ab to timothy with a median level of 20 
kUA/l, while 44 children were sensitized to wheat with a median level 
of 1,2 kUA/l. Inhibition with timothy extract was performed on 20 sera 
before analyzing the remaining IgE reactivity to wheat. In some sera 
the reactivity was completely inhibited while other sera, to different 
degrees, retained their IgE reactivity to wheat. Five children, displaying 
reactivity to both timothy and wheat, had IgE-ab binding to CCD (7 %) 
and 12 to timothy profiling, Phl p 12 (17 %). Inhibition of two sera with 
timothy extract the reduced the binding to CCD and wheat by >93 % 
and >86  %, respectively. Inhibition of three sera with wheat extract 
reduced the binding to Phl p 12 and timothy by >83 % and 7–20 %, 
respectively.
Conclusions: Sixty percent of the wheat tolerant children with grass 
pollen allergy were also sensitized to wheat, although the level of 
IgE-ab was significantly lower than that to grass. In the wheat sen-
sitized children the reactivity to wheat could neither be entirely 
explained by cross-reactivity with timothy nor by cross-reactive 
responses to CCD or profilins. Thus, further cross-reacting allergens 
remains to be identified and/or co-sensitization to wheat needs to 
be considered.
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Background: Oil body associated proteins (OAPs)’s role in nuts allergy 
is still poorly known. Conventional skin prick test (SPT) reagents deter-
mine mainly water soluble proteins (WPT) as well as it happens with 
allergen-specific IgE antibodies (sIgE), so OAPs are not well detected. 
We study the sensitization profile in children with suspected nuts 
allergy.
Methods: We evaluated children (median: 5 years old) with suspected 
allergies to nuts. WPT and OAPs of peanut, almond, hazelnut and wal-
nut were determined through SPT and sIgE.
Results: Peanut suspected allergy: 31 patients. WPT’s SPT was positive 
in 74.2 % and OAPs SPT in 45.2 % of those patients. WPT-sIgE was posi-
tive (>0.35 kU/l) in 80 % (Median 2.29kU/l) and OAP-sIgE was positive 
(>0.1 kU/l) in 64.5 % (Median 0.66kU/l).
Almond suspected allergy: 9 patients. WPT-SPT positive: 33.3 %, OAPs-
SPT positive: 66.7 %. WPT-sIgE positive: 62.5 % (Median 1.51kU/l), OAP-
sIgE positive: 55.6 % (Median 0.11 kU/l).
Hazelnut suspected allergy: 23 patients. WPT-SPT positive: 87 %, OAPs-
SPT positive: 52.2 %. WPT-sIgE positive: 90.9 % (Median 2.84kU/l), OAP-
sIgE positive: 78.3 % (Median 0.27 kU/l).
Walnut suspected allergy: 30 patients. WPT-SPT positive: 70  %, OAPs-
SPT positive: 60  %. WPT-sIgE positive: 86.7  % (Median 3.5kU/l), OAP-
sIgE positive: 83.3 % (Median 0.61 kU/l).
They were a total of 69 patients. Of them, 50 had at least one OAPs-
SPT positive and 39 were sensitized to more than 1 nut, being mainly 
involved the walnut (33 patients), followed by hazelnut (25 patients). 
No differences were found in reaction’s severity in terms of OAPs 
sensitization.
Conclusions: A considerable number of patients had any of OAPs 
tests positive (SPT or sIgE). Among these children, 78  % were sensi-
tized to several nuts, being the walnut the most common. No rela-
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The published version of this abstract can be found at [1].
Reference
1. Allergy. 2015;70(Suppl 101):614–49. http://onlinelibrary.wiley.com/
doi/10.1111/all.12724/epdf.
PP47 
Anaphylaxis pathway: A road tryp‑tase to success?
Helyeh A. Sadreddini, Mia Warnes, Donna Traves
Derbyshire Children’s Hospital, Royal Derby Hospital, Nottingham, United 
Kingdom  
Correspondence: Helyeh A. Sadreddini
Clinical and Translational Allergy 2016, 6(Suppl 1):PP47
Introduction: Anaphylaxis is a life threatening condition with a UK 
incidence increasing by over 6 fold between 1992 and 2012. Our 
hospital provides an acute pediatric service to a population of over 
110,000 children within Southern Derbyshire.
Aims: To assess the compliance of anaphylaxis management in chil-
dren presenting to our Emergency Department against local and 
national guidance.
Methods: We retrospectively reviewed Emergency Department 
attendances over a 2-year period from April 2012-March 2014. Clinical 
records with a discharge code of “anaphylaxis” were examined by two 
independent doctors to ensure diagnosis consensus.
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Results: A total of 24 cases were identified. Features of the acute reac-
tion were well documented (Fig.  4). The circumstances around the 
reaction were not documented in 7 cases and the time of the onset 
not documented in 22. Nuts were a trigger in 2 children.
Pharmacological management is illustrated in Fig. 5. An initial serum 
mast cell tryptase level was only taken in 4 of the children, no repeat 
samples were obtained (Fig. 6).
17 children were given an epipen of which 14 parents were trained in 
its use. 4 additional children were identified as requiring an epipen. 
10 children received information about the signs and symptoms of 
an allergic reaction and what to do in this instance. No parents were 
advised about the risk of a biphasic reaction.
Conclusions and discussions: Although standards are high with 
regards to the acute management of anaphylaxis areas for improve-
ment include documenting the specific circumstances of the reaction 
as well as the time of onset. This will help to identify likely triggers and 
improve allergen avoidance advice. Moreover this will help the attend-
ing doctor to decide when a serum mast cell tryptase level should be 
performed. This will assist in the longer term management of children 
presenting with anaphylaxis.
Overall there is good adherence to published guidance however sim-
ple measures including the introduction of a local anaphylaxis guide-
line, patient information leaflets and personal action plans will be 
implemented. We plan to re-audit in 2016.
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Introduction: Dust mites are the highest prevalence of allergen sen-
sitization in the north-eastern Thailand. Subcutaneous specific immu-
notherapy (SCIT) is considered as a standard and effective treatment 
of respiratory allergies. However, there have been no data reported on 
clinical efficacy of mixed mite SCIT in the north-eastern of Thailand.
Aim: To evaluate the clinical efficacy of mixed Dermatophagoides 
pterronyssinus (Der p) and Dermatophagoides farinae (Der f ) SCIT (ALK-
Abellò) in allergic rhinitis (AR) patients visited Khonkaen Ram hospital.
Method: We performed a 3  years prospective descriptive study to 
evaluate the clinical efficacy of mixed Der p and Der f SCIT (ALK-Abellò) 
in AR patients visited Khonkaen Ram hospital. Fifteen patients (9 male 
and 6 female, age 5.33–37.33 years, median age = 14.75 years) with AR 
due to Der p and Der f were enrolled in the study. Main outcome of the 
study was the rhinoconjunctivitis symptom score (RSS). RSS was evalu-
ated every year after SCIT in relation with the pre-treatment period in 
which patients suffered the highest symptomatic levels.
Results: The RSS was 11.26 ± 1.03 (mean ± SD) in the pre-treatment 
period and decreased to 6.13 ± 2.35 in the first year follow up period 
(p < 0.0001) and 1.93 ± 1.48 in the third year follow up period.
Conclusion: This study revealed that our mixed mite SCIT regimen 
decreased the RSS in patients with intermittent and persistent AR indi-
cating the effectiveness of the north-eastern mixed mite SCIT regimen 
of Khonkaen Ram hospital.
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Method: The study was conducted in women [aged 37] treated 
with steroids because of asthma in order to assess the activity of the 
Fig. 4 Completed documentation of features in an acute reaction
Fig. 5 Initial pharmacological management initiated
Fig. 6 Initial serum mast cell tryptase measurements
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brainstem. The study was conducted with the fMRI reader [3T GE] after 
the administration of beclomethasone (BC) at 250, 500 and 1000 µg or 
placebo. BC and placebo were administered every 14 days. To ensure 
the deposition of aerosol in the central-(CAD) or peripheral-(PAD) air-
ways, applied inhalation chamber integrated with a spirometer [PNEU-
MOlogic® abcMED] was used. Data analysis was performed using FSL, 
ImageJ integrated program of anatomical atlases. The data were aver-
aged over intervals of 5 min. The first 0–5 min interval taken as Refer-
ence. Changing the strength of the signal was calculated in standard 
deviation units for each subsequent 5 min period.
Results: After inhalation, with a predominance of central deposition (CAD) 
placebo and 250  µg BC showed an increase in signal, whereas 500 and 
1000 µg of BC was found dose-dependent decrease in the signal (Fig. 7).
Discussion: This is the first study to assess the impact of dose and space 
BC deposition on the function of selected brain structures. The study may 
be important for understanding the role of the knowledge of the brain 
and the need to harmonize the treatment of asthma with the brain.
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Background: Aeroallergens as one of the most common cause of 
allergic disease derived from pollens, dust mites, fungi, cockroach and 
animals. The prevalence of aeroallergens is different in various areas. 
This study was designed to identify the frequency of sensitization 
to aeroallergens in patients with asthma, allergic rhinitis and atopic 
eczema in Shiraz, southwestern Iran.
Methods: Six hundred and fifty-six patients with allergy were included 
in this cross-sectional study from southwestern Iran during 2014. Sen-
sitization to aeroallergens was assessed by skin prick test using a panel 
of common 15 aeroallergens in studied patients.
Results: A positive skin test to at least one of the applied allergens was 
seen in 74.5 % of our patients. The female to male ratio and mean age of 
the patients were 1.27 and 27.6 ±  14.7  years, respectively. Pollens were 
the most common type of aeroallergens (64.6 %), followed by dust mites 
(34.6 %), cockroach (30.6 %), molds and cat hair (each 16 %). Among pol-
lens, the frequency of sensitization to weeds, grasses and trees was in turn.
Conclusion: The results of the present study revealed that pollens play a 
main sensitizing allergen in asthma, allergic rhinitis and eczema. This pat-
tern was compatible with the results from studies carried out in this area.
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Aim: To study the epidemiology and appropriateness of referral of 
allergy tests performed in a peripheral hospital in Republic of Ireland
Materials and methods: Data was gathered retrospectively in all chil-
dren up to 14 years of age, who had allergy tests (Total IgE and spe-
cific IgE) done between periods 1st January 2014 to 30th June 2014. 
Specific IgE values more than 0.35 were considered positive. Data was 
tabulated with variables of age, mode of delivery, associated asthma 
or eczema, family history of asthma or eczema, any anaphylaxis reac-
tion and was NICE guidelines followed or not. Data was analysed and 
conclusions were drawn.
Results: 297 allergy tests were performed in the six month period. 
154(51.8 %) of 297 had positive specific IgE values. 44.44 % had posi-
tive IgE. 5.8 % were performed under 1 year of age, 40.1 % performed 
between 1–5 years and 62.4 % performed over 5 years. 27 % born by 
section, 59.2 % by vaginal delivery and 13.8 % data was not available. 
46.08  % had positive family history. 46.08  % has associated eczema 
and 55.68 % had associated asthma. 52.84 % followed NICE guidelines 
for performing the allergy test.
Conclusion: A vast number of children are subjected to allergy tests 
and only 52.84  % met NICE guidelines. As the cost of each test was 
Total IgE = €37.08, Basic RAST = €38.70, IgE and RAST = €75.78, Each 
individual separate request ranges from €4.30 to €27.54 (depending 
on allergen) on top of the €75.78, huge savings of about 22430.88 
Euros could be saved per year. Appropriate training should be consid-
ered for all physicians who order allergy tests. By following NICE guide-
lines and performing alternate testing methods like skin prick tests, we 
can improve the health economics of Letterkenny hospital.
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Introduction: The infection of B-cells by EBV provokes a marked 
activation of immunoregulatory T-cells and requires restoration of 
immune homeostasis during convalescence. Therefore patients with 
immune defects resulting in impaired T-lymphocytes failed to destroy 
EBV-infected cells and may develop to sever lymphoproliferative dis-
orders and lymphomas. STK4 plays an important role in activation of 
transcription factors involved in T cell homeostasis and response to 
chronic viral infections.
Case: We are presenting an eleven-year-old girl of consanguine fam-
ily with chest pain and shortness of breath that has been diagnosed 
as STK4 deficiency, as a novel gene since the age of eight. She had 
history of neutropenia, recurrent skin abscesses, mouth ulcers, warts, 
molloscum contagiusum, herpetic lesions, recurrent fever, bacte-
rial and fungal respiratory infections and positive family history of 
Stk4 deficiency in her aunt and uncle. She suffered from persistent 
fever and generalized lymphadenopathy which was reported as EBV-
associated B-lymphoproliferative disorder in lymph node biopsy. 
Afterwards, she presented with cardiomegaly with no mediastinal 
involvement, pericardial effusion and cystic like echogenic masses 
on inter atrial septum which has been progressed. After few missed 
follow up visits, she has been admitted to the cardiology emergency 
with respiratory distress and syncope which required an emergency 
cardiac surgery. The excised specimen was positive for ICA, CD30, 
Ki67, EBV and EMA, suggesting the diagnosis of “T-cell non-Hodgkin’s 
Lymphoma”.
Conclusion: Primary cardiac lymphomas (PCL) account for about 
1 % of the primary cardiac malignancies and 0.5 % of the extranodal 
Fig. 7 The effect of the dose of beclomethasone [BC] (Cortare TEVA) 
or placebo and aerosol deposition adventage in central airways [CAD] 
on the activity of the brain stem
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lymphomas while disseminated lymphoma with cardiac involvement 
can occur in up to 20  % of lymphomas. PCL occurs more frequently 
in immunocompromised patients. There was no report of cardiac 
lymphoma associated with STK4 deficiency till now. Another study 
investigating 4 patients with STK4 deficiency, found development 
of EBV-associated lymphoproliferative syndrome and Hodgkin lym-
phoma in 2 and 1 patients respectively.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: The use of bee venom as a medicine is nothing new. The 
ancient Iraqi′s and Egyptians were the first known civilization to try 
bee venom. The emperor Charlemagne and Ivan the Terrible used bee 
venom to help alleviate sore joints and stiffness, according to “Medici-
nal Uses for Bee Venom” at Swedish.org, Today the medical uses of bee 
venom remain slightly clouded with evidence both for and against its 
medicinal benefits.
Methods: An 18 years old Iraqi girl who is atopic type was massively 
attacked by honeybees. She directly attended the nearest hospital 
suffering from severe allergy and asthma. Blood sample was drawn. 
Several biochemical, immunological and haematological tests were 
done for this patients. Urea, creatinine, transaminases, total bilirubin, 
alkaline phosphatase, uric acid, serum sodium, serum chloride and 
creatine kinase were carried out according to manufacturer instruc-
tions. Blood film were examined to differentiate different leukocytes. 
IgE, IgG.IL-I beta, IL-6 and TNF cytokines were assessed. Phospholipase 
A(2) was demonstrated.
Results: It was found that most of the biochemical parameters con-
cerned were elevated. IgE, IgG, cytokines and phospholipase A(2) were 
increased. Eosinophils and basophils were elevated as well haemo-
globin. It was shown that this girls was suffering from acute asthma 
and breathing difficulty. Skin and her eyes were red with oedema. The 
patient was recovered due to management by cortisone and antihis-
tamine drugs as she is atopic type suffered from severe allergy of skin 
and asthma with very difficult breathing due to bee strings.
Conclusions: Bee stings could be very dangerous and fatal especially for 
the allergic individuals. The complications might involve different organs 
of the victim particularly the respiratory system, liver and kidneys.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: It is known, that during viral infection DNA or RNA 
molecules are detected in the cytoplasm of infected cells. The most 
important signaling pathways, taken part in the DDR (DNA damage 
response) are: cGAS-STING, Rad50-Card9. The result of activation of 
these and TLR signaling pathways is secretion of proinflammatory 
cytokines (IL-1β, IL-6, TNF), IFN, chemokines, AMP etc.
The aim is to investigate expression of genes of TLR9, NLRP3 and 
proIL-1β genes, which play role in detection of viral infection and acti-
vation of innate immunity.
Methods: In our work we used the cell culture Vero. In experiments of 
activation TLR9-mediated signaling pathways we used 48 h Vero cells 
and CpG-rich DNA antigens (Sintol, RF) in concentration 10, 1, 0.1 pg/
ml. We use «Ribosorb» (ILS, RF), set for reverse transcription and PCR 
(Sintol, RF) for the detection of gene expression. To investigate the 
blocking of signalling pathways of innate immunity we use the siRNA-
interference technology. The cells Vero were transfected by siRNA (Sin-
tol, RF). We discover the CpG-rich DNA antigens-dependent expression 
of TLR9 increased in 46(10 pg/ml), 26 (1 pg/ml), 4 (0.1 pg/ml) times.
Results: The results in experiment with knockdown of components 
of signaling pathways of antiviral cytokine IL-1b demonstrated link 
between NLRP3 expression and IL-1b secretion. The transfection of 
NLRP3’s gene siRNA lead to decreasing of the level of NLRP3 expres-
sion in 1129 times and pro-IL-1b expression in 288 times.
Conclusions: So, CpG-rich DNA activates the TLR9 expression, that 
plays important role in viral DNA detection. The block of NLRP3 gene 
expression leads to decreasing of pro-IL-1b expression in 288 times. 
In future it is important to investigate more properly the mechanisms 
and signaling pathways of cell antiviral immunity.
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Background: Overnight pulse oximetry is a one of the new investigative 
modalities performed in the home environment to diagnose Obstruc-
tive Sleep Apnoea (OSA). Research has demonstrated that home sleep 
tests could be an accurate method of identifying patients with OSA.
Aim: To study the efficacy of Overnight pulse oximetry as a screening 
and referring tool for obstructive sleep apnoea in a peripheral hospital 
in Republic of Ireland.
Methods: Children aged between 3 months and 14 years, clinically sus-
pected to have moderate to severe obstructive sleep apnoea from June 
2013 to June 2015 were included in the study. Acute Pediatric link nurse 
receiving a referral would educate the parents and the child regarding 
the procedure of overnight pulse oximetry. Pulse oximetry readings, an 
average from 3 consecutive nights were recorded. Results were inter-
preted from Working party on sleep physiology and respiratory control 
disorders in childhood September 2009. Appropriate referrals to tertiary 
centres were done either to otorhinolaryngology or pulmonologist.
Results: A total of 31 were referred for Overnight pulse oximetry. The 
study was performed on 28 (90.32  %). None of the children experi-
enced difficulty in recording at home. In all cases the study report 
matched the clinical indicators of suspected apnoea. In 100 % of the 
cases, pulse oximetry was found to be positive and which displays the 
clinical appropriateness of referrals.
Conclusion: Overnight Pulse oximetry has proved be a definite 
screening tool to diagnose Obstructive sleep apnoea. As 100 % posi-
tive results are obtained, we feel more studies are needed to study the 
population with extended inclusion criteria. It has definitely helped to 
conduct appropriate referral to various specialities, thus improving the 
waiting time and decreased the inappropriateness in referrals.
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Introduction: Urticarial rash and allergic reactions are common symp-
toms in children presenting to the emergency department (ED) and 
vary geographically.
Aim: To describe the characteristics and management of children pre-
senting to a London Teaching hospital ED with urticaria and allergic 
reactions to identify areas of focus for improvement and aid current 
guideline implementation.
Method: Retrospective review of electronic notes of 58 children 
(aged < 17 years), presenting to ED from March- June 2015 with diag-
nosis “allergic reaction”, “urticaria”, “urticarial rash” and “anaphylaxis”.
Results: 58 children over 3  m, 1.3  % of total children seen in the ED. 
Median age 5  years, M: 48  %, 34  % known allergy or atopy. 90  % first 
presentation, 4 (7 %) had anaphylaxis, 33 (56 %) had urticaria alone. Sus-
pected triggers Food: 19 (32 %) (commonest nuts), Idiopathic 14 (24 %), 
Virus 12 (21 %), Drugs 12 (21 %) (mainly antibiotics), Other 1(2 %).
Anaphylaxis management: Adrenaline Auto-injector (AAI) not used, no 
written plans and no AAI on discharge but allergy follow up arranged.
Drugs given: Antihistamine 72 %, Steroids 22 % (variable indication).
Follow up arranged in most cases of suspected food allergy 13/19, few 
of drug allergy 1/12.
Limitations: The study is limited by size and by specific search criteria prob-
ably leading to an underestimate of incidence of allergic presentations.
Conclusion: Urticaria and allergic reactions account for at least 1.3 % of 
children seen in the ED. Anaphylaxis accounted for 7  % of these. Food 
especially nuts were the commonest trigger. Antibiotics are the com-
monest drugs implicated; however over reporting due to intercurrent 
infections also being a trigger may occur. Few of these are referred for 
formal testing with implications for future management of infection. 
Management is poor with respect to variable use of steroids, use and 
prescription of AAI and written action plans. Future educational interven-
tions and guideline implementation in the ED will target these issues.
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Introduction: Casein-free and gluten-free (CFGF) diet has been consid-
ered a potentially beneficial dietetic intervention of children diagnosed 
with autism spectrum disorder (ASD). IgE mediated cow’s milk allergy 
and wheat allergy have not been found to be more common in chil-
dren with autism as compared to the general population. In the current 
study, we evaluated delayed-type sensitization to cow’s milk, wheat, gli-
adin and other common food allergens in children diagnosed with ASD.
Materials and methods: Atopy Patch Tests with food allergens were 
performed in 103 children, including 47 children diagnosed with 
autism (median 4.7 years), 29 with IgE mediated food allergy (median 
4.6 years) and in 27 children without IgE food allergy (median 4.2 years). 
Patients of the Consultant Allergy Clinic of Children’s University Hospi-
tal in Białystok, aged 2–10 years, were included in the study between 
April 2009 and May 2012. A Chi square test was used for analysis.
Results: Delayed skin response to gliadin was found in 11 of 47 
(23.4  %) children with autism, in 1 of 29 (3.45  %) children with 
food allergy and in 0 of 27 (0.0  %) children without IgE food allergy 
(p = 0.003). Delayed skin response to cow’s milk was noted in 3 of 47 
(6.38 %) children with autism, in 3 of 29 (10.34 %) with food allergy and 
in 2 of 27 (7.41 %) children with abdominal symptoms (p = 0.831). No 
difference was observed in the study group between soya (p = 0.882), 
cocoa (p  =  0. 850), rice (p  =  0.746), barley (p  =  0.637), peanuts 
(p =  0.589), corn (p =  0.527), oat (p =  0.187), sesame (p =  0.195), 
wheat (p = 0.183) and yolk (p = 0.071).
Conclusion: Delayed-type sensitization to gliadin found in children 
diagnosed with autism may be considered in future research as a 
potential mechanism involved in multi-symptomatic clinical manifes-
tation accompanying autism.
Funding: Project funded by the Ministry of Science and Higher Educa-
tion No. N N407 53 1538.
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Introduction: Asthma is a multifactorial disease with many well-
known triggers. One suspected environmental trigger factor (TF) 
is incense smoke that is generated during religious ceremonies 
by the traditional custom of burning incense at places of worship, 
and also in homes to eliminate odours and freshen the air. In view 
of this widespread practice by billions, it is imperative to deter-
mine if this suspected link between incense smoke and asthma is 
evidence-based.
Study objective: Null hypothesis: Incense smoke is a TF for asthma. 
Alternative hypothesis: Incense smoke is not a TF for asthma.
Methodology: A search of the medical literature published in the 
English language from 1960 up to 2014 using PubMed, TRIP Data-
base, Cochrane Library Ebsco Host, Google Scholar and bibliographies 
of retrieved articles, was carried out to look for objective evidence 
that support, incriminate, question or refute the role of incense as a 
potential trigger for asthma. The articles reviewed: 1. Epidemiologi-
cal association between inhalation of incense and asthma. 2. Associa-
tion between genetic susceptibility, inhalation of incense smoke and 
asthma, and, 3. Evidence incriminating incense smoke as a trigger for 
inflammation in human lung biopsy material and/or tissue culture of 
respiratory mucosal cells of experimental animals.
Results: 1–2. Control studies show evidence based epidemiological 
and genetic relationship between incense smoke and asthma. 3. Ani-
mal and human lung cell studies show that exposure to incense smoke 
causes inflammation of mucosal cells lining the airways and pneumo-
cytes; findings that are the hallmarks of asthma.
Conclusion: There is strong evidence incriminating incense smoke as 
a trigger factor for asthma.
Take home message: Incense is a trigger for asthma.
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Background: Asthma and mental health problems are common 
among youth and young adults. Their relationships exist, but study 
results are not entirely consistent.
Objective: The study was to determine the associations of mood and 
anxiety disorders with asthma in Canadian children.
Methods: The analysis was based on data from the Canadian Com-
munity Health Survey conducted in 2011–2012, and included 10,396 
Canadian children aged 12–17  years. The survey used a multistage 
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stratified sampling design, and a questionnaire covered the informa-
tion on mood disorder, anxiety disorder and asthma.
Results: In Canadian children aged 12–17 years, the prevalence was 
12.2 % for asthma (11.6 weighted to the population), 3.2 % for mood 
disorder (2.7  % weighted to the population) and 5.2  % for anxiety 
disorder (4.9  % weighted to the population), respectively. Logistic 
regression analysis was used to determine the associations of mood 
and anxiety disorders with asthma after taking account for sex, age, 
body mass index, leisure time physical activity, smoking, and social 
economic status. Children with asthma had increased risks of mood 
disorder (adjusted odds ratio (OR): 2.07, 95  % confidence interval 
(CI): 1.57, 2.71) and anxiety disorder (adjusted OR: 1.75; 95 % CI: 1.40, 
2.20).
Conclusion: Children with asthma had increased risks of mood disor-
der and anxiety disorder in Canadian children.
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Objective: In this study we aim to evaluate the association of Paediat-
ric Asthma Quality of Life Questionnaire (PAQLQ) with Asthma Control 
Test (ACT) in children with persistent asthma.
Material and method: Children aged 7–17  years with poorly con-
trolled persistent asthma were involved. At first visit, ACT and PAQLQ 
were applied to and pulmonary function test (spirometry) was per-
formed in all subjects. Daily Inhaler therapy were initiated based on 
asthma severity according to international asthma guidelines. Patients 
were reevaluted following 6 week inhaler therapy and ACT, PAQLQ and 
PFT (Pulmonary function test) were performed.
Results: Out of 77 patients, 35 (45 %) were female. The mean age was 
11.62 ±  2.35  years. Following 6  weeks daily inhaler therapy, the ACT 
scores, PAQLQ scores and all the parameters of PFT except FEV1/FVC 
were significantly increased (p  <  0.05). There was a significant corre-
lation between ACT scores and PAQLQ scores (r:  <  0.5, p:0.001). The 
most asthma-related restricted activities were running (85.7 %), soccer 
(42.9 %), and climbing stairs (40.3 %) subsequently.
Conclusion: There is a strong correlation between ACT and PAQLQ.
Keywords: Asthma; children; pediatric asthma quality of life question-
naire; Asthma Control Test.
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Purpose: There is no consensus on the association between vitamin D 
and asthma. In the last few years, there have been few studies show-
ing the association between Vitamin D levels and asthma. We aimed to 
examine seasonal variation in vitamin D status in children with asthma 
and its association with pulmonary function tests.
Methods: We recruited children 8–17  years old diagnosed with 
asthma. Vitamin D levels (serum hydroxy vitamin D3) were obtained 
and pulmonary function tests were performed both in winter months 
(Jan, Feb, and March) and at the end of summer (August, September 
and October). The seasonal variation of vitamin D levels and lung func-
tion were examined.
Results: 56 children with asthma (M: 26, F:30, mean age: 
11.9 ±  1.97) were recruited. The mean vitamin D level in winter was 
13.36 ± 6.31 ng/ml. There was no significant correlation between vita-
min D levels and lung function. The mean vitamin D level at the end of 
summer was increased to 22.89 ± 7.83 ng/ml. It was increased 74.6 % 
in male, 163.7 % in female. There was no correlation between vitamin 
D levels and lung function performed at the end of summer.
Conclusion: There is a seasonal and gender variation in vitamin D sta-
tus in asthmatic children. Vitamin D levels do not correlate with lung 
function.
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Background: Genetic variation may partly explain heterogeneity in 
response to asthma treatment. Recently the Pharmacogenomics in 
Childhood Asthma (PiCA) consortium was initiated to unite pediatric 
asthma cohorts, (high risk) birth cohorts and clinical studies and to 
perform large-scale pharmacogenomics studies.
Aims: To describe the characteristics of the patients included in PiCA 
and to assess treatment response definitions within this consortium.
Methods: An online survey was send to the 22 studies included in the 
PiCA consortium. The survey included questions about data collection, 
patient characteristics and outcome phenotypes.
Results: In total, 14,809 children/young adults (up to 23  years) from 
11 different countries are enrolled in the PiCA consortium. Preliminary 
analysis shows that half of the asthmatic patients (55  %) are male. 
PiCA is ethnically diverse: approximately 52  % participants are Cau-
casians, 21  % Asians, 18  % Latinos and 9  % African-Americans. PiCA 
currently includes data of 1775 severe asthmatics. Furthermore, PiCA 
currently includes 14,179 short acting β2-adrenergic agonists (SABA) 
users, 11,314 ICS users, 1977 leukotriene modifiers (LTMs) users and 
1964 users of long acting β2-adrenergic agonists (LABA). Most stud-
ies had information regarding exacerbations despite treatment (95 % 
of the studies), lung function measurements (85 % of the studies) and 
asthma symptoms despite treatment (80 % of the studies).
Discussion: The children within the PiCA consortium are a good 
reflection of the global heterogeneous pediatric asthma population. 
Different outcome measures reflect different dimensions of asthma. 
Therefore, by classifying three outcome measures using data that are 
widely available within the PiCA consortium, we will identify non-
responders to asthma maintenance treatment.
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Objective: Increased incidence of atopy and asthma has been 
reported in autoimmune disease such as celiac diseases and inflam-
matory bowel disease (IBD). In this study we aimed to investigate the 
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prevalence of asthma and allergic disease in IBD compared to celiac 
disease.
Materials and methods: The validated ISAAC questionnaire in Turkish 
was applied to all patients with celiac disease and IBD.
Results: A total of 153 patients (70 with IBD and 83 with celiac dis-
ease) were involved. 52.9 % of patients were female and the mean age 
was 13.21 ±  3.80  years. The prevalence of wheeze was 26.6  % at any 
time (24.3 % in IBD and 28.9 % in celiac disease), and 18.2 % for the last 
12 months (17.1 % IBD, 19.3 % celiac disease). The prevalence of allergic 
rhinitis was 3/.5 % at any time (41.4 % in IBD and 33.7 % in celiac disease).
Conclusion: The prevalence of asthma and allergic disease were simi-
lar in both children with IBD and celiac disease.
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Severe, difficult-to-treat asthma still constitutes a diagnostic and ther-
apeutic problem. The diagnosis of asthma can be difficult, especially in 
preschool children. It is difficult to determine which wheeze is related 
with asthma or cystic fibrosis lung disease. A personal history of atopy, 
and a family history of atopy are probably the most useful guides of 
asthma.
Case report: A 7  years old boy was appeared in our consulting ser-
vice. He had severe episodes of breathless, productive cough, wheezes 
frequently, nasal obstruction, several viral illnesses per year, etc. He 
had patches of dry skin on elbows and cheeks. Nasal polyps noted. 
The child was diagnosed with atopic bronchial asthma and he was 
uncontrolled patient, despite optimal conventional therapy and spe-
cific immunotherapy for mites. He was followed up in an allergy clinic 
assigned as “treatment resistant asthma patient”.
Clinical and laboratory evaluation were performed: blood tests, 
biological tests, induced sputum cell profile for eosinophils and 
neutrophils, ECP concentration, skin prick test and serum radioal-
lergosorbent tests for the common aeroallergens, serum total IgE, 
sweat test (CF). We evaluated the level of nitric oxide in exhaled 
and nasal air. We performed standard spirometric tests and body 
plethysmography which resulted obstructive pattern with pulmo-
nary hyperinflation and increased airways resistance. High resolu-
tion CT scanning was very useful, it reveals extensive small airways 
disease manifest by distal air trapping due to fixed obliterative 
bronchiolitis. Based on clinical and functional examinations we 
concluded the diagnosis of CF asthma, and we stopped specific 
immunotherapy.
Conclusion: The diagnosis of “CF asthma” is problematic and it is diffi-
cult to determine which patients have a combination of CF and asthma 
and which have asthma like symptoms caused by inflammation of CF 
lung. We know what have in common CF and asthma, but we have to 
consider the differences between them based on: genetic basis, single 
gene versus many, tissue and organ affected, airway inflammation, dif-
ferent treatments, antibiotics and nutrition, and which is more impor-
tant the different progression of disease.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Asthma, the most common chronic disease of childhood 
and one of the leading causes of morbidity in children worldwide is 
currently affecting more than 14  % of world`s children (The Global 
Asthma Report 2014). The relationship between asthma and pneumo-
thorax still needs to be established since several reports emphasize 
that pneumothorax is an uncommon complication of asthma (Por-
podis K, Zarogoulidis P, Spyratos D, et al. Pneumothorax and asthma. 
Journal of Thoracic Disease. 2014;6(Suppl 1):S152-S161. doi:10.3978/j.
issn.2072-1439.2014.03.05).
Case report: We report a case of a 9-year-old-girl with asthma, in treat-
ment with Salmeterol and Fluticasone proprionate, with poor adher-
ence to treatment, who presents to the Emergency Department with 
cough, wheezing and respiratory distress. The episode began 4  days 
earlier and it had been accompanied by a runny nose. She received 
symptomatic treatment but she has become more short of breath 
prior to coming to the ED.
On physical examination, she was afebrile, with pale teguments, cya-
nosis of nail beds and lips, in moderate respiratory distress, with flaring 
of the nostrils, rapid, shallow breathing and intercostal retractions. The 
vitals include a respiratory frequence of 40 rate/min, a heart rate of 
150 beats/minute and pulse oximetry of 95 % on room air. The remain-
der of the examination is unremarkable.
Therapy is initiated with Ampicillin and Sulbactam, Methylpredniso-
lone, Aminophylline, Albuterol, Fluticasone propionate. Over the next 
24 h, her condition worsens, with frequent desaturation periods until 
88 % while being under oxygen therapy, therefore she is transferred to 
the Pediatric Intensive Care Unit where she develops apical right sided 
pneumothorax. The further evolution is favorable, with dismissal after 
2 weeks.
Conclusion: This case illustrates several issues related to management 
of a patient with an acute exacerbation of asthma complicated with 
pneumothorax in a child with poor adherence to treatment due to 
undisciplined parents.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Rational: PedsQL 3.0 Asthma Module is an instrument developed 
to measure the impact of asthma on health-related quality of life 
(HRQOL) in children and adolescents.
Objective: To evaluate the Portuguese version (Brazilian culture) of 
PedsQL Asthma Module among low income asthmatic children and 
adolescents.
Methods: PesdsQL Asthma Module was applied to 200 asthmatic chil-
dren and adolescents (2–18  years) living in São Paulo, Brazil, and to 
their parents. HRQOL was also evaluated by PAQLQ and asthma con-
trol was measured by ACT or C-ACT.
Results: Moderate correlation was observed between children (Ped-
sQL Child) and parents (PedsQL Parent) mean scores (r:0.67). Ped-
sQL Child-Parent correlation was stronger among young children 
(5–7  years; r:0.76) and weaker among teens (13–18  years; r:0.54). 
Among the four questionnaire subscales, symptoms subscale showed 
the highest child-parent correlation (r:0.77) and communication sub-
scale the lowest (r:0.46). Moderate correlation was found between 
mean PedsQL Child and mean PedsQL Parent scores and PAQLQ (r:0.66 
and 0.64, respectively). Mean symptoms and worry subscale scores 
were higher among males (68 vs. 59 and 100 vs. 83, respectively; 
p < 0.05). No significant correlation was noted between mean PedsQL 
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Child and mean PedsQL Parent scores and BMI, asthma duration and 
maternal education. The presence of atopic dermatitis and allergic rhi-
nitis did not alter mean PedsQL scores. Progressive reduction in mean 
PedsQL Child and mean PedsQL Parent scores was noted with GINA 
treatment steps (PedsOL Child: 85 in GINA step 1 to 63 in GINA step 5).
Conclusions: The Portuguese PedsQL Asthma Module version showed 
to be a valid instrument among low income children and adolescents. 
In this group, we observed higher symptoms and communication sub-
scale scores among males. Asthma severity was the main factor associ-
ated with impaired HRQOL.
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Introduction: During the everyday practice patients with allergic 
asthma and allergic rhinitis are treated with inhaled corticosteroids, 
long-acting beta agonists, oral antihistaminic, specific immunotherapy 
(SIT). Specific Immunotherapy is indicated in patients with respiratory 
allergies (pollen, dust mite, mold) and Hymenoptera allergy. Specific 
immunotherapy, in addition to relieving symptoms, fights the causes 
of allergy.
Case report: We report a case of a 6  year-old girl, who suffered of 
frequent respiratory problems since she was born, manifested with 
cough (especially during the night), nocturnal dispnoae, wheezing, 
sneezing and runny nose. The little girl was diagnosed with allergic 
asthma and allergic rhinitis at the age of 3. In April 2013, skin prick 
tests were performed and resulted positive to house dust mites, cat 
and dog. During these years the doctors treated her with antibiotics, 
ketotifen, antihistaminics, inhaled corticosteroids, leukotriene recep-
tor antagonists and nasal corticosteroids. Despite the regular use of 
controller medication she suffered several times a year of asthma exac-
erbations, where short-courses of oral corticosteroids were needed. In 
August 2013, we decided to start the subcutan immunotherapy with 
D. Pteronyssinus and D. Farinae. After 1  year of immunotherapy, last 
winter she had less severe asthma symptoms. She had no need for the 
rescue medication. The overall patient‘s conditions are improved.
Conclusion: Early initiation of Specific Immunotherapy can allevi-
ate the symptoms of allergic rhinitis and alters positively the immune 
response. Allergen specific immunotherapy is the only treatment with 
immunomodulatory effect and capability to change natural course of 
allergic diseases.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Primary ciliary dyskinesia (PCD) is a relatively rare condi-
tion mainly inherited as an autosomal recessive with other inheritance 
patterns still under study. The incidence of PCD varies from 1:17,000 
and 1–35,000 live births. Clinical symptoms in this pathology are; 
neonatal respiratory distress, recurrent lower respiratory tract infec-
tion, chronic rhino-sinusitis, bronchiectasis and visceral mirror image 
reported in approximately 50 % of cases. The prognosis is good, but if 
it is not managed properly, it leads to high morbidity levels. PCD, even 
though very rare, enters the differential diagnosis of atypical asthma 
and unusually severe upper and lower airway chronic diseases.
Method: We present the case of a 14  years old female asthmatic 
patient with chronic cough and rhinosinusitis resistant to treatments 
with local and inhaled steroids and bronchodilatators as well as oral 
antibiotics. She referred a neonatal respiratory distress and rhinitis 
from the early childhood and difficult to expectorate chronic pro-
ductive cough and nasal yellowish discharge during the last 3  years 
with recurrent pulmonary infections, despite the aggressive asthma 
treatment.
Results: Auscultation evidenced labile cough-related ronchi and rales. 
Normal blood count and biochemical results found, negative skin prick 
test and sIgE for food and inhalant allergens. Thoracic- abdominal CT 
findings: situs inversus of liver, spleen and stomach, without dextro-
cardia or bronchiectasia. ORL investigation confirmed pan-sinusitis. 
Audiometri tests were normal. Respiratory function test showed a mild 
restriction. Sweat test resulted negative. Genetic testing and other 
specific diagnostic tools such as nasal nitric oxide, saccharin test, cili-
ary beat frequency and pattern on light microscopy are not available 
in Albania, so she was referred to a specialized clinic abroad.
Conclusion: A difficult to treat asthma with chronic rhinosinusitis 
is not a very rare scenario in allergist’s office. Difficult to expecto-
rate sputum in asthmatic children with persistent rhinosinusitis, are 
important symptoms to consider PCD in the differential diagnosis. 
Despite the lack of the right diagnostic tools, thoracic-abdominal CT 
is very suggestive, even though half of the PCD patients have situs 
inversus. A multidisciplinary management and follow-up is essential 
in order to prevent the development of bronchiectasis and other 
morbidities.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: With higher exposure to animal during the life, the risk 
of sensitisation to animals may get more. The purpose of this study 
was the comparison of sensitisation to animal allergens in children 
with asthma from those with adult-onset asthma.
Methods: This cross-sectional study included 100 children and 100 
adults with asthma as well as 100 healthy individuals with no history 
of asthma and atopy. Skin tests were performed in patients and con-
trols to allergens using a panel of 15 animal allergens.
Results: The rate of sensitisation to animal allergens was 33 % in chil-
dren with asthma, 39  % in patients with adult- onset asthma com-
pared to 10 % in the control group. Children with asthma were most 
commonly sensitised to dog (10  %), hamster (8  %) and cat (7  %). 
Among patients with adult-onset asthma, the most common sensitisa-
tions were to dog (19 %), canary (14 %) and cat and goat (each 7 %). 
The frequency of sensitisation to animal allergens was not significantly 
different between children- and adult-onset patients with asthma.
Conclusions: We observed that sensitization to dog and canary was 
higher in adult-onset than children with asthma. Efforts to improve 
conditions at the public buildings to reduce the load of airborne aller-
gens are also potentially helpful.
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Introduction: Wheezing has been for a long time a frequent cause for 
consultation in pediatric hospitals. The aim of this study was to charac-
terize children under 5 years old with wheezing episodes in the outpa-
tient setting of a high complexity institution in Cali, Colombia.
Methods: A prospective study was conducted between April 2014 
and March 2015. Patients from 0 to 5 years old with at least one wheez-
ing episode were evaluated and studied for possible allergy disease. 
A complete medical record was taken, including possible risk/protec-
tive factors. Sensitization was determined by prick test for aeroaller-
gens and food when we consider necessarily. We pursued correlation 
between risk/protection factors and asthma/wheezing.
Results: A preliminary analysis included 157 patients. 94 (59 %) were 
male. Mean age was 34.6  months old. 73 (47  %) received exclusive 
breastfeeding for 6 months. 25 (15.9 %) were in presence of smoking 
environment. 56 (35.7 %) had bronchiolitis in the first year of life. 109 
(69.4 %) had history of atopia in first degree. In 94 patients (60 %), the 
skin prick test was performed. 42 (44.6  %) were positive for aeroal-
lergens, of which the main sensitization was to D. pteronyssinus in 28 
patients (67 %), D farinae in 16 (38 %), animal dander in 4 (9.5 %) and 
grass pollen in 2 (4.5 %). 64 patients (40.7 %) had rhinitis, 51 (32.4 %) 
had atopic dermatitis, 9 (5.7 %) had food allergy, and 2 (1.7 %) had urti-
caria. There was no correlation between protective/risk factors and the 
presence of asthma/wheezing.
Conclusions: This is the first prospective cohort in our country, in 
which clinical and epidemiologic data of wheezing children less than 
five years old are described. We did not find any correlation among dif-
ferent risk/protective factors and the presence of the disease.
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Background: Childhood asthma and obesity are significant pub-
lic health problems, affecting more children with each passing year. 
Excess weight and obesity in children may be fuelling the “asthma epi-
demic” faced in many developed countries in the latest years. After an 
excessive weight gain one seemingly “well-controlled” asthma, turns 
out to be “uncontrolled” despite the increase in therapy.
Clinical cases: We present a case of 13-year old boy with asthma since 
infancy, well controlled till 2 years ago with inhaled corticosteroid. Last 
2 years the boy gained over 40 kilos and despite his combined therapy 
he has very poor asthma control for this period.
The second case is a 17-year old girl with bronchial asthma, poorly 
controlled despite high dose of combined corticosteroids as a control-
ler medication. For the last 4 years she starts to show protest behavior 
towards therapy, that’s modifying in the course of psychological mat-
uration-denial of the medicines, unhealthy and hazardous life styles. 
She gained over 30 kilos and at the age of 16-years depression was 
diagnosed, and was pharmacological and psychological therapy.
Conclusion: A modern team-work approach with respiratory/allergy 
specialist, nutritionist and psychology/psychiatry specialist sometimes 
is the best way to manage teenagers with difficult to treat asthma and 
obesity.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
PP75 
Sleep behavior in children with persistent allergic rhinitis
 Gustavo F. Wandalsen, Jessica Loekmanwidjaja, Márcia Mallozi, Dirceu 
Solé
Federal University of São Paulo, São Paulo, Brazil  
Correspondence: Gustavo F. Wandalsen
Clinical and Translational Allergy 2016, 6(Suppl 1):PP75
Objectives: To evaluate sleep disorders in children (4–10  years) with 
persistent allergic rhinitis (PAR) and its relation with rhinitis severity.
Methods: Parents from 90 PAR children followed in a Reference clinic 
answered the Children Sleep Habits Questionnaire (CSHQ). This one-week 
retrospective questionnaire is composed by 33 questions and divided in 
7 subscales. Total nasal symptom score (TNSS, range 0–12) and total extra 
nasal symptom score (TENSS, range 0–16) were recorded as well as nasal 
peak inspiratory flow (NPIF).
Results: Mean group age was 7.9  years. All of them were in regular 
use of nasal steroids or oral antihistamines. 74  % had concomitant 
asthma which was not controlled in 33 %. Mean CSHQ total score was 
54 ± 8. No significant correlation was observed between CSHQ total 
scores and TNSS, TENSS and NPIF. Significant correlation was observed 
between CSHQ sleep duration subscale and NPIF (r: 0.25), between 
CSHQ parasomnias subscale and TENSS (r: 0.25), and between CSHQ 
sleep-disordered breathing subscale and TNSS (r: 0.32) and TENSS (r: 
0.27). The presence of asthma or uncontrolled asthma did not change 
CSHQ total scores.
Conclusions: CSHQ total scores showed no correlation with rhinitis 
symptom scores. Some questionnaire subscales, however, could iden-
tify specific sleep disorders possibly related to allergic rhinitis severity.
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Background: MP29-02* (a novel intranasal formulation of azelastine 
hydrochloride (AZE) and fluticasone propionate (FP)) is approved for 
use in patients aged 12  years or older with moderate/severe allergic 
rhinitis (AR). The objective of this study was to evaluate the safety of 
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MP29-02* compared to FP, administered as 1 spray per nostril twice 
daily, in pediatric AR subjects ≥4 to <12 years.
Methods: This was a randomized, open-label, 3-month study in 
patients (≥4–12  years). Qualified subjects had a history of AR, 
were in good health, and had no evidence of nasal mucosal ero-
sion, nasal ulceration, nasal septum perforation, or any significant 
nasal disease. Subjects were randomized in a 3:1 ratio to MP29-02* 
(n = 304) or FP (n = 101) and were stratified by age as follows: (i) 
≥4 years to <6 years; (ii) ≥6 to <9 years; and (iii) ≥9 to <12 years. 
Safety was assessed by subject and/or caregiver-reported adverse 
events (AEs), nasal examinations, vital signs, and laboratory 
assessments.
Results: Overall, 94  % of subjects treated with MP29-02* and 92  % 
treated with FP completed the study. Completion rates were similar 
in each age strata. The percentage of subjects with AEs was compa-
rable between treatment groups and across the age strata. The most 
frequently reported AEs (i.e. ≥4  % in either group) with MP29-02* 
and FP, respectively, were: epistaxis (10 and 9  %), headache (7 and 
3 %), cough (4 and 3 %) and diarrhoea (1 and 4 %). The discontinua-
tion rate due to AEs was 2 % with MP29-02* and 4 % with FP. Labora-
tory parameters showed no meaningful increase in mean or median 
values in either treatment group. Improvements in nasal examina-
tion findings were observed in both treatment groups and in each 
age stratum and there were no findings of nasal mucosal ulceration 
or septal perforation. The two treatment groups were compara-
ble for mean changes in vital sign measurements regardless of age 
stratification.
Conclusion: MP29-02* and FP were well-tolerated during this 
3-month study when administered as 1 spray per nostril twice daily in 
pediatric subjects ≥4 to <12 years with AR.
*Dymista
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Objective: The main objective of this study was to assess safety and 
tolerability of bilastine, antihistamine marketed for adults and ado-
lescents with pediatric development ongoing, in a 10  mg once daily 
dose for children aged 2–11 years with allergic rhinoconjunctivitis or 
chronic urticaria.
Methods: Multicenter, double-blind, randomized, placebo-controlled, 
parallel group study in 504 boys and girls aged 2–11 with either aller-
gic rhinoconjunctivitis (AR) or chronic urticaria (CU). The primary 
endpoint was the occurrence of TEAEs (Treatment Emergent Adverse 
Events) throughout the 12  week treatment period to the last non 
treatment safety follow-up visit at week 16.
Results: The study has demonstrated the primary hypothesis of non-
inferiority for Bilastine 10 mg with respect to placebo (p = 0.015). The 
proportion of children without TEAEs was 31.5 % (82 patients) in the 
Bilastine 10 mg group and 32.5 % (81 patients in the placebo group, 
showing a mean difference of 0.99 with a 95  % confidence interval 
ranging from −9.10 to 7.10. No statistically significant differences 
between treatment groups were found regarding the TEAEs and the 
related TEAEs reported (5.8 % in bilastine group and 8.0 % in placebo 
group). The most frequently reported TEAEs were headache, reported 
by 11.5  % patients in the Bilastine group and 10.4  % in the placebo 
group, followed by cough, reported by 23 and 22 patients in the Bilas-
tine and placebo groups. Both Bilastine 10 mg and placebo showed a 
slight decrease in the somnolence and sedation as assessed with the 
Pediatric Sleep Questionnaire, with no statistically significant differ-
ences between groups.
Conclusions: Based on the study results, the incidence of TEAEs of 
Bilastine 10  mg in children 2–11  years old was similar to placebo. It 
confirms that Bilastine 10 mg once daily as a good and safe antihista-
mine for children with allergic rhinoconjunctivitis or urticaria.
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Introduction and aim: Allergic rhinitis (AR) is a worldwide condition 
with a lifetime prevalence ranging from 10 to 30 %. In some pediat-
ric studies, sensitization to Alternaria alternata (AA) had been associ-
ated with more persistent and severe asthma in adulthood. Fungal 
sensitization is also found in allergic rhinitis without asthma, but 
there are no studies showing AA as a risk factor for more severe dis-
ease. Authors aim to clinically characterize a group of patients with 
AR without asthma, compare those sensitized and non-sensitized 
to AA and evaluate if sensitization to AA was a risk factor to rhinitis 
severity and co-morbidities.
Materials and methods: Retrospective study involving pediatric 
patients with AR without asthma admitted at our outpatient clinic in 
2014. Clinical files were reviewed. ARIA classification was used and AA 
sensitization was assessed by skin prick test.
Results: 168 participants, 64.9 % boys, with a median age of 12 years 
old. A family history of atopic disease was found in 49.4 and 16.9 % 
were sensitized to AA. According to ARIA classification, 66.1  % pre-
sented with intermittent symptoms and 67.9  % with mild AR. Con-
junctivitis and atopic dermatitis were found in 25.6 and 14.9  %, 
respectively. Among AA-sensitized patients, 6  % were monosensi-
tised, 39.4 % were mainly sensitized to mites, 21.2 % to grasses and 
15.2 % to both. Any significant differences were found between AA-
sensitized and no-sensitized patients concerning to disease sever-
ity using ARIA classification, previous month use of anti-histaminic, 
nasal glucocorticoid or montelukast or immunotherapy. There were 
also no differences in co-morbidities rates, namely conjunctivitis, 
atopic dermatitis, sinusitis, nasal poliposis or upper-airway surgical 
interventions.
Conclusions: The prevalence of AA sensitization in AR without rhinitis 
was similar to previous studies and the prevalence of monosensitised 
patients was lower. This study failed to demonstrate an association 
between AA-sensitization and AR severity.
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Introduction and objectives: Allergic rhinitis (AR) is a high-preva-
lence disease in children and adolescents in Western countries. We 
developed a specific version of the Patient Benefit Index (PBI) ques-
tionnaire for the assessment of patient-relevant treatment needs and 
benefits in children and adolescents with AR. The objective was to 
validate the PBI in patients receiving allergen immunotherapy (AIT), 
which is currently the only causal treatment of AR.
Page 41 of 60Clin Transl Allergy 2016, 6(Suppl 1):42
Methods: The questionnaire “PBI-AR-K” was developed by an expert 
panel including pediatric patients with AR. It consists of two ques-
tionnaires with 19 items each. In the first part, patients rate treat-
ment goal importance; in the second part, they rate the extent to 
which the goals have been fulfilled by therapy. The PBI-AR-K was 
validated in a non-interventional, longitudinal, multi-center study. 
Children (5–12 years) and adolescents (13–17 years) with grass pol-
len-induced AR were treated with the 5-grass pollen tablet and fol-
lowed up from the first exposure of sublingual AIT until the end of 
the first treatment year.
Results: Data of 246 children and 135 adolescents (35  %/44  % 
female) under AIT with the 5-grass pollen tablet were evaluated. The 
feasibility of the PBI was supported by a low rate (0.8  %/0.7  %) of 
patients with >25 % missing item pairs, the threshold for score calcu-
lation. However, many did not complete one or both questionnaires 
(33 %/34 %). All subscales, developed on the basis of factor analyses, 
were internally consistent (Cronbach’s alpha ≥ 0.8). The PBI and most 
subscales correlated highly significantly (p  <  0.001) with patients’ 
and physician’s judgments on treatment benefit and with changes 
in frequency of rhinitis symptoms. Mean PBI was 2.6 in children, 2.5 
in adolescents (0 “no benefit” to 4 “maximum benefit”). Applying 
a threshold of 1, 95  % of the children and 91  % of the adolescents 
gained a relevant benefit from sublingual AIT treatment with the 
5-grass pollen tablet.
Conclusion: The PBI-AR-K is a valid, reliable and suitable instrument 
for the assessment of patient-reported benefit in the treatment of 
pediatric AR. Treatment with the 5-grass tablet showed a considerable 
patient benefit.
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Background: Allergen immunotherapy with house dust mite (HDM) 
sublingual tablet has proven efficacious and safe in subjects with aller-
gic rhinitis (AR). Here we report efficacy results in the subset of adoles-
cents with HDM-associated AR in a Phase III rhinitis study.
Methods: In a DBPC study conducted in Japan, adults and adoles-
cents (12–64 years) with HDM-associated AR confirmed by a positive 
HDM-specific IgE test and a positive response to a nasal provocation 
test were randomised 1:1:1 to receive HDM tablet at 500IR or 300IR, or 
placebo once daily for 1 year. The primary efficacy endpoint was the 
Average Adjusted Symptom Score (AASS, an Average Rhinitis Symp-
tom Score adjusted for rescue medication use; scale 0–15) over the last 
8 weeks of treatment. This criterion was analysed using an analysis of 
covariance.
Results: Of the 968 subjects randomised, 181 were adolescents 
aged 12–17 years (500IR = 61, 300IR = 60, Placebo = 60) and 171 of 
these were included in the efficacy analysis set. In this subset, statis-
tically significant differences between 500IR (p =  0.0001) and 300IR 
(p  <  0.0001) compared to placebo were observed on the primary 
efficacy endpoint. Over the last 8 weeks of treatment, the AASS Least 
Squares mean differences vs. placebo were −1.88 (CI95% [−2.84, 
−0.93]) and −2.04 (CI95% [−3.01, −1.08]) for 500IR and 300IR respec-
tively, corresponding to relative reductions vs. placebo of −24.8 % for 
500IR and −26.9  % for 300IR. These results were consistent to those 
obtained in the overall population.
Conclusion: In a Phase III study of subjects with HDM-associated aller-
gic rhinitis, treatment with 500IR and 300IR sublingual tablets of HDM 
allergen extracts administered for 1 year was efficacious in the subset 
of adolescents.
Conflict of interest disclosure: Presenting author is an employee of 
Stallergenes.
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Background: Omalizumab is a recombinant humanized monoclonal 
antibody that binds to IgE molecules, forming biologically inert com-
plexes. It is indicated as add-on therapy to improve asthma control in 
children aged ≥6 years.
Objective: Clinical case report.
Methods and results: The authors present the case of a 15-year old 
boy with a 10  year history of asthma. Despite optimized treatment 
with high dose inhaled corticosteroids, long acting bronchodilator and 
leukotriene antagonist, he continued to present symptoms consistent 
with severe persistent asthma with frequent visits to the emergency 
department and oral corticosteroid treatment. Skin testing was posi-
tive for house-dust mites and total serum IgE levels ranged from 244 
to 597 UI/mL. Lung function assay’s showed FEV1 levels of 52 % of the 
predicted value. At the same time, asthma control tests (ACT) scores 
ranged from 6 to 9. He was started on Omalizumab 225 mg monthly 
and after 16  weeks of therapy there was a marked clinical improve-
ment, without the need of systemic corticosteroid rescue therapy 
since the beginning of the therapy, improved ACT scores (≥20) and 
it was possible to reduce the required dose of inhaled corticosteroids. 
We also noticed a marked improvement in lung function, with FEV1 
levels of 88 % of the predicted after 16 weeks of treatment.
Conclusion: Besides the clear effect of Omalizumab in reducing exac-
erbations and the required dose of inhaledcorticosteroids with no 
need of oral corticosteroidtreatment, the authors point to the fact that 
it may also improve lung function. Further assessments are needed to 
study this effect.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Disruption of immune tolerance in early childhood 
causes different diseases such as allergic and autoimmune diseases.
Objective: We report the case of boy, aged 11, suffering from diabetes, 
with high atopical status and difficult-to-control asthma.
Methods and results: The patient has diabetes mellitus type 1 since the 
age of 4 and had been treated with different insulin regimens. He has 
been hospitalised more than 14 times due to suboptimal diabetes con-
trol. Two years after establishing the diagnosis of diabetes, at the age of 6, 
viral upper respiratory infection triggered wheezing symptoms. Eczema 
is diagnosed in 7, while allergic rhinitis in 8  years of age. The patient’s 
older brother has a diagnosis of asthma. Four months after the initial 
wheezing episode, 4 recurrent episodes of wheezing occurred in the 
springtime, thus leading to establishing the diagnosis of allergic asthma. 
He presented a high atopical status: total IgE level of 12 300 IU/ml and 
allergen-specific IgE tests to birch pollen, Hordeum murinum, timothy 
grass, meadow grass, meadow foxtail, couch grass, orchard grass >100, 
(class VI), ambrosia 3.08, house dust mites 5, 41, peanuts >100 (VI), soya 
93.4 (VI), egg whites 30.7; wheat 9.17; milk 3.07  IU/ml; and peripheral 
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eosinophilia 12  %. Therapy started with low doses of inhaled corticos-
teroids (ICS). However, there was a major problem of adherence to the 
prescribed treatment. In the autumn the same year, the patient experi-
enced 3 wheezing episodes as well as clinical manifestations of allergy to 
peanuts in the form of rash and angioedema. Spirometry test detected 
no pulmonary ventilation defect. The following year, partially controlled 
asthma was further complicated by rhinitis symptoms. The treatment 
with montelukast combined with low dose ICS was prolonged.
Conclusion: Our patient suffers from Th1 autoimmune disease (Diabetes 
mellitus) combined with Th2 mediated allergic diseases (asthma, rhinitis, 
eczema) which is commonly found in literature, yet rarely seen in medi-
cal practice. Being difficult to treat and put under control, having chronic 
course, affecting negatively both the patient and his family in a sense of 
quality of life, these conditions represent a major challenge to doctors.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Aim: The examination of nitric oxide in exhaled air in children suffer-
ing from asthma and to establish the relation with the degree of sensi-
tization to aeroallergens.
Materials and methods: The examination included fifty-two children 
(aged 12.40 ±  2.35  years), twenty-eight male (53.85  %) and twenty-
four female (46.15  %), with the average length of suffering from 
asthma 8.33 ±  3.93  years. FeNO was measured by using the online 
method, the NIOX MINO device. The degree of sensitization to aeroal-
lergens was determined by skin prick testing and assessed using the 
atopic index. The atopic index was indicated by the number of posi-
tive prick tests (AI 0—a negative prick test, AI 1—a positive number of 
prick tests <2 allergens, AI 2—a positive prick test <4 allergens and AI 
3—a positive prick test ≥5 or more allergens).
Results: The average value of FeNO in exhaled air of children suffering 
from stable allergic asthma was 43.92·35.63 ppb, and after a 4 week anti-
inflammatory treatment it decreased to 34.92·32.04  ppb (p  <  0.05). In 
relation to AI (AI I, AI II i AI III), the level of FeNO in exhaled air was 41.00 
vs. 40.69 vs 50.88 ppb, in the given order without statistically significant 
difference. The highest values of FeNO in exhaled air were present in 
children suffering from a mixed type of sensitisation (sensitisation to 
seasonal and common environmental allergens), 56.85 ppb (Me 48.50) 
in comparison to sensitisation to seasonal allergens 15.29 ppb (Me 12) 
and indoor allergens 32.22 ppb (Me 26). Allergic rhinitis, the duration of 
asthma and the gender were not significantly related to the values of 
FeNO in exhaled breath, while significant was the negative correlation 
between the body mass index and FeNO, r = −0.43 (p˂0.01).
Conclusion: Children suffering from allergic asthma possess increased 
values of nitric oxide in exhaled air, which is a useful indicator of daily 
dosage adjustment in patients treated with anti-inflammatory drugs.
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Background: Current diagnosis of pediatric asthma can’t include all its 
clinical variants and results to be a complex task.
Aim: To analyze the most common diagnostic errors in pediatric 
asthma.
Materials and methods: 82 patients aged 4–18 years were observed. 
Mild asthma was in 20.7 % of patients, moderate—in 79.3 %.
Results: In 37.1  % of patients community-acquired pneumonia (CAP) 
was diagnosed, caused in 51.6 % of cases by Mycoplasma pneumonia 
(MP), in 29 %—by Cytomegalovirus (CMV), and provoked asthma exac-
erbation in them (rxy = 0.9). In 62.2 % of cases CAP recurrent episodes 
occurred (CAP). In 64.7 % of patients somatic pathology of osteoarticu-
lar, cardiovascular, gastrointestinal systems, besides respiratory, was 
observed, that resulted in variety of non-respiratory complains with dif-
ficulties in asthma diagnosis. In the first 2 years of life asthma diagnosis 
and adequate therapy was provided in 22  % of children, in 3–5  years 
since asthma onset it was revealed in 75.6  % of patients, after 5  years 
of disease manifestation—in 2.4 %. In the first 2 years of asthma mani-
festations its symptoms were assessed as “frequent acute respiratory 
infections“(ARI) in 55  % of children, in 44.4  %—mild heart abnormali-
ties (MHA) were detected. 38.7 % of children with asthma diagnosed in 
3–5 years since its onset were observed with frequent ARI, 6.5 %—with 
recurrent bronchitis (RB), 17.7  %—with recurrent CAP, 16.1  %—with 
MHA, 9.7 %—with autonomic dysfunction, 11.3 %—with gastroesopha-
geal reflux (GER) and frequent ARI. Absence of asthma controller therapy 
led to development of complications: pulmonary hypertension (PH)—
in 32.9  % of patients; pulmonary fibrosis (PF)—in 40.7  % of asthmatic 
patients with CAP; emphysematous bullae (EB)—in 45.5 % of them.
Conclusions:
1. Somatic pathology of 3–4 systems in asthmatic patients caused 
variety of complains and delayed asthma diagnosis with devel-
opment of complications at diagnosis since 2 years of its onset.
2. Close relationship between asthma exacerbation and recurrent 
CAP caused by MP, CMV that led to development of PH, PF, EB is 
revealed.
3. Thorough examination of patients with frequent ARI is impor-
tant to exclude asthma.
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Background: To try to investigate how is childhood asthma controlled 
in Serbia and is Asthma educational intervention (AEI) on children and 
parents/caregivers effective in asthma control improvement.
Materials and methods: 20.042 children from 28 primary schools 
(6–15  years old) in Belgrade, Serbia, were investigated and invited 
for the asthma education. According to questionnaire, we separated 
707 children already diagnosed as asthma (prevalence rate 8.61  %), 
however, only 527 children and parents/caregivers completed AEI 
(education and 2 control check-ups 6 and 12  months later). For the 
assessment of asthma control, children and parents/caregivers com-
pleted the Asthma Control Test before the education (ACT1) and at 
the control check-ups (ACT2, ACT3). For children 7–11  years old, we 
put together answers of children and parents; children older than 
12 answered solely. The sum >19 points represented good control of 
asthma, while sum ≤19 represented poor control of the illness.
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Results: There were 321 (60.9  %) of boys and 206 (39.1  %) of girls 
(mean age 10.7; the first wheezing episode at 2.3 and diagnose of 
asthma at 3.3 years; 4.5 ± 4.6 asthma exacerbations, 2.2 ± 2.8 nights 
disturbed by asthma exacerbation, 1.0  ±  2.6 hospitalizations, and 
8.9 ±  5.4 school days lost 12  months before the study). At least one 
positive skin prick test had 385 children (73.1  %). There were 296 
(56.2 %) children 7–11 years old, mean ACT1 was 20.3 ± 5.3, 130 chil-
dren had ACT1 ≤ 19 (43.9 %); after the AEI, control of asthma statisti-
cally improved (ACT1114 children had ACT1 ≤  19 (49.4  %); after the 
AEI, control of asthma statistically improved ACT1).
Conclusions: Childhood asthma is not successfully controlled in Ser-
bia, as in many other countries. There is a space for intervention. Edu-
cation of children and parents/caregivers about asthma is valuable 
tool for asthma control improvement.
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Background: Omalizumab, a subcutaneous anti IgE monoclonal anti-
body, is shown to be effective in severe allergic asthma.
Aim: To evaluate the effect of group based education and structured 
dialogue among adolescents being treated with omalizumab in 
enhancing knowledge and insight in the asthma disease, treatment, 
social behaviour and experience.
Method: The adolescents were invited to share their experience after 
treatment with omalizumab. A group of 4 (13–16  years of age) par-
ticipated some hours one afternoon. They received education about 
asthma and treatment using question and answer cards and they were 
informed about effect and adverse effects of omalizumab. The dialogue 
included questions about life before and after omalizumab treatment, 
relation to family and friends, ability and lack of ability to perform phys-
ical activities and dreams of the future. One week later they completed 
a telephone interview based on questions handed out at the session.
Results: All 4 adolescents experienced a positive change in everyday 
life and ability to manage the asthma disease. Furthermore, they all 
experienced an enhanced physical ability and appreciated the knowl-
edge about omalizumab and asthma. In the interview they reflected on 
their own disease and physical ability, and they were satisfied by know-
ing that all in the group had the same thoughts and feelings. Besides 
one in the group, who in many years had struggled with the ability to 
perform sports, found out, that her expectation was unrealistic.
Conclusion: Adolescents with a chronic disease seems to have a bene-
ficial effect being together in a group sharing thoughts, emotions and 
knowledge about their disease and treatment.
THEMATIC POSTER SESSION 1: Prevention and Treatment—
Epidemiology (TP01–TP18)
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Introduction: There are on average 2 children with asthma in every 
classroom.
It is thought that as many as 75  % of deaths from asthma are 
preventable.
Building on children’s curiosity in the classroom about asthma is a 
possible method of increasing awareness of the condition and its 
treatment, with the overall aim of reducing hospital admissions and 
deaths.
Methods:
  •  UCL medical students who were trained in asthma education 
visited 14 schools in inner city London.
  •  1443 children between the ages of 7 and 13 took part.
  •  The children completed a quiz before and after a 15  min pres-
entation on asthma. The presentation and the quiz questions 
addressed treatment, emergencies, triggers, misconceptions 
and basic physiology.
 •  The average total score (out of 13) and marks for each question 
were calculated and the pre and post presentation test results 
compared.
Results:
  •  The average pre-presentation score was 37  % and the average 
post presentation score was 83 %.
  •  The most poorly answered pre-presentation questions were 
those about asthma treatment and triggers.
  •  Knowledge in all areas of the quiz was improved on average after 
the presentation. The greatest areas of improvement were how 
to deal with an asthma emergency and misconceptions about 
asthma.
 •  Participating medical students gave positive feedback.
Conclusion:
  •  Medical student run education sessions provide a cost-effective 
and simple method of teaching school children about asthma.
  •  The improvement in quiz scores before and after the presenta-
tion demonstrates the efficacy of the programme.
  •  Expanding the education programme across the high preva-
lence asthma areas may help reduce hospital admissions due to 
asthma (Fig. 8).
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Background: The prevalence of allergic diseases has increased dur-
ing the second half of the 20th century in children although the 
Fig. 8 Asthma‑scores
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prevalence of asthma seems to have reached a plateau. Using data 
from two unselected prospective population-based birth cohorts from 
Odense, Denmark, the Odense85 cohort and the DARC (Danish Allergy 
Research Center) cohort we aimed to compare the 12 months preva-
lence of allergic diseases in adolescence over a period of 14 years.
Methods: The 15  years follow-up of the Odense85 cohort (n =  276) 
born in 1985 was carried out in 2000 and the 14 years follow-up of the 
DARC cohort (n = 562) born 1998–1999 was carried out in 2013–2014. 
In both cohorts the participant underwent questionnaire-based inter-
views, physical examinations, skin prick tests, specific IgE testing and 
spirometry. The diagnostic criteria of asthma, atopic dermatitis and 
rhinoconjunctivitis were the same in both cohorts.
Results: Follow-up rates in both cohorts were high, 78  % (215/276) 
and 66  % (372/562) respectively. At the 15  years follow-up of the 
Odense85 cohort the 12  months prevalence of asthma, atopic der-
matitis, rhinoconjunctivitis and any allergic diseases was 10.2, 9.5, 
16.7 and 28.4 % and at the 14 years follow-up of the DARC cohort the 
12 month prevalence of the same diseases were 12.4, 7.3, 25.5, 38.4 % 
respectively.
Conclusion: The prevalence of rhinoconjunctivitis has significantly 
increased from 2000 to 2014 in Odense, Denmark.
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Background: Grass pollen is one of the most common seasonal aller-
gens that cause allergic symptoms in children. Many patients with 
allergic rhinitis, with or without asthma (AR, AR·A, A) are allergic to 
Timothy grass (Phleum pratense). Molecular characterization of Phleum 
pratense, has revealed different allergen components: rPhl p 1 and 
rPhl p 5 as species specific, while rPhl p12 (profilin) and the rPhl p7 
(polcalcine) are the principal Cross-Reactive Components.
Patient and methods: We included a total of 178 children diagnosed 
AR·A and grass pollen allergy (SPT and IgE results). We evaluated: The 
frequency of sensitization to allergenic molecules of Phleum pratense 
and olive pollen (rPhlp1, rPhlp5, rPhlp7, rPhlp12). The correlation of 
sensitization to major allergens and panallergens and its variation 
according to age and level of IgE and the presence of AR·A and other 
pollen concomitant SPT sensitization.
Results: Mean age was 9.5 years. 87.64 % had AR, AR + A in 71.5 % 
and A 86.51  %. rPhlp1, rPhlp5, rPhlp7, rPhlp12 IgE were found in 
82.6, 39.88, 6.1 and 10.11  % We performed an age distribution of 
patients in 3 groups. 1: ≤7  years-old 2:7–12  years-old 3: ≥12  years 
old. Group 1: Phlp1, 5, 7, 12: 76.8, 39.3, 1.78, 0 %; Group 2: Phlp1, 5, 
7, 12: 80.9, 39.7, 7.35, 11.76  %; Group 3: Phlp1, 5, 7, 12: 84.5, 37.9, 
8.62, 10.34 %; Older children were more polysensitized (SPT to Olive 
88.2 % > weeds 74 % > cupressus 58.2 %). Asthma reacting to rPhlp5 
was 41.6 % (ns).
Conclusion: rPhlp1 is the most relevant sensitizing allergen in our 
population, at all ages, while rPhlp5, rPhlp12 and rPhlp7 increase 
according to age. No differences were found in sensitization to rPhlp5, 
rPhlp7, rPhlp12 and their IgE levels, by groups. We didn’t find a correla-
tion between rPhlp5 and asthma.
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Introduction: Severe eczema is an early marker for peanut allergy. The 
LEAP study demonstrated a successful absolute reduction in develop-
ment of peanut allergy in high-risk infants if peanut was introduced 
between 4 and 11  months of age in children with severe eczema or 
egg allergy.
Aims: To establish the number of children who would require screen-
ing, intervention, and monitoring, if the LEAP protocol were to be 
implemented in Ireland, based on a cut-off of SCORAD  >  40; and to 
quantify the potential reduction in peanut allergy.
Methods: The Central Statistics Office provided data regarding births 
in Ireland for 2013. There were 68,684 births in Ireland in 2013. The 
BASELINE birth cohort provided data regarding prevalence and sever-
ity of eczema in Irish infants. 18.7  % of Irish children have eczema 
at six months, of whom 13.5  % (2.4  % overall) had severe eczema 
(SCORAD > 40).
Results: 1647 children (SCORAD > 40) would require initial screening.
175 would be excluded from peanut consumption due to a strongly 
positive skin prick test (SPT ≥ 3 mm), 225 would have a minimally posi-
tive SPT (1–2  mm), and 1247 would have a negative SPT (0  mm). Of 
the minimally positive SPT group, 55 cases of peanut allergy would 
be avoided with peanut consumption (24.7 % absolute reduction). Of 
the negative SPT group, 147 cases of peanut allergy would be avoided 
with peanut consumption (11.8 % absolute reduction). The total num-
ber of peanut allergies that could be avoided in Ireland per annum 
would be 202.
Conclusions: If the LEAP protocol could be fully implemented nation-
ally, it would substantially decrease the incidence of peanut allergy in 
Ireland. Major new resources for staff, training and facilities would be 
needed to identify, treat and monitor children during such a public 
health intervention.
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Background: Skin care practices influence skin barrier function during 
the first weeks of life. The application of sunflower seed oil for neona-
tal skin care has been investigated in previous studies, with controver-
sial findings, varying from lowering mortality rate to decelerating skin 
barrier maturation in preterm infants.
Objective: To investigate the effect of sunflower seed oil compared to 
a commercially available skin care lotion on the skin barrier function 
of healthy full-term newborns using standardized, objective, non-inva-
sive methods.
Methods: In a prospective, randomized clinical study, 50 healthy full-
term newborns aged ≤96  h were randomly assigned to two groups 
receiving three times per week: topical baby lotion application (group 
L, n  =  22) and topical sunflower seed oil application (group SSO, 
n = 24). Skin barrier function was evaluated in three anatomical areas 
(front, abdomen, upper leg) by non-invasive assessment of transepi-
dermal water loss (TEWL), stratum corneum hydration (SCH), sebum 
and skin-pH at inclusion and after 5 weeks. Clinical skin condition was 
assessed using the neonatal skin condition score.
Results: Both groups showed a significant decrease of skin-pH 
(p  =  0.001) and an increase of SCH (p  =  0.001) in all measured 
anatomical areas after 5  weeks compared to baseline. A significant 
decrease of TEWL was observed on the forearm in both groups 
(p  =  0.015). TEWL decreased significantly on the leg in group L 
Page 45 of 60Clin Transl Allergy 2016, 6(Suppl 1):42
(p = 0.002) and on the abdomen in group SSO (p = 0.018). Skin con-
dition remained stable.
Conclusions: The use of sunflower seed oil showed comparable 
results to the use of an infant specific emollient in healthy term neo-
nates. Both skin care regimes seem to maintain postnatal maturation 
of skin barrier function and skin condition.
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Background/objectives: In infants with atopic predisposition, topical 
emollients may play a pivotal role in improving the skin barrier func-
tion and reducing the likelihood of the onset of atopic dermatitis. We 
aimed to evaluate the effect of daily emollient use on the skin bar-
rier function in infants with dry skin and at risk for developing atopic 
dermatitis.
Methods: A monocentric, prospective open-label clinical study was 
performed in 25 infants with clinically dry skin and atopic predisposi-
tion (Erlangen Atopic Score ≥4). The included infants received a daily 
combined topical skin care regimen containing ice plant (Mesembry-
anthemum crystallinum L.) pressed juice over 16 weeks: intensive ice 
plant cream on the face, ice plant body care lotion on the body and 
both products on the forearm. Transepidermal water loss (TEWL), stra-
tum corneum hydration (SCH), skin surface pH (pH) and sebum were 
assessed on the forehead, upper leg and forearm at inclusion (base-
line) and at weeks 4, 12 and 16. Skin condition was evaluated using the 
SCORAD index.
Results: In all anatomic regions, SCH increased until week 12 
(p =  0.026). TEWL at all investigational sites and pH and sebum on 
the forearm and leg remained stable between baseline and week 16. 
On the forehead, pH (p =  0.013) and sebum (p =  0.003) decreased 
until week 16. SCORAD decreased significantly during the study 
(p = 0.035).
Conclusion: The daily application of a plant-based moisturizing 
lotion and cream showed an improvement of skin barrier func-
tion and clinical skin condition in infants with dry skin and atopic 
predisposition.
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Introduction: Immunotherapy is a proven treatment for aller-
gic rhinoconjunctivitis and moderate asthma in children, but it 
has proved difficult to predict who will respond, leading to years 
of therapy for sometimes no benefit. In a small study presented 
4  years ago [EAACI Istanbul 2011] we showed serial exhaled nitric 
oxide levels did not predict response to therapy but change in 
sum total wheal diameters from a standard range of skin test aer-
oallergens (house dust mite, dog, cat, grass pollen mix, tree pol-
len mix and Aspergillus fumigatus (Hollister Stier Ltd Spokane 
USA) appeared to discriminate responders from non-responders 
(Ong, S Stanley TV Allergy 66 Suppl.94, 2011 (211-2) We wished to 
review this observation using a much larger cohort of sixty pedi-
atric patients (age 5–17  years) who had completed subcutaneous 
immunotherapy (Alustal, Stallergenes, France) for these indications 
between 2003 and 2015.
Method: Retrospective case note review using recently published 
EAACI consensus guidelines on scoring rhinoconjunctivitis severity to 
judge response to therapy (Pfaar O et al. Allergy 69: 854–867; 2014).
Results: The sum total aeroallergen skin prick test wheal diameters 
reduced by a mean of 2.24 mm after 6 months maintenance treatment 
in the children who responded to immunotherapy by 3 years [highly 
beneficial, or significant improvement] but increased by a mean of 
8.3 mm in the non-responders [no benefit, or worse after treatment] 
in the same time frame. None of the non-responders registered a 
reduced skin prick wheal diameter (p < 0.015). Interestingly skin test 
diameters diminished even for allergens for which the child had not 
received immunotherapy raising the possibility of a class effect of 
immune suppression for immunotherapy such as has been noted for 
Timothy Grass with sublingual immunotherapy (Grazax, Alk-Abello A/S 
Denmark). Reduction in cat allergy after dust mite immunotherapy has 
recently also been reported.
Conclusions: A reduction in sum total wheal diameter after 6 months 
maintenance immunotherapy appears to predict a successful outcome 
at 3 years. Alternative therapy should be considered for those children 
without such a response. It may be possible to develop a multipotent 
vaccine that allows children to be treated for multiple allergens with 
only one vaccine.
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Objectives: The teenage years are the transitional stage from 
childhood to adulthood which heralds physical and psychological 
changes and issues relating to independence. We wanted to exam-
ine risk taking behaviour in this group and evaluate if young people 
are appropriately educated in the management of allergic reactions. 
In addition to traditional resources such as health care profession-
als, there are many virtual support mechanisms available such as 
included mobile apps and websites which are also available to fulfil 
this purpose.
Method: We surveyed young people who attended outpatient allergy 
clinics as well as those attending for day case procedures. We aimed 
to find out what resources they accessed to supplement the teaching 
they received regarding management of allergic reactions and use 
of their Adrenaline Auto-Injectors (AAI). The inclusion criteria were: 
young person aged 12  years and over, who has been prescribed an 
AAI.
Results: Early data suggests that none of the adolescents who com-
pleted the questionnaire were aware of an iPhone or Android mobile 
App which provides education and support relating to the leading 
brands of AAI.
Conclusion: Young people are a group known to engage in risk tak-
ing behaviour, therefore any opportunities should be utilised to pro-
vide education and offer support. Reasons such as a suitable time, lack 
of anonymity, appearing to lack knowledge, have all been identified 
as barriers which prevent young people from accessing traditional 
support services such as health care professionals. Mobile Apps and 
websites, in this technical savvy group seem the most likely solution. 
However, for these to be effectively accessed, it is vital that these ser-
vices are well publicized, available, easily accessible and friendly. This 
would allow patient education and empower young people to man-
age any allergic reactions.
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Case report: Omalizumab is an anti-IgE antibody, approved for severe 
asthma and chronic idiopathic urticaria. Solar urticaria (SU) is a rare 
disease, hypothesized to be IgE-mediated, often unresponsive to con-
ventional treatment, burdened by the risk of anaphylactic shock.
We present the case of a 16-year-old Caucasian girl with an 18-month 
history of severe SU unresponsive to several conventional treatments, 
dramatically improved after omalizumab.
This adolescent, with a poorly disturbing allergic rhinitis to Grami-
nacee and Alternaria, had a quality of life seriously compromised by 
SU. After about 15 min from also minimal sunlight exposure, she pre-
sented erythema, intense itch, swelling and hives in the sun-exposed 
areas with complete resolution after about 30 min from the avoidance 
of sun exposure. Phototest was positive for UVA (>5  J/cm2) and UVB 
(>1.2  J/cm2). Negative all tests for investigating other causes of urti-
caria and photodermatosis. After treatment failure of conventional 
therapies (triple combination of antihistamines with high-grade sun 
blockers and association with anti-leukotriene) the patient has been 
subjected to omalizumab. On the basis of her initial serum IgE level 
(moderately elevated, 228  IU/mL) and weight (57.7  kg), a calculated 
dose of 450 mg every 2 weeks of omalizumab was performed. Thera-
peutic response has been excellent and persistent since the second 
administration. After 6 months we tried to reduce dose progressively 
in line with the coming up indication for chronic spontaneous urticaria 
up to suspension. Now, at 4 month since omalizumab wash-out, SU is 
still in remission clinically. Phototest is negative both for UVA and UVB. 
The patient is going on follow-up.
Conclusions: This case reports a successful treatment of SU with omal-
izumab. At this time, it is an experimental treatment but our case could 
contribute to a new therapeutic scenario for SU and throw light on the 
potential pharmacologic mechanism of omalizumab in this disease. In 
fact, it is conceivable that omalizumab, depleting IgE, attenuates the 
multiple effects of IgE to maintain and enhance mast cells activities, 
reducing mast-cells-depending inflammatory mechanisms. Further 
studies are needed.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Water hardness is determined by minerals such as Ca2+ 
and Mg2+ that form insoluble precipitates with fatty acid salts includ-
ing in soap, termed metallic soap. Metallic soap irritates the skin, 
inducing pruritus and dryness, and thus exacerbating the dermatitis.
Objective: The present study investigated the effect of ultra-pure 
soft water (UPSW) lacking Ca2+ and Mg2+ on the skin in patients with 
atopic dermatitis (AD).
Methods: A pilot study was conducted and the clinical benefits 
of UPSW were assessed in adult patients with mild AD. We also per-
formed a randomized, double-blind, placebo-controlled, crossover 
pilot study to evaluate clinical improvements in skin barrier functions 
of UPSW in child patients with mild to moderate AD. Finally we tried 
to find out effects of metallic soap on allergic responses in the animal 
model of AD, NC/Tnd mice.
Results: After 4  weeks of showering with UPSW, the skin of patients 
with mild AD improved, with a reduction in dryness and itching. In 
child patients, the eczema area and severity index score showed ten-
dency to improve, though out-in skin transparency and Visual Analog 
Scale for pruritus and satisfaction with therapy were improved with 
statistical significance. Application of metallic soap to the skin of tape-
stripped NC/Tnd mice induced an allergic inflammatory response with 
itch and elevation of plasma IgE.
Conclusion: UPSW treatment reduced symptoms of AD in adult and 
child patients. Application of metallic soap onto the barrier disrupted 
skin induced allergic inflammation in mice. Since UPSW abrogates the 
formation of metallic soap, washing with UPSW may be beneficial for 
subjects with skin trouble.
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Background: Immunotherapy has been proven effective in asthmatic 
therapy by modulate immune response. The usage of immunomodula-
tors, Nigella sativa and probiotics, also has positive effects on allergic dis-
ease. Combined immunomodulator and immunotheraphy had shown 
no improvement in clinical or immunological parameters during build-
ing-up phase. The aim of this study is to evaluate the adjuvant effect of 
immunomodulators on maintenance phase of immunotherapy.
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Method: Thirty-one mild-asthmatic children were divided into four 
groups: immunotherapy only, in combination with Nigella sativa, with 
probiotics, and with both Nigella sativa and probiotics. Treatment 
was given for 56  weeks. Th2 (CD4+IL-4), Th17 (CD4+IL-17+), and Treg 
((CD4+CD25+Foxp3+), were measured using flowcytometri. Clinical 
improvement was assessed by Asthma Control Test (ACT). All of the param-
eters are analyzed with ANOVA test to compare the mean of differences.
Result: There was a decreasing trend in the number of Th2 and Th17 
after the administration adjuvant immunomodulators compared with 
the immunotherapy-only group, although it was not statistically sig-
nificant. These phenomena did not reveal in building-up phase. The 
number of Treg was likely to be increased in both building-up and 
maintenance phase. ACT score indicated a significant improvement 
after immunomodulator administration.
Conclusion: Immunomodulator can make improvement in mainte-
nance phase of specific immunotherapy in clinical asthmatic children.
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Background: The most important pollens that induce seasonal aller-
gic rhinitis or asthma in pediatrics population in Spain, are grass and 
olive. Both pollination is overlapped and it may complicate the recog-
nition of real causing agent for an appropriate SIT prescription, even 
worse if cross reactivity due to common panallergens is present.
Objective: Determinate how knowledge of the sensitization pattern 
to major grass pollen allergens species specific of Phleum pratense 
(rPhlp1 and rPhlp5) and Olive (Ole e1) might influence SIT prescription.
Patients and methods: A total of 155 children with seasonal rhinitis 
with or without asthma with a positive SPT to Phleum pratense and 
olive test were included. Determination of serum IgE to Phleum, Olive, 
rPhlp1, rPhlp5 and Ole e1 was performed. Different positive cut-off 
points values to IgE were considered, in order to include both grass 
and olive pollen or not, in a theoretical composition of SIT, pre and 
post CRD results.
Results: A decrease in the number of children reacting to 
rPhlp1 + rPhlp5 + Olee1 with higher cut off levels of IgE was observed, 
opposite to an increased of those only positive to Ole e1, Phlp1 or 
Phlp5. A discordance in the composition of SIT selected before and 
after the knowledge of CRD, was observed (prior based on clinical data 
and SPT positive to Phleum and Olive) in 28.4  % of patients (Kappa 
index: 0.27 p < 0.05). 34.20 % and 54.2 % of children would have been 
prescribed a different composition of SIT based on cut off point of 0.7 
KU/L and 25 % IgEOlee1 level of the total value of rPhlp1.
Conclusion: Accuracy of CRD improves SIT prescription in grass and 
olive polysensitizated patients, changing its composition up to 50  % 
respect those based only in positive SPT. It is still difficult to establish 
an appropriate sera IgE positive threshold in case of polysensitization.
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Objectives and study: Preliminary findings suggest that mitochon-
drial dysfunction (MD) could play a role in the pathogenesis of aller-
gic diseases. We aimed to see whether if MD is also present in food 
allergy, and if it could be modulated by a nutritional intervention with 
an extensively hydrolyzed casein formula containing the probiotic L. 
rhamnosus GG (LGG).
Methods: 4-week-old female C3H/HeOuJ mice were sensitized by oral 
route with five weekly doses of peanut extracts (6  mg) plus cholera 
toxin (10 μg) as adjuvant in the presence or absence of a 14-day pre-
treatment with an extensively hydrolyzed casein formula containing 
LGG (EHCF +  LGG). Liver mitochondrial respiration rates were evalu-
ated polarographically in isolated mitochondria in the presence of 
succinate (substrate FAD dependent) or palmitoyl-L-carnitine (fatty 
acid oxidation) using the Clark electrode, soon after oral food chal-
lenge. The carnitine-palmitoyl-transferase (CPT) (rate limiting enzyme 
of the mitochondrial fatty acid oxidation) and aconitase (oxidative 
stress marker) activities were measured spectrophotometrically. H2O2 
yield was assayed by following the linear increase in fluorescence (ex 
312 nm and em 420 nm) due to the oxidation of homovanillic acid in 
the presence of horseradish peroxidase.
Results: Peanut sensitized mice showed a lower state 3 respiration 
rate in presence of succinate and decreased fatty acid oxidation than 
controls (−36  %, p  <  .05). No difference in CPT activity was observed 
between these two groups. An increased oxidative stress in sensitized 
group was proven by inactivation of aconitase activity (−25 %, p < .05) 
and higher H2O2 yield (+52 %, p < .05). Pre-treatment with EHCF + LGG 
induced an improvement of mitochondrial function (+85  %, p  <  .05) 
and redox state (−57  %, p  <  .05), compared to sensitized group. No 
changes on CPT activity was observed in mice receiving EHCF + LGG.
Conclusion: Peanut allergy is characterized by mitochondrial dysfunc-
tion and increased oxidative stress. EHCF +  LGG efficiently prevents 
both effects.
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Background: Double blind provocation tests (DBPTs) are considered 
the gold diagnostic standard in food allergy. Our cohort of children 
suspected of cow’s milk allergy (CMA) predominantly showed non-IgE 
mediated symptoms. Previously published data on incidence of pla-
cebo reactions were on patients with Type I food allergic reactions. We 
hypothesized that the non-specific and subjective nature of symptoms 
leads to a higher percentage of placebo reactions, especially with pla-
cebo administered at the first day. Our aim was to analyze the occur-
rence of placebo reactions in DBPTs in non-IgE mediated CMA and 
examine its effect on validity of the supposed gold standard.
Methods: Retrospective analysis of data from a single center cohort, 
prospectively included between July 2011 and August 2014, was 
performed.
Results: 374 DBPTs were performed and resulted in 168 (44.9 %) posi-
tive, 197 (52.7  %) negative and 9 inconclusive tests. In the negative 
outcome group 56/197 children showed placebo reactions, these reac-
tions occurred significantly more often when placebo was adminis-
tered on the first day. None of these reactions mimicked IgE mediated 
response. In the positive test group there was no difference in admin-
istration of placebo on first or second test day. There was no correla-
tion between order of administration and test result. In 153/197 cases 
with a negative test cow’s milk was successfully reintroduced.
Conclusions: The occurrence of placebo reactions in negative tests 
(28 %) is higher than previously published. Placebo reactions occurred 
more often with placebo administered on the first day of testing. The 
delayed nature of non-IgE symptoms determines an important role 
for parent observed complaints at home. Therefore DBPTs should be 
strongly recommended in patients with delayed type of complaints. A 
seemingly positive reaction, however convincing, should not lead to 
deviation from blinding. If performed correctly the higher percentage 
of placebo reactions does not affect validity of DBPT.
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Background: Our previous results with BE suggest a good tolerance 
with safety. Also, the regular consumption of baking goods seems to 
accelerate the tolerance to regular egg.
Methods: 25 children were treated with a progressive introduction 
of BE into their diets. 21 patients had a history of immediate reaction 
and 4 were sensitized to egg with egg white (EW) sIgE >50 KU/L. All 25 
underwent an open food challenge (OFC) with BE performed in 3 dif-
ferent days. Day one: OFC with cookies (brand containing egg). Toler-
ant patients incorporated cookies and food containing egg traces into 
their diet. A second challenge with home-breaded chicken was per-
formed a week later. 15 days later they were challenged with a serving 
size of home-made cake containing 3 eggs. After each steps, regular 
consumption (cookies, breaded foods and baked goods) was advised 
for tolerant kids. 24 h mobile contact was given for possible reactions. 
All children continued regular ingestion and were periodically con-
trolled. Factors including SPT and sIgE levels were used to determine a 
subsequent challenge with less-heated-egg.
Results: All patients tolerated cookies (2–4). 1/25 presented mild 
anaphylaxis (MA) during OFC with breaded chicken (exercise cofac-
tor); 1 week after, he tolerated it. During next step (cake), a 14 months 
old girl presented a MA but she continued regular intake up to 
tolerated omelet. All the remaining patients tolerated BE without 
reactions.  23/25 patients were successfully challenged with hard-
boiled egg, 22/25 were challenged with omelet (19 without problems 
and 2 with cutaneous symptoms and 1 MA). 12 patients (48 %) came 
to raw egg ingest. The home phone contact allowed us check only 
mild symptoms in few patients.
Comments: BE is well tolerated and safe even from the diagnosis 
moment. Thus, dietary avoidance may not be necessary improving the 
quality of life and minimizing risks in our patients.
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Background: The best, safest and most effective clinical protocol of 
egg SOTI has not been established. Our aim was to compare 2 egg 
desensitization protocols to improve efficiency, safety and easy to per-
form SOTI.
Methods: 101 children (5–9 years old) with egg allergy proved by DBCCP 
were randomized to 25 controls, to follow an egg free diet, and 76 to fol-
low SOTI with pasteurized white egg (PWE) during 1 year. The initial dose-
escalation phase started with a water solution (1/1000) 1  ml, doubling 
dose every 30  min until allergic symptoms appeared (threshold dose). 
Then, patients followed 2 different protocols of build-up phase: I (5 % daily 
increases at home and 30  % weekly in the hospital) vs. II (30  % weekly 
increases in the hospital) until reaching the final programmed dose of 
30 ml (3.3 g protein). At T12 tolerance was assessed in control group by a 
DBCCP with PWE. Then, patients in group C with demonstrated persistent 
egg allergy followed SOTI if parents and they want. We value adverse reac-
tions and analyse the associated factors to safety and efficacy.
Results: At T12, 3 control patients and 9 of SOTI group had with-
drawn; 2/22 (18 %) of control group passed the egg DBCCP and were 
considered to be tolerant vs 64/76 (84 %) desensitized of SOTI group 
(p  <  0.001). Then, 10 patients of control group decided follow SOTI. 
Finally, twenty-six children had followed pattern I and 60 pattern II 
of desensitization, 12 did not reach total desensitization (3.84 % pro-
tocol I vs 15.62  % protocol II); 25/26 I protocol vs 49/60 II protocol 
reached 30 ml in 70.12 ± 29.045 I vs 149.80 ± 101.365 days pattern II) 
(p < 0.001). Dropouts and adverse reactions were associated to proto-
col II, allergic asthma and atopic dermatitis (p < 0.05).
Conclusions: A daily protocol of induction with minor increases is 
more effective and safer.
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Background: There are described some different maintenance pat-
terns of SOTI, but has not been established what are better. Our aim 
was investigate the more effective, safer and reasonably easy to per-
form maintenance (daily vs. every two days) pattern.
Methods: 101 children (5–11 years of age) with persistent egg allergy 
proved by DBCCP were randomized to 25 controls to follow an egg 
free diet or 76 to follow SOTI with pasteurized white egg (PWE) during 
1 year, 38 group A (GA) and 38 group B (GB). Once children with SOTI 
reached the final programmed dose of 30 ml (3.3 g protein), followed 2 
different maintenance patterns: GA 30 ml per day and GB 30 ml every 
2 day. At 12 months (T12), and 6 months after discontinuing treatment 
and following diet with egg (T18), a DBCCP with PWE was carried out. 
We assessed the influence of maintenance patterns and the consump-
tion of egg on the efficacy and safety of SOTI.
Results: At T12 96  % patients that reached desensitization tolerated 
cooked egg; 31/32 (96.8 %) AG, 31/32 (98.8 %) BG, 8/10 (80 %) CG.
At T18, 72/74 (98.6 %) patients that reached total desensitization eat 
cooked egg without problems (93.9 % AG, 86.8 % BG and 80.0 % CG). 
At this time 54/74 (72.9 %) tolerated 3.3 g protein of PWE in the DBCCP 
(27/29 patients in AG vs 22/27 in BG and 5/8 in CG (p  <  0.01). Egg 
consumption during T12-T18 was related to PWE tolerance in DBCCP 
(p  <  0.01). There were no differences in adverse reactions of A vs B 
maintenance protocol.
Conclusion: A daily is a more effective than an every two days proto-
col of maintenance and did not related to adverse reactions.
TP25 
Determining the safety of baked egg home reintroduction 
for children with mild egg allergy
 Brenda DeWitt1, Judith Holloway2, Donald Hodge1
1Leeds Children’s Hospital, Leeds, United Kingdom; 2University of South‑
ampton, Southampton, United Kingdom  
Correspondence: Brenda DeWitt
Clinical and Translational Allergy 2016, 6(Suppl 1):TP25
Background: Egg allergy is one of the most common food allergies in 
children, but many children with IgE-mediated egg allergy can toler-
ate baked egg in their diet. The British Society of Allergy and Clinical 
Immunology (BSACI) guidelines recommend home introduction of 
baked egg for children with mild egg allergy. Home reintroduction is 
controversial, as anaphylaxis to baked egg in children with mild egg 
allergy has been observed.
Objectives: To determine whether the BSACI guidelines for home 
reintroduction of baked egg to children with mild egg allergy could be 
safely implemented at the Leeds Children’s Hospital.
Methods: A retrospective cohort case note analysis of baked egg chal-
lenges over an 18-month period was conducted. Challenge outcome, 
severity of reactions, co-morbidities and markers of atopic disease 
were assessed to see if challenge outcome could be predicted. Sub-
group analysis was performed for low and high-risk subjects.
Main Results: Case notes of 91 children who had a baked egg OFC 
were reviewed. 21 subjects had a positive challenge and 70 subjects 
had a negative challenge resulting in 77 % of the participants success-
fully completing the baked egg food challenge. Symptoms experi-
enced during a positive challenge were predominantly cutaneous and 
gastrointestinal. No subject had respiratory difficulties or anaphylaxis 
to baked egg.
Age (p  =  0.021), asthma (p  =  0.002), eczema (p  =  0.048), peanut 
allergy (p = 0.006) and total IgE (p = 0.001) were found to be signifi-
cant in relation to a positive outcome. Subgroup analysis further sup-
ported significance of peanut allergy and age in relation to positive 
challenge. High-risk subjects, identified as egg allergic with asthma 
or complex allergy, were more likely to have a positive challenge 
(p = 0.007).
Conclusions: BSACI recommendations for home introduction of 
baked egg are suggested to be safe. However, given concerns about 
safety and reported instances of anaphylaxis to baked egg, supervised 
challenged are recommended.
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Background: Allergic reactions to food allergens commonly occur 
after oral ingestion, although reactions after inhalation have also been 
reported, which causes fear in many patients.
Aim: To investigate airborne reactions for peanuts in children.
Methods: Eighty-four children were referred to the Children and 
Youth Hospital in Stockholm for an airborne peanut challenge 
2008–2014. The median age was 10 years (range 2–18). At the air-
borne peanut challenge the children were exposed to 300 g of pea-
nuts in a bowl for 30 min in a small room and observed two hours 
after.
Results: Among the 84 children only 2 (2.4  %) reacted at challenge. 
A 12 year old boy with IgE level 58 kU/L to peanut and 37 kU/L to Ara 
h 2, reacted with rhinoconjunctivitis only. A 10  year old girl with IgE 
level 700 kU/l to peanut and 115kU/l to Ara h 2, reacted with itching 
of the mouth and rhinoconjunctivitis. The boy had asthma but did not 
develop any asthmatic symptom during the challenge. Neither patient 
required any medical treatment during or after the challenge. The 
median IgE level in all children was 100 kU/l (range 0.1–3000 kU/l) to 
peanut and 55 kU/l (range 0.1–810) to Ara h 2. There was no significant 
difference for the median IgE level to peanut (379 and 100 kU/l respec-
tively) or to Ara h 2 (76 and 55 kU/l respectively) between the group 
of patients with objective allergic reactions from the group of patients 
without reactions.
Conclusion: Very few patients reacted at airborne peanut challenge 
and the reactions observed were mild. Neither an asthma diagnosis 
nor high levels of IgE to peanut or Arah2 could predict reactions. Aller-
gic reactions to airborne peanut allergens exist but are rare.
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Objective: We wished to determine the number of children currently 
in nurseries in Sheffield with food allergy, how the nurseries manage 
the children’s allergies, who provides staff training and is the training 
adequate.
Methods: We achieved this by asking 5 questions which included the 
number the children in nursery with food allergies with or without an 
adrenaline auto-injector (AAI), number of staff trained in allergy treat-
ment and use of an AAI and the training provider.
Results: Ninety-eight (98) questionnaires were returned with a return 
rate of 60 %.
Most nurseries had at least one child with a food allergy and only 13 % 
didn’t have any child with a food allergy. Just over half of nurseries had 
less than 5 children with food allergies, a quarter of nurseries had chil-
dren with an AAI and no nursery had more than 3 children with one. In 
about one-third of nurseries all staff had some form of allergy training, 
22 % had no staff trained and 8 % were unsure. Nearly three quarters 
of nurseries had some staff trained to use an AAI but 20 % had no staff 
trained and 6 % were unsure.
A variety of training providers were used with about a quarter using 
NHS or school nurses, a third using first aid or online training only, and 
another third had no training or were unsure where to access training.
Conclusions: It is essential that nursery staff are fully trained in the care 
of children with food allergies. Education plays a key role in the manage-
ment of allergies in the nursery setting. The results of our questionnaire 
show that the quality of allergy education for nurseries in Sheffield is 
inconsistent and immeasurable. Standardising the delivery of allergy 
education will help to ensure the safety of these preschool children.
TP32 
Food allergy in the first year of life
 Tânia Lopes, Cristina Madureira, Filipa Almeida, Susana Lopes, Paula 
Fonseca, Clara Vieira, Fernanda Carvalho
Centro Hospitalar do Médio Ave, Santo Tirso, Portugal  
Correspondence: Tânia Lopes
Clinical and Translational Allergy 2016, 6(Suppl 1):TP32
Introduction: Food allergy is an adverse health effect arising from a 
specific immune response to a given food. This immune response can 
be IgE-mediated or non IgE-mediated. Apart from the nine major food 
allergens, any food can trigger an allergic response.
The aim of this study is to draw attention to less frequent food allergy 
cases that forced a large degree of suspicion.
Methods: Five infants with less frequent food allergy followed in out-
patients of our Hospital were selected. The medical files were reviewed 
and the following variables were evaluated: gender, age, personal and 
family history of atopy, food allergen and allergic manifestations, spe-
cific and total IgE, skin prick test, oral food challenge and tolerance, co-
morbidities and others allergies.
Results: Five infants were selected, three males. The mean age at onset 
of symptoms was five months. The implied foods were: potato, corn, 
wheat and banana. In two cases (wheat, corn) the initial manifestation 
was anaphylaxis and in other three (potato, corn, banana) vomiting and 
prostration. In the latter group research revealed a non IgE-mediated 
allergic reaction, most likely food protein that induced enterocolitis syn-
drome. In these cases food challenge carried to confirm the diagnosis.
Conclusions: Any food can induce a severe allergic reaction such as 
anaphylaxis. In the first year of life with food diversification it is neces-
sary to be aware of any symptoms related to food intake.
Through a careful food history, physical examination and interpreta-
tion of specific tests, the food allergen can be found. In all our cases, 
the food allergen was mixed with other food which led to the perfor-
mance of several tests and food challenges for its identification.
Food avoidance is the only treatment so it’s important to alert the 
medical community that any food can induce allergy preventing delay 
in diagnosis.
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Background: Oral allergy syndrome (OAS) is a common adverse reac-
tion to the ingestion of pollen-related foods in patients with pollen-
induced rhinoconjunctivitis.
Objectives: To investigate prevalence, risk factors and clinical rel-
evance of oral allergy syndrome in a large cohort of Italian children liv-
ing in different geographic areas.
Methods: This cross-sectional study assessed 1271 children, aged 
4–18  years, with pollen-related seasonal allergic rhinoconjunctivitis, 
who were enrolled by 16 pediatric outpatient clinics throughout Italy. 
Clinical data were assessed using a standardized questionnaire. Skin 
prick tests (SPTs) with commercial pollen and food extracts as well as 
profilin-enriched extract of date palm pollen were performed. Total 
and specific IgE to major pollen and food related allergenic molecules 
as well as to the pan-allergens Phl p 12 (profilin), Bet v 1 (PR-10 pro-
tein) and Pru p 3 (lipid transfer protein) were tested by ImmunoCAP 
FEIA.
Results: Oral allergy syndrome was observed in 300 patients (23.6 %), 
with a higher frequency in Northern Italy. The most commonly 
reported foods causing OAS were kiwi (38.0 %), peach (28.3 %), apple 
(24.0 %), hazelnut (22.0 %) and peanut (20.3 %). Symptoms were asso-
ciated with female gender, at least one atopic parent, an OAS-affected 
mother and longer duration of allergic rhinoconjunctivitis. Other 
comorbidities (asthma, anaphylaxis, urticaria and/or angioedema, 
atopic dermatitis, gastrointestinal symptoms) as well as positive SPT 
to date palm profilin, were more frequently observed in children with 
OAS. More than 76 % of the patients with OAS produced specific IgE 
to at least one group of pan-allergens. Children with OAS had an 
increased risk for IgE sensitization to pan-allergens, respectively 32 % 
were sensitized to Phl p 12, 36 % to Bet v 1 and 43 % to Pru p 3.
Conclusions: Oral allergy syndrome in pollen-allergic children is more 
common than previously reported. Geographic differences were 
described with a higher frequency in Northern Italy. Children reporting 
OAS showed significantly longer rhinoconjunctivitis duration. Most of 
the patients with OAS sensitized to at least one group of pan-allergens.
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Background: The use of standardized allergen extracts in skin prick 
tests (SPT) is in general safe and allows and effective diagnosis and 
treatment of allergic disease. However, in extraction procedures used 
for nuts, defatting steps are included. As a result, water soluble pro-
teins (WPT) are present in diagnostic reagents whereas many oil body 
associated proteins (OAPs) are absent, so a number of nut-allergic 
patients could not be correctly diagnosed.
Methods: We evaluated 61 children with a convincing history of pea-
nut or walnut ingestion related symptoms. WPT and OAPs of peanut 
and walnut were determined through SPT and allergen-specific IgE 
antibodies (sIgE). An SPT was considered positive if the ratio to hista-
mine wheal was ≥0.5. We want to determine how many patients with 
WPT-SPT negative, showed an OAPs-SPT positive.
Results: Peanut: 8 patients had a WPT-SPT negative. One of them pre-
sented an OAPs-SPT positive. Walnut: 9 children with WPT-SPT nega-
tive. 55.5 % of them (5 patients) showed an OAPs-SPT positive. Patients 
with WPT-SPT negative and OAPs-SPT positive: 66.6  % had asthma 
and 100 % family history of atopy. Age of symptom’s onset: 29 months 
(median). Reactions occurred within 30 min after ingestion (1 patient 
after walnut contact). 83.3 % presented skin symptoms, 33.3 % respira-
tory and 50 % digestive symptoms. Reaction’s severity: 4 mild, 2 mod-
erate. No differences were found in reaction’s severity depending on 
OAPs sensitization. 50 % were sensitized to other nut (2 hazelnut and 
1 cashew nut). Total IgE: 78.8kU/l (median). Case with peanut allergy: 
peanut-WPT-sIgE 0.81kU/l, peanut-OAP-sIgE 0.76kU/l. Walnut-allergy 
patients: walnut-WPT-sIgE 3.8kU/l, walnut-OAP-sIgE 1kU/l.
Conclusions: The deffating procedures performed in obtaining stand-
ardized reagents may be the cause of false negative SPT in patients 
with nut allergy. We consider very important to develop adequate 
allergen extracts to improve nuts allergy diagnosis.
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Background: Allergic Proctocolitis (AP) is a disease of early infancy that 
represents the benign end of, non-IgE-mediated to Cow’s Milk Protein 
(CMP), allergy spectrum. The aim of the present study was to evaluate 
IgE sensitisation to CMP in infants with AP, its relation to the natural 
course of the disease and the presence of atopic dermatitis (AD).
Methods: We retrospectively reviewed the medical records of 73 infants 
(60.3 % boys, mean age 2.3 ± 1.84 months, 84 % exclusively breastfed), 
consistent with AP, in a 2 year period. IgE sensitisation (SPTs, CAP), his-
tory of AD and results of open food challenges (OFC) to milk were 
recorded.
Results: Positive CMP SPTs were found in 11 infants (15  %) out of 
which 45  % were also sensitised to other food proteins (egg, fish, 
wheat). Co- morbidities in the form of AD and gastroesophageal reflux 
(GER) where found in 27 and 14 % respectively. IgE sensitisation was 
significantly associated with the presence of AD (p = 0.009), whereas 
there was no relation between IgE sensitisation neither with breast-
feeding nor with GER.
During re-introduction of CMP, 2 OFC turned out positive with symp-
toms related to IgE-mediated milk allergy (2.7  %) both children had 
high levels of sensitization.
Conclusion: Although AP is classically considered a non IgE mediated 
allergy to CMP, a significant percentage of infants can present with 
IgE sensitization. The sensitization is related to AD either genuinely or 
false positively in the context of barrier dysfunction.
Allergic work-up is important before milk re-introduction in infants 
with AP as there is a small but existent risk of IgE-mediated reaction. 
Further studies are needed to clarify the role of IgE sensitization in 
determining the natural history of AP.
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Background: Poor management of food allergy in children during 
their first presentation resulted in multiple re-presentation to the 
emergency department (ED).
Aim: To evaluate the management and diagnosis of acute food 
allergic reaction presenting to a busy Pediatric ED, Dublin, Ireland. 
Methods: 221 patients presented to Temple Street Children University 
Hospital, from 1st January 2013–31st December 2013 with a diagnosis 
of allergy. Data were collected using a designated audit tool by extract-
ing information from our Electronic Patient System (Symphony).
Results: 61 patients were diagnosed with food allergy from 1st Janu-
ary 2013-31st December 2013. Average age of presentation was 
45  months old. 39.3  % of patients presented with food allergy had 
background history of eczema, asthma or allergic rhinitis. 45 (73.77 %) 
patients were newly diagnosed, while 16 (26.22  %) patients were 
known to have specific food allergy. Only 1(1.63 %) patient presented 
with an anaphylactic reaction. The rest of the patients presented with 
facial swelling (49.1  %), urticarial rash (36.0  %), facial swelling and 
rash (9.8 %), wheeze (1.6 %), bloody diarrhoea (1.6 %) and lump in a 
throat (1.6  %). Oral anti-histamines were given to 68.9  % (n =  42) of 
the patients with acute allergic reaction while 22.9 % (n = 14) received 
a combination of oral anti histamine and oral steroids. 51 (83.6  %) 
patients were kept for observation more than 2  h. Only 14 patients 
(31.1  %) were referred for a further consultation with an allergist or 
general pediatrician. One patient was referred to the dietician.
Discussion: Children with suspected with food allergy reaction in 
ED should be referred for further tests and specialised management. 
However, only a third of them were referred to allergist or general 
pediatrician. There was also lack of information-giving to parents and 
dietician follow up. Appropriate management prevents re-presenta-
tion and improved the quality of care for children with food allergy.
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Background: It has defined Oil body-associated proteins (OAPs) as 
allergenic proteins found in peanut, almond, walnut and hazelnut. The 
aim of this study is to show a pattern of IgE recognition to OAPs in a 
pediatric population with suspected allergy to these nuts.
Methods: A total of 90 children were selected. Skin prick test (SPT) and 
specific IgE, both to OAPs and water soluble proteins (WSP), to peanut, 
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almond, walnut and hazelnut were tested. OAPs and WSP were ana-
lyzed by SDS PAGE under reducing conditions. Immuno-BLOT with 
the pooled sera was done and biotiniled OAPs from almond, hazelnut, 
peanut, walnut were coupled to Streptavidin-InmunoCAP solid phase.
Results: Positive SPT OAPs: peanut 23.3  %, almond 8.9  %, walnut 
45.6  %, hazelnut 25.6  %. OAPs and WSP from the sources described 
were mainly detected around 15–25 kDa, but WSP around 50 kDa from 
almond, hazelnut, peanut and WSP around 30 to 65 kDa from walnut. 
Specific IgE from OAPs were positive for peanut 61 patients (67  %), 
almond 34 (37  %), walnut 58 (64  %) and hazelnut 47(52  %), consid-
ering IgE cut off point >0.1  KU/L.). Proteins around 15–25  kDa were 
recognized in OAPs and WSP, but WSP around 50  kDa from almond, 
hazelnut, peanut and WSP around 30–65 kDa from walnut (Fig. 9).
Conclusions: More than 50 % of children with suspected nuts allergy 
are sensitized to OAPs. Our data show that peanut and walnut, are the 
most implicated. Some of the proteins around 15–25 kDa recognized 
in OAPs, may correspond to oleosin. These potential allergenic sources 
should be included in commercial SPT reagents.
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Background: The relationship between vitamin D status and asthma 
has been the subject of several studies in the last decade. The aim of 
the present study was to investigate the relationship between serum 
vitamin D levels and indices of asthma control, asthma severity and 
quality of life in children with asthma and comorbidities.
Methods: The study included 29 children who were diagnosed with 
asthma according to the GINA criteria and who did not receive immu-
notherapy for their allergy. Serum 25-hydroxyvitamin D [25(OH) D] 
levels were measured in blood samples collected at first enrollment in 
summer and in reevaluation 6 months later. Subjects were categorized 
into deficient (<20  ng/ml), insufficient (21–30  ng/ml) and sufficient 
(>30  ng/m). The asthma control, asthma severity and quality of life 
were evaluated using the ACT (asthma control test), GINA criteria and 
PedsQL (pediatric quality of life questionnaire). Atopy biomarkers and 
spirometry were also measured for analysis.
Results: 6.9  % percent of subjects were deficient and 27.6  % insuf-
ficient in serum vitamin D at baseline. The study revealed a highly 
decrease in vitamin D levels from 38.4 ng/ml to 22.1 ng/ml in the win-
ter, (p < 0.001). None of the children had vitamin D sufficiency during 
winter. Asthma severity and asthma quality of life showed no signifi-
cant association with serum 25(OH) D levels. We found an association 
between asthma control and vitamin D levels (p = 0.0665) in summer. 
Furthermore, there is an association between 25(OH) D and severity of 
comorbit rhinitis (p = 0.03).
Conclusions: Vitamin D deficiency and insufficiency are common in 
asthmatic children. Lower serum levels are prevalent in winter sea-
son. Vitamin D status is associated with asthma control and severity of 
rhinitis.
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Introduction: Paradoxical bronchospasm describes an unexpected, 
rare and under recognised, adverse life threatening reaction of bron-
choconstriction following β2 adrenergic receptor agonist inhalation. 
Several previous case reports have been described in adults, but to our 
knowledge, none in children.
Case report: A 10-year-old boy, with a history of intermittent asthma 
and sensitisation to dust mites was admitted for an asthma exacer-
bation. Following an initial improvement, he developed a sudden 
Fig. 9 .
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unexplained severe cyanotic episode with loss of consciousness and 
bradycardia a few seconds after salbutamol neb. He was admitted to 
ICU where prednisolone, aminophylline and nebulised salbutamol 
were administered. He was discharged on a Formoterol/budeson-
ide inh. combination. One month later, during a scheduled visit, a 
spirometry test with bronchodilation was performed. A few second 
after salbutamol inhalation, a sharp drop of FEV1 was noted (from 
96 to 35 % of predicted value) while the boy developed severe res-
piratory distress and ultimately silent chest and cyanosis. He was 
transferred to ICU and treated with oxygen, nebulised ipratropium, 
systematic corticosteroids with gradual clinical improvement. The 
patient’s respiratory distress resolved over 20  min and completely 
normalised within 2 h.
Both events were attributed to paradoxical bronchospasm following 
salbutamol. In the past, when the patient had tolerated salbutamol on 
several occasions, there has always been a co-administration of sys-
tematic steroid treatment, that may have had a protective effect. It is 
also worth noting that there is a family history of similar adverse bron-
choconstrictive reactions to salbutamol.
Conclusion: Salbutamol is one of the most common and effective res-
cue bronchodilator medications used to treat asthma. Yet, paradoxical 
life threatening bronchospasm, is a well described adverse effect in 
adults. While a massive influx of eosinophils has been proposed, the 
exact mechanism remains unknown. A high index of awareness of this 
adverse effect can be life saving to the patient.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Children with co-existing physician-diagnosed asthma 
and allergic rhinoconjunctivitis (AR) have worse asthma outcomes 
than those with asthma only. Proper treatment of AR might benefit the 
lower airways. It is unclear how INCS or oral antihistamine use can con-
tribute to more controlled asthma in children with both conditions.
Methods: In a single-blind RCT with three parallel treatment groups 
the effectiveness of hay fever treatment in children was studied using 
intranasal corticosteroids or oral antihistamines. All patients had AR and 
some concomitant asthma. A daily online (AR and asthma) symptom 
diary was completed during the hay fever season. Patients with con-
comitant asthma also received an asthma specific quality of life ques-
tionnaire and recorded their asthma control. In all patients the primary 
outcome is the comparison between AR symptom scores and asthma 
symptom scores. Furthermore, in patients with concomitant asthma the 
secondary outcome is asthma control and asthma specific quality of life.
Results: General practitioners (n = 155) invited 4858 children, 419 of 
which responded positively. Finally 150 children and adolescents were 
randomized, of which 23 with concomitant asthma. Of those patients, 
70 % used any type of asthma medication in the last month. At base-
line, most patients had their asthma under control. Analyses on mean 
daily AR symptoms score and mean daily asthma symptom score will 
be performed. As well as asthma control and asthma specific quality of 
life in patients with concomitant asthma.
Conclusion: In this study we were able to provide explorative data 
on the effect of AR control on asthma symptoms and specific asthma 
outcomes. The results will provide more insight for the theory that bet-
ter controlled AR will lead to better controlled asthma. It also will give 
insight in the asthma symptoms in patients with AR but no co-existing 
physician-diagnosed asthma during the hay fever season.
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Introduction: Exercise-induced bronchoconstriction (EIB) is more 
common in athletes compared to the general population. The eucap-
nic voluntary hyperventilation test is the gold standard (IOC-MC) to 
detect EIB. We previously demonstrated the presence of epithelial 
damage and increased damage associated molecular patterns in elite 
athletes compared to control individuals [1].
Methods: Young athletes (basketball (n = 13), football (n = 20), swim-
ming (n =  12)) were recruited at the start of their elite sports career 
(12–14  years). In some of the individuals (75  %), a second or third 
EVH test after 1 and 2  years. Eight age-matched controls were also 
recruited. Eucapnic voluntary hyperventilation test was performed 
according to ATS guidelines in all subjects as previously described [2]. 
Serum Clara Cell protein 16 (CC16) was measured by ELISA as a marker 
of airway epithelial damage.
Results: At time of first evaluation, 3/13 basketball players, 4/20 foot-
ball players, 5/12 swimmers and 1/8 controls met criteria for EIB (fall 
in FEV1 >10 % after EVH test). The maximal fall in FEV1 after the EVH 
test was significantly lower in atopic compared to non-atopic athletes 
both after 1 and 2 years but not at time of first analysis. Atopic athletes 
furthermore showed significantly decreased maximal fall in FEV1 after 
one year, whereas this was unchanged in non-atopic athletes. Serum 
CC16 was significantly increased in athletes compared to controls at 
time of first analysis.
Conclusion: EIB is detected in young athletes, especially in swim-
mers. The degree of EIB response in young athletes was associated 
with atopy. Signs of epithelial damage were already found in young 
athletes at the start of their elite sports career. Follow up of the devel-
opment of EIB is advised in young athletes, performing sports at elite 
level, especially in those with atopy.
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Introduction: Asthma and obesity have a considerable impact on 
public health with obesity being a risk factor for asthma. Obesity can 
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reduce pulmonary compliance, lung volumes and the ventilation-per-
fusion relationship.
Aims and objectives: To assess the effect of higher BMI on risk for 
asthma, airway inflammation and treatment outcomes in asthmatic 
children.
Methods: Of 2000 children (healthy and asthmatics), a cohort of 475 
children with asthma was recruited. They underwent physical exami-
nation, basic anthropometric measurements, blood sampling and 
lung function tests. We clinically assessed their health status and 
treatment outcome at the point of diagnosis, after 6 months and after 
12 months.
Results: Participants were categorized into 4 groups according to BMI 
percentile: underweight, normal, overweight and obese. Increased 
body weight was more prevalent in male participants, both over-
weight and obese, than in female. Baseline levels of hsCRP were 
elevated both in overweight and obese participants, compared to 
children with normal BMI. When treatment success was assessed by 
changes in airway inflammation after 6  months, increased FeNO lev-
els were more frequent in inadequate and bad responders, compared 
to children with good response to treatment. The risk for asthma in all 
2000 children was higher in overweight participants compared to chil-
dren with normal BMI, but not in obese.
Conclusions: The effect of obesity appears to be insufficient in the 
development of asthma alone. Increased BMI (overweight) increases 
the risk for asthma and obesity rather increases the level of airway and 
systemic inflammation and potentially affects the level of disease con-
trol and response to asthma treatment.
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Background: Despite all recommendations supporting the use of 
pressurised metered dose inhalers with spacers (pMDI + S) for acute 
asthma treatment, there is still a considerable lack of its use of in Por-
tugal not only within the emergency departments (ED) but also the 
home setting.
Objectives: The aim of this study was to evaluate the impact of the Opti-
misation of Inhaler Therapy in Children Project (OITCP) upon the use of 
pMDI + S at the ED and at home, considering the perspectives of children 
with asthma/wheezing, their parents/caregivers and health professionals.
Methods: Parents/caregivers (n  =  325) and health professionals 
(n =  220) included in the OITCP were asked to complete question-
naires. Data related to respiratory/asthma control, device prescriptions 
and costs associated with this project were also analysed.
Results: Ninety-two (28  %) caregivers and 163 (74  %) health profes-
sionals responded to the questionnaires. Most parents/caregivers rec-
ognise the benefits of pMDI + S for asthma/wheezing treatment and 
more than 80 % expressed a pReference for their use either at home or 
the ED. Similarly, most healthcare professionals recognise the advan-
tages of these devices and the merits of the OITCP in changing their 
opinions and attitudes. Nearly 55  % of children surveyed had their 
asthma controlled, 4  % were hospitalised due to asthma/wheezing 
and 24 % had at least one hospital ED visit in the previous 12 months. 
Accounting for costs, the OITCP led to substantial savings to ULSM 
(over 30,000€) at no additional expense for families.
Conclusions: This study showed that the OITCP had a positive impact 
on both parents/caregivers and health professionals and was success-
ful in encouraging use of pMDI + S at ED and at home.
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Background: True beta-lactam antibiotic hypersensitivity (BLAH) is 
very rare in childhood. The predictive values of skin and in  vitro test 
are unknown. Oral provocation tests (OPT) are generally safely per-
formed. We report our experience in the evaluation of children with 
suspected BLAH.
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Methods: We reviewed patients attended for suspected BLAH in the 
allied pediatric allergy units of 6 close hospitals from 2010 to 2014. We 
collected data related to patients, past episodes, allergic workup and 
results. We analyzed the trends of in vitro and skin tests by means of 
Pearson’s correlation coefficient. We compared the characteristics of 
patients diagnosed of BLAH with those with a negative OPT by means 
of Fisher’s exact test.
Results: 668 patients. From 2010 to 2014, specific IgE test orders 
decreased from 45 to 27 % of patients (p < 0.001) and skin tests from 
52 to 41 % (p = 0.003). OPT were performed in 89 % of patients (594 
patients). BLAH was diagnosed in 27 patients (4 %): 26 by OPT results 
and 1 with a history of anaphylaxis and positive specific IgE and skin 
tests. BLAH was ruled out in 86 % of patients and 10 % did not con-
clude the study. All 26 patients with a positive OPT showed early or 
delayed skin signs (exanthema, urticaria, angioedema…) but none 
had severe or anaphylactic reactions. BLAH was more commonly diag-
nosed in patients with a history of more than one episode (9 vs. 3 %, 
P =  0.024), with a history of anaphylaxis (40 vs. 4  %, P =  0.017) and 
with cephalosporins (9 vs. 4 %, P = 0.086).
Conclusions: OPT is an easy and safe procedure to definitively diag-
nose or rule out BLAH in children. The role of skin and in vitro tests in 
pediatric patients is been questioned and needs clarification.
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The incidence of severe allergic reactions after vaccination ranges 
from 0.5 to 1/100.000 cases.
A 12-month old infant was referred to our Consult after an anaphy-
laxis (urticaria and wheezing) appearing 1 h after receiving simultane-
ously the 1st dose of MMR (mumps, measles and rubella), 3rd dose of 
meningococcal C and the 4th dose of 13-valent pneumococcal vac-
cines (PCV13).
Intradermal tests showed positive results with PCV13. Meningo-
coccal and MMR tested negative. PCV13 comprises 13 capsular 
Streptococcus pneumoniae polysaccharide serotypes conjugated 
to a non-toxic diphtheria toxin mutant (cross-reactive material 
[CRM(197)]). Current vaccination schedules recommend 4 doses of 
DTP (Diphtheria-tetanus toxoid-pertussis) within the first 2 years and 
a booster dose at 6. Therefore, skin tests were performed with 2 DTP 
variants, authorized for children of different ages: DTP1 (Composi-
tion: at least 30 international units [IU] of diphtheria, 40 IU of tetanus, 
and 25mcg of pertussis toxoids; authorized for infants) and DTP2 
(Composition: at least 2 IU of diphtheria, 20 IU of tetanus, plus 8mcg 
of pertussis toxoids; authorized for children older than 4 years) with 
positive results for both.
Basophil activation tests (BAT) performed with PCV13, 23-valent pneu-
mococcal vaccine and both DTP vaccines showed positive results with 
PCV13 and both DTP vaccines. Two controls tested negative.
Further tetanus and pertussis doses have been suspended since there 
are no mono-component vaccines available in Spain. Reevaluation 
of DTP sensitization has been offered in a few years since there have 
been reports of DTP hypersensitivity resolution.
This is the first report of anaphylaxis after PCV13 administration and 
the first time its carrier protein, CRM (197), is identified as its cause, 
demonstrated by BAT and skin tests results.
Carrier proteins are used to enhance infants’ immune response against 
capsulated bacteria. They should be considered in the assessment of 
hypersensitivity reactions to combined and/or conjugated vaccines.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Group B streptococcus (GBS) is the leading infectious 
cause of neonatal morbidity and mortality in the Unites States. Intra-
partum antibiotic delivery to GBS positive mothers is performed for 
prevention of neonatal infection with penicillin being the drug of 
choice. Previous studies have noted an increased risk of atopic dis-
eases associated with intrapartum antibiotic exposure. This study 
sought to determine if intrapartum exposure to penicillin for GBS 
increased the likelihood of penicillin allergy in children.
Methods: Retrospective, chart review was performed on patients from 
a birth cohort. Birth cohort included children born in 2007 at a local 
tertiary care hospital with local addresses. GBS status of mother, intra-
partum antibiotic exposure, delivery mode and birth order was col-
lected and analyzed.
Results: We identified 927 children with 812 included in the cohort. 
Eighty (10  %) of the children had a reported penicillin allergy, most 
were Caucasian (79 %) males (61 %). Intrapartum exposure to penicil-
lin (OR 0.84, CI 0.45–1.57, p = 0.59), amoxicillin or ampicillin (OR 0.22, 
CI 0.01–2.71, p =  0.29) did not increase the risk of penicillin allergy 
in children. The timing of antibiotic therapy (OR 1.00, CI 0.53–1.88, 
p =  0.99), GBS status of mother, mode of delivery or birth order did 
not affect the risk of penicillin allergy in the offspring.
Discussion: To our knowledge, this is the first study to evaluate intra-
partum exposure to penicillin for GBS treatment and the subsequent 
development of penicillin allergy in the child. However, our study was 
limited as it was a retrospective, chart review of a birth cohort from a 
tertiary care facility with children lost to follow up.
Conclusions: In contrast to other atopic diseases, intrapartum antibiotic 
exposure as well as mode of delivery is not associated with the develop-
ment of penicillin allergy in children. Parents and obstetricians should 
be reassured when using Penicillin for prevention of neonatal GBS.
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Background: The aim of our study was to evaluate the diagnostic 
work-up of children referred to a general hospital due to suspected 
drug hypersensitivity reactions (DHR), with the emphasis on children 
with immediate or severe non-immediate DHR, who were also referred 
to the University children’s hospital Ljubljana.
Methods: We retrospectively analysed medical documentation of 
169 children who were referred to the General Hospital Izola due to 
a suspected DHR from 2009 to 2014. 125 children (73.9  %) had mild 
DHR due to which oral provocation test (OPT) were planned/made. 
All OPT in this group were negative except one. For further analysis 
were selected 44 children (16 female, 28 male, aged 1–9 years, mean 
2.5 years) with clinical manifestation suspicious of immediate or severe 
non-immediate DHR that were further evaluated at the University Chil-
dren’s Hospital Ljubljana.
Results: 17/44 (39 %) children were treated with penicillin G, one (2 %) 
with penicillin V, 17 (39 %) with amoxicillin, five (11 %) with amoxicillin 
and clavulanic acid, two with cefuroxime (5 %) and one (2 %) with cef-
triaxone. Clinical manifestations of DHR were immediate urticaria (21), 
immediate urticaria with angioedema (seven), anaphylaxis (three), 
maculopapular exanthema in first two hours (three), maculopapular 
exanthema with additional alert signs (four), vasculitis (four), fixed 
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drug erythema (one) and erythema multiforme (one). Beta lactam 
allergy was confirmed in seven children (4 penicillin G, 3 amoxicil-
lin with clavulanic acid) by skin testing (ST). Five children were solely 
allergic to penicillin and two also to cephalosporins and meropenem. 
All children had negative specific IgE to betalactams, two children had 
also positive basophil activation test results. ST was inconclusive in 
two patients due to collapse and dermographism. Eight patients have 
not come for further investigations yet.
Conclusion: Drug hypersensitivity was confirmed in 4.7 % of referred 
children, more often when immediate or severe non-immediate DHR 
were suspected (in 15.9 %).
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Introduction: All drugs have the potential to cause adverse reactions, 
although not all are allergic reactions. Drug allergy can be defined as 
any reaction caused by a drug, clinically compatible with an immu-
nological mechanism. This study aims to understand the pediatric 
population with suspected drug allergy, followed in a specialized 
consultation.
Methods: This is an observational, cross-sectional, descriptive study. 
The study included children followed in a pediatric drug allergy con-
sultation, from January 2012 to April 2015. The collection of demo-
graphic, clinical and laboratory data was obtained from the clinical 
records.
Results: In the studied period, 83 children were followed, of which 
57 (69  %) were submitted to the oral provocation test (OPT) and 26 
(31 %) are currently on a waiting list. In total, 80 OPT were performed, 
of which 26  % were re-provocations and 7  % were for alternative 
drugs. Drug allergy was confirmed in 8 patients. Even though the most 
suspected drugs were amoxicillin (75 %) and ibuprofen (18 %), only 4 
children showed a positive OPT to amoxicillin (7 %) and 2 to ibupro-
fen (4  %). The most common clinical manifestations were cutaneous 
(urticaria and/or angioedema), in 91  % of children. In 2 patients the 
reaction was understood as being an anaphylactic reaction, but only 
in one of them the allergy was confirmed. Half of the patients with 
confirmed drug allergy were tested to an alternative drug, all of which 
were negative.
Conclusion: Our results are consistent with other studies in which 
penicillin appears as the most frequently identified drug with con-
firmed allergy in only 7 % of the patients. Studies show that only 10 % 
of the population believed to be allergic to penicillin is truly allergic. 
Children with unconfirmed allergies risk greater exposure to broad-
spectrum antibiotics, with all its implications, as well as sub-optimal 
therapy and should be promptly oriented to a specialized consultation 
for diagnosis.
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Background: Serious adverse events are unusual during surgeries. 
Allergic reactions are among the major factors that contribute to peri-
operative morbidity and mortality. The literature on perioperative ana-
phylaxis is scarce, especially in the pediatric population.
Aim: To characterize pediatric patients with adverse allergic periopera-
tive outcomes and to examine the most commonly involved agents.
Methods: We reviewed the medical records of patients ≤18-years-old 
with a perioperative anaphylaxis history referred to our drug allergy 
unit, between January 2009 and April 2015. The culprit drugs were 
assessed by positivity of intradermal skin tests (IDT) with nonirritant 
concentrations, in accordance to the published guidelines. All patients 
were screened for latex allergy by skin prick test (SPT) with commercial 
extract and specific IgE (sIgE) assay.
Results: Data of 10 patients (6 male, median age [minimum–maxi-
mum] 10 [1–17] were collected; 7 were atopic (6 allergic rhinitis; 4 
asthma and 1 atopic eczema). In 2 patients, the SPT and the sIgE to 
latex were positive; nonetheless, in these cases, we also performed 
IDT to the used drugs which were all negative. Two patients had a 
positive IDT with a 1/100 dilution of cis-atracurium; 1 to neostig-
mine (1/100); 1 to fentanyl (1/100); 1 to ropivacaine (1/1000); 1 to 
midazolam (1/10) and 1 cefazolin (1/10). In 1 patient, latex screening 
and all the IDT to drugs involved during the surgery were negative 
and so it wasn’t possible to relate the reaction to any of the drugs 
used.
Comments: Perioperative anaphylaxis is becoming more common 
and thus recognition and evaluation by anesthesiologists in concert 
with allergists is of paramount importance. As other studies suggest, 
the presence of allergic disease seems to be positively associated to 
perioperative anaphylaxis. According to previous studies, neuromus-
cular blocking agents and latex were the main causes of IgE-mediated 
perioperative reactions. In this study, other pharmacologic groups 
were implicated including a local anesthetic (ropivacaine), which is 
rarely described as a cause of anaphylaxis.
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Background: Non-steroidal anti-inflammatory drugs (NSAIDs) are a 
common cause of hypersensitivity (HS) reactions and they are widely 
prescribed for paediatric use. Few studies have specifically addressed 
NSAID-HS in this age group.
Aim: To review cases of children and adolescents with suspected 
NSAID-HS.
Methods: Medical records’ review of 37 patients under 18 years of age, 
studied in the Drug Allergy Division of our Department for suspected 
NSAID-HS, during a 3 year period. Reactions were classified according 
to Kowalsky et al. (2013).
Results: Patients’ median age was 11.0  years (interquartile range 
6.5–15.5; min–max 1–17) with a similar gender distribution (54.1  % 
female); 43.2 % were atopic (81.3 % with single NSAIDs reactivity).
Reactions to a single NSAID were reported by 30 (81.1 %) of all patients 
(30.0  % with more than one episode), and ibuprofen was the most 
common incriminated drug (83.3 %). In this group, the reactions were 
acute (until 24  h) in 83.3  %, the most frequent clinical manifestation 
was urticaria and/or angioedema (76.7 %) and 10 % presented anaphy-
laxis; diagnostic oral provocation test (OPT) was performed in 76.7 %.
Of the 7 (18.9  %) patients with reactions to multiple NSAIDs, 
71.4  % presented with urticaria and/or angioedema and none with 
anaphylaxis.
In the total sample, NSAID-HS was confirmed in 4 of the 26 (15.4  %) 
patients that underwent diagnostic OPT:
  •  three with acute urticaria to ibuprofen (2 reacted with the total 
cumulative dose; all tolerated paracetamol and one performed 
safely OPT with the alternative drug nimesulide);
  •  one with acute urticaria to paracetamol (elicited by the age-
recommended full dose; the child had a reported tolerance to 
ibuprofen and no alternative drug was tested);
 •  all reactions were managed in an outpatient basis, with antihis-
tamine/corticosteroid treatment.
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All 14 patients that performed OPT with an alternative NSAID (85.7 % 
with drugs more selectively inhibiting COX-2) tolerated the tested 
drug, including the 3 cases of anaphylaxis (to ibuprofen).
Discussion: NSAID-HS was confirmed only in 15.4 % of those who per-
formed diagnostic OPT. Alternative drugs were safely tested, even in 
patients with more severe index reaction.
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Background: Perioperative anaphylactic reactions are immediate, 
potentially life-threatening, hypersensitive reactions. Recognition by 
anesthesiologists and allergic study by allergists is of outmost impor-
tance. The most frequent causing agents are neuromuscular blocking 
agents (NMBAs), latex and antibiotics with latex being the first cause in 
pediatric age.
Aim: The authors describe two cases of anaphylaxis to ropivacaine and 
rocuronium in a 10 and 11 years old, both males, and discuss in vivo 
and in vitro diagnosis work up.
Case 1: Ten year old boy, submitted to a circumcision surgery, with 
immediate symptoms and signs of severe anaphylaxis coincident with 
ropivacaine administration. Tryptase level by the time of reaction was 
15.60 mcg/l (<11 mcg/l).
Latex allergy was first excluded by negative skin prick tests (SPT) and 
specific IgE (sIgE). Intradermal test (IDT) with ropivacaine 2 mg/ml at a 
dilution of 1/1000 was clearly positive. Tests to lidocaine, without vaso-
constrictor were doubtful.
As both drugs were from the same local anesthetic group, a subcuta-
neous provocation test with procaine was performed in the presence 
of an anesthesiologist, without any reaction.
Case 2: Eleven year old boy reacted with generalized urticaria and 
bronchospasm during an appendicectomy. Latex allergy was excluded 
as in the previous case.
Because many drugs were used (propofol, fentanyl, tramadol and 
rocuronium), SPT and IDT tests were performed to each one, according 
to the guidelines, with a clear positivity to rocuronium. As alternatives 
to the culprit, we tested vecuronium and suxamethonium with nega-
tive results.
The authors discuss that specific IgE, basophil activation tests (BAT) 
to the culprit drugs or passive sensitization by histamine release test 
(HRT) are expected to be performed to confirm the mechanism of the 
reaction.
Comments: Any suspected hypersensitive reaction during anesthe-
sia must be extensively investigated by pre and post-operative tests, 
independent of patient’s age.
The authors discuss a complete in vivo and in vitro diagnosis work up 
in pediatric age especially in young children where the IDT cannot be 
feasible.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Objectives: Many children in the UK are suspected to be penicil-
lin allergic. Having the incorrect label of a penicillin allergy can have 
implications for life long health care. As per the BSACI beta lactam 
allergy guidelines, it is recommended that drug provocation test-
ing (DPT) be used as a first line diagnostic procedure in children with 
mild adverse reactions. Often a child will return to the unit for further 
DPT to establish a safe alternative, to treat further infections. This case 
study discusses the importance of correct identification and DPT of 
suspected drugs to arrive at an accurate diagnosis.
Methods: A 3 year old boy presented to the allergy outpatients in Jan 
2014 with a history of multiple food allergies. During the allergy con-
sultation it was noted he had reacted to Amoxicillin syrup with imme-
diate and widespread itching whilst being treated for an ear infection. 
He had previously tolerated oral Amoxicillin for treatment of a chest 
infection. The patient was switched to oral Azithromycin by his GP 
and reacted with an urticarial rash and eye swelling. Incremental, oral 
DPT to Amoxicillin and Azithromycin were planned with further DPT if 
needed to establish a suitable antibiotic alternative.
Results: The patient had a positive oral DPT to Amoxicillin syrup and 
Azithromycin syrup resulting in immediate urticaria and delayed 
eczema flare. An oral cefuroxime axetil syrup DPT resulted in a delayed 
eczema flare. A reaction to an excipient of the syrup preparations was 
suspected. After involvement from the medicines information team, 
the patient had a successful DPT to Amoxicillin tablets in July 2014 
which did not contain any of the suspected excipients.
Conclusions: Children who experience allergic reactions to multiple 
types of antibiotics require consideration of whether an excipient of 
the antibiotics is the cause.
Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Objectives: Hypersensitivity reactions to parenteral administered antibi-
otics (HRPA) are a substantial problem in managing pulmonary disease 
in Cystic Fibrosis (CF), especially in advanced CF. This group of patients 
requires a life long antibiotic treatment with extremely high cumula-
tive doses compared to other patients. In our daily routine we observed 
a growing number of hypersensitivities. Therefore we conducted this 
observational study to assess HRPA’s impact on the daily clinical work 
with CF, as well as its nature, frequency and predisposing risk factors.
Methods: By reviewing medical records and conducting interviews, 
age, sex, FEV1, ΔF508genotype, onset and duration of pseudomonal 
colonisation, allergy history (including IgE serum levels, past ABPA 
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and results of screening tests for inhalative aeroallergens), parenteral 
antibiotic exposure and HRPA (timing, symptoms and treatment) were 
recorded. Included were all pediatric and adult patients at our centre 
with >3 intravenous antibiotic treatment courses.
Results: Of 100 patients included in the study, 60 had ≥1 HRPA. Over-
all, 3205 antibiotic courses with 185 HRPA were ascertained. 15  % of 
HRPA met the criteria for anaphylaxis. Symptoms were mostly dermal 
(53 %). 81 % of all and 80 % of anaphylactic HRPA occurred during days 
14. Approximately 10  % of all treatment courses with cefepime and 
piperacillin/tazobactam caused HRPA. The number of years with pseu-
domonal colonisation and the cumulative annual exposure of the given 
antibiotic were significant risk factors for HRPA in our patient cohort.
Conclusions: Our results demonstrate that HRPA with a prevalence of 
60 % are very relevant. During days 14of antibiotic Treatment courses 
patients might be at elevated risk to experience HRPA. HRPA appear 
to be drug specific and to be dependent on cumulative annual drug 
exposure of the given drug. High cumulative dose of the same anti-
biotic over a short period of time may lead to a higher risk of HRPA 
than the same dose over a longer period of time. Is this an argument 
to change the therapeutic regimen more often? Diagnostic algorithms 
for this CF specific problem should be developed further. Besides 
recent publications about drug specific lymphocytes in patients with 
CF, we believe that further elucidation of HRPA’s immunological mech-
anisms is needed.
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Objectives: Hypersensitivity reactions to parenteral antibiotics (HRPA) are 
a major problem in the management of patients with CF. These patients 
require lifelong treatment with antibiotics in high cumulative doses. 
Allergy testing methods such as specific IgE in serum are not available for 
antipseudomonal antibiotics. Skin tests seem to have limited value. This 
pilot study was carried out to assess the diagnostic value of in vitro allergy 
testing methods for HRPA and the underlying immune reactions.
Methods: Patients with CF and a documented hypersensitivity to 
≥1 parenteral antibiotic were recruited. The suggested antibiotic 
had never been prescribed after the initial reaction. For a total of 13 
patients, basophil activation tests (BAT) and lymphocyte transforma-
tion tests (LTT) for each suspected antibiotic were performed (pipera-
cillin/tazobactam (pip/taz), ceftazidime, meropenem and others). BAT 
with an activation index (AI) of >2.5 and LTT with a stimulation index 
(SI) >2 were considered positive.
Results: Two positive BAT (each for pip/taz, AI  =  2.7 and 3.1) and 
seven positive LTT in five patients were ascertained (pip/taz SI = 76.6 
and 2.2; cefepime SI =  10.5, 3.0 and 2.4; sulbactam SI =  8.7; ceftazi-
dime SI = 2.1).
Conclusions: The pilot study showed mostly for LTT positive results. 
This may indicate a T-cellular genesis of HRPA that is consistent with 
the lack of association to atopy. These results could be an argument for 
this method as a diagnostic tool for HRPA. The sample size was small 
though and clinical trials with re-exponation of the negative tested 
patients are pending. Therefore, no clear recommendations can be 
applied for the routine clinical setting.
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Introduction: Children are often labeled as allergic to antibiotics with-
out good evidence. We have previously shown that many children will 
pass an antibiotic challenge under such circumstances. Consequently 
we altered the protocol used during an antibiotic challenge to reduce 
the doses given and time needed. The hope being that this will even-
tually be used in primary care.
Method: Children were initially seen in general allergy clinic with 
either an urticarial rash or maculopapular rash developing during a 
treatment course of oral antibiotics. All of these children had negative 
SPT and RAST to the antibiotic of concern or by default Amoxicillin. 
Sixty-one children underwent the new protocol for antibiotic chal-
lenge from January to June 2015. This comprised three doses given 
20  min apart at 1/10th dose, 4/5th dose and half for the final dose. 
Children where then observed for an hour and discharged if well to 
complete a 5 day course of antibiotics at home.
Results: No child failed the escalating challenge protocol in hospi-
tal however three developed rashes during the continuation phase 
at home. The antibiotic challenged was either Amoxicillin (27), or 
Penicillin (11), Macrolide (14), Cephalosporins (5) or other (4). All of 
the rashes developed in children challenged to either Amoxicillin or 
Co-Amoxiclav.
Conclusion: Oral antibiotic challenges are safe in children even using 
a shorter protocol. In theory reducing the protocol further and re-eval-
uating may allow more children access to the service, thus enabling 
de-labelling. We may even be able to perform challenges without 
allergy tests having been done. Public Health relies on rationale use of 
antibiotics and the current state of labelling antibiotic allergy in chil-
dren is irrational.
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Introduction: Hypersensitivity reactions to vancomycin can occur 
through two different mechanisms. Although both reactions involve 
mast cell activation, vancomycin-induced anaphylactic reactions are 
mediated by immunoglobulin E (IgE), whereas anaphylactoid reac-
tions (i.e. Red Man Syndrome) are not. In some infections, vancomycin 
is the antibiotic of choice. Therefore, in IgE mediated reactions, vanco-
mycin desensitization can be a reasonable option and be performed 
successfully in most cases.
Case report: A 5-year-old boy, with congenital hydrocephalus and 
double carrier ventricular peritoneal shunt valve, was admitted to 
our hospital for valve dysfunction and infection. The cerebrospi-
nal fluid culture was positive for Staphylococcus epidermidis. The 
patient required valve cystoperitoneal replacement. Few minutes 
before the surgery, vancomycin was administered intravenously. 
Immediately, he suffered generalized urticaria, pruritus, tachycardia 
(170 beats/min), hypotension (62/24 mmHg) and severe respiratory 
distress. Patient was treated with antihistamines, corticoesteroids 
and adrenaline with clinical improvement. Serum tryptase was 
measured at 1, 2 and 6  h following onset of the episode and at 
basal conditions. As the patient had experienced an anaphylactic 
shock due to vancomycin, linezolid treatment was started without 
clinical improvement. For this reason, a vancomycin desensitization 
protocol was designed. Dosing was administered at intervals of one 
hour, in the following increasing doses: 0.05, 0.5, 1, 5, 10, 20, 30, 
50, 60 and 80  mg. Premedication with dexchlorpheniramine was 
administered.
Allergy test: Laboratory data: Total serum IgE 80.2 KU/L. Tryptase 
concentration at 1 h: 19.6 mcg/l, at 2 h: 15.2 mcg/l, at 6 h: 10.7 mcg/l. 
Baseline tryptase 3.39 mcg/l. Skin test (prick and intradermal) to van-
comycin were negative.
Conclusions: We report a new successful vancomycin desensitization 
protocol in a pediatric patient who experienced an anaphylactic shock. 
Vancomycin desensitization should be considered for severe reactions 
to vancomycin when substitution for another antibiotic is not feasible.
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Consent to publish
Written informed consent for publication of this clinical details and/or 
clinical images was obtained from the patient/parent/guardian/rela-
tive of the patient. A copy of the consent form is available for review 
by the Editor of this journal.
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Background: Recent evidences showed an association between FLG 
gene mutations and other allergic diseases in children with atopic der-
matitis (AD) [1–3]. The frequency of mutations varies widely among 
different population [4].
Methods: We enrolled Italian children suffering from AD aged 
6  months–18  years. Patients underwent clinical evaluation, skin prick 
test (SPT) and blood sampling for determination of total and specific IgE 
and to analyse FLG gene. Purified PCR products were sequenced on both 
strands using a Big Dye Terminator v1.1 Cycle Sequencing kit (Applied Bio-
systems) and run on an ABI 3730 Genetic Analyzer (Applied Biosystem).
Results: 223 patients with AD were recruited from June 2011 to June 
2014. 57.8 % of them were males, the mean age was 6.1 years. The prev-
alence of asthma was 26.5 %, rhinoconjunctivitis (RC) 48.4 % and food 
allergy (FA) 42.0 %. We detected heterozygous FLG gene null mutations 
in 16 patients (7.2 %): R501X in 14 cases, 2282del4 in 2 cases. By com-
paring FLG null carriers vs. wild type patients, we didn’t found differ-
ences in gender (males: 43.8 vs. 58.9  %), family history of atopy (68.8 
vs. 58.5 %), severity of AD (mild 37.5 vs. 71 %, moderate 50 vs. 22.7 %, 
severe 12.5 vs. 6.3  %). The mean age at onset of AD was 3.9  months 
among FLG null carriers and 12.7  months among wild type patients 
(p = 0.015), without differences in the remission rate (37.5 vs. 37.9 %). 
The prevalence of asthma (12.5 vs. 37.1  %) and RC (50 vs. 47.3  %) 
didn’t differ between FLG null carriers and wild type FLG patients, while 
the prevalence of FA was higher in FLG null carriers (75 vs. 39.1  %, 
p = 0.007). Total IgE levels and IgE sensitization to airborne allergens 
wasn’t different among the two groups, while IgE sensitization to food 
allergens was higher in FLG null carriers (75 vs. 42.5 %, p = 0.017).
Conclusions: Our data confirmed the low frequency of FLG mutation 
among Italian children with AD. The presence of FLG null mutations 
was related to an earlier age at onset of AD, to a higher prevalence of 
IgE sensitization to food allergens and FA.
References
1. Palmer CAN, et al. Nat Genet. 2006.
2. Venkataraman D, et al. JACI. 2014.
3. Brough HA, et al. JACI 2014.
4. Cascella, et al. J Invest Dermatol 2011.
TP73
WITHDRAWN
Clinical and Translational Allergy 2016, 6(Suppl 1):TP73
TP74 
Urticaria in children: clinical and epidemiological features
 Katerina Neskorodova, Asya Kudryavtseva
I.M. Sechenov First Moscow State Medical University, Moscow, Russia  
Correspondence: Katerina Neskorodova
Clinical and Translational Allergy 2016, 6(Suppl 1):TP74
Background: Ubiquitous growth of allergic diseases and a limited 
number of publications dedicated to epidemiology of urticaria in chil-
dren determine significance of the study.
Objective: To assess clinical and epidemiological features of acute and 
chronic urticaria in pediatric population.
Materials and methods: 63 children aged 0–16 years with clinical 
signs of urticaria were included in an observational, cross-sectional 
study. 45 of them had acute, 18 had chronic urticaria. M:F ratio was 1:1.
Results: The mean age at diagnosis of acute urticaria was 6.2 years. Iso-
lated appearance of wheals was observed in 27 %, angioedema in 13 %, 
combination of two symptoms -in 60 %. Causative factors were identi-
fied in 69 % of cases. Common triggers were: foods (42 %), medication 
use (22.6 %), exposure to pollen (16 %), insect stings (9.7 %), cosmetics 
(9.7 %). 47 % of patients have a history of allergic diseases. Laboratory 
studies revealed high IgE in 65  % and high eosinophil count in 18  %. 
Most patients were treated with sAH (55.6 %), others with nsAH. 42 % of 
patients received at least one injection of corticosteroids.
The mean age at diagnosis of chronic urticaria was 8.7 years, the 
mean disease duration was 17 mths (max 48). Patients were classified 
as having chronic spontaneous urticaria (94 %) and physical urticaria 
(6 %). Isolated appearance of wheals was observed in 53 %, together 
with angioedema—in 47 %. Causative factors were identified in 28 % 
of cases and included: helminthic infection, foods and insect stings. 
Common comorbidities were: allergic diseases (41 %), H. pylori infec-
tion (35  %), thyroiditis (16.6  %). Exacerbation with emotional stress 
was reported by 17.6  % of patients. High IgE level was detected in 
47  %, allergen-specific IgE tests were positive in 25  %. In 82.3  % for 
treatment were used nsAH. The efficiency of standard doses was 
83 %. In 27.8 % of cases patients received short parenteral courses of 
corticosteroids.
Conclusions: The mean age of patients with chronic urticaria is higher, 
than with acute urticaria (p < 0.05). The etiologic agent is more likely 
to be identified in acute urticaria. In most cases chronic urticaria can 
be effective treated with standard doses of nsAH.
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Objective: Acute urticaria (AU) is a frequent complaint in Pediatric 
Emergency Departments (PED). We searched for clinical data during 
the acute episode that may enable us to inform the parents about its 
origin, assessing a cohort of children attended at our PED and referred 
to Allergy Consults.
Methods: Retrospective review of PED charts of children attended 
for AU at both the PED and Allergy Consults (2009–2013). According 
to the allergy work-up they were included as allergy-induced urticaria 
(AIU) or non-allergic urticaria (NAU). We analysed: symptoms before 
urticaria onset, identification of triggers in the chart, atopy, fever and 
management of the episode (Chi Square). Patients’ ages and duration 
of symptoms at PED admission were also assessed (Mann–Whitney).
Results: We reviewed 44 charts (AIU Group: 22 patients; NAU Group: 
22). There were significant differences in the age of the patients 
(median age in AIU Group: 2.2 years (3 months–14 years) vs. 6.5 years 
(1–15) in NAU Group; p = 0.035), previous atopic diseases (45.5 % in 
AIU vs. 5  % in NAU; P =  0.002), symptoms before the urticaria onset 
(27.2  % in AIU vs. 65.6  % in NAU; p =  0.013) and in the identifica-
tion of triggers (foods in 81.8 % and drugs in 18.2 % of AIU vs. none 
in 71.3  % of NAU cases). No differences were detected in: coexisting 
fever (27.3 % in both; p = 0.632), pharmacological treatment: 81.8 % 
in AIU vs. 72.7 % in NAU (p = 0.951) or the duration of symptoms at 
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PED arrival (median of 2 h (1–3 h) in AIU Group vs. 6 h (1–72 h) in NAU 
Group (p = 0.316).
Conclusions: Patients’ age, the identification of specific triggers in 
the anamnesis, presence of symptoms previous to the AU onset and 
coexisting atopy may be useful data in predicting whether an AU may 
be allergy related. However, the presence of fever and the duration of 
symptoms at PED arrival were not useful in our sample.
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